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Abstract 
In this research the mechanisms by which Hathewaya (Clostridia) histolytica 
collagenases are secreted and work together to degrade collagens are investigated. While H. 
histolytica collagenases Col G and Col H have similar multi-domain structures the difference in 
number of and orientation of the domains hint that the two target different regions in collagen. 
Study small angle x-ray scattering (SAXS) was used to give a low-resolution envelope of full-
length Col G and Col H and Col G/Col H non-catalytic domains bound to a collagen-like peptide 
(mini-collagen). SAXS derived envelopes along with structural information was used to tease out 
the mechanisms by which Col G and Col H degrade collagen. Structures of collagenase:mini-
collagen complexes along with acid solubilized collagen hydrolysis studies was used to 
hypothesis a mechanism of synergy between Col G and Col H. Using all information from this 
research Col G to Col H ratio of 3:1 was proposed for optimal isolation pancreatic islets. 
For V. alginolyticus, the VarS/VarA two-component systems is responsible for regulating 
the expression of collagenase. All two-component systems consist of a extracellular sensing 
domain, a catalytic and ATP binding (CA) domain, a dimerization and histidine phosphor-
transfer (dHp) domain and a response regulator. For REC domain, itasser homology model and 
limited proteolysis revealed a two-domain structure connected by a flexible linker. Based on B-
factor of linker truncation may be necessary for crystallization of the domain. In this study we 
initially sought to gain structural information on VarS, a sensor histidine kinase from VarS/VarA 
two-component system in V. aglinolyticus. It was discovered that the protein forms soluble 
aggregates in the absence of reducing agent. Trypsin digestion coupled with mass spectrometry 
revealed the existence of Cys883/Cys892 disulfide bridge. Homology modeling and DALI server 
was used to show that Cys892 is fairly conserved in HPT domains across species. qRT-PCR 
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showed that in the presence of menadione VarS induced transcription of sRNA2 was slightly 
downregulated. This study speculates that Cys883/Cys892 disulfide bond stops collagenase 
expression in the presence of oxidative stress allowing V. alginoltyicus to turn on necessary 
repair pathways. 
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Chapter 1: Introduction 
Hathewaya histolytica (Clostridium histolyticum) is a gram-positive bacterium found in 
soil and feces that is known to cause gas gangrene (see figure 1A). Hathewaya histolytica’s 
pathogenicity is due to the different exotoxins (alpha, beta, gamma, delta, epsilon) it secretes [1]. 
The β-exotoxin of this bacteria consist of two enzymes, Col G and Col H, which seek out and 
degrade collagen fibers located in extracellular space. Destruction of collagen exposes new 
nutrient sources for the invading bacteria and helps spread the infection [2]. Col G and Col H 
have similar multi-domain structures consisting of collagen binding domains (CBDs; CDB1 and 
CBD2 for Col G and CBD for Col H), polycystic kidney disease like-domains (PKD for Col G 
and PKD1 and PKD2 for Col H) and a catalytic domain, a zinc peptidase from the M9B family 
that is responsible for collagen hydrolysis (see figure 1B) [3]. Catalytic domain contains two 
sub-domains; an activator domain responsible for unwinding tropocollagen and a peptidase 
domain containing the catalytic Zn2+ responsible for hydrolysis [4]. Helper domain is thought to 
help the catalytic domain fold correctly [4]. 
CBDs are responsible for anchoring enzymes to substrate. In Col G CBD2 is thought to 
be necessary for processive degradation of collagen fibril while CBD1 is used to feed collagen 
substrate into the active site [5]. In chapter 2, a mechanism behind Col G hydrolysis is proposed. 
The specific role of PKD domains for Col G/Col H collagen hydrolysis is currently unknown. 
Col H PKD1 and PKD2 contain surface aromatic residues located along a proposed collagen 
binding ridge [6]. These residues are not present in Col G PKD suggesting the two play different 
roles. In chapter 3, the role of Col H PKD domains in collagen hydrolysis is discussed. The 
difference in domain orientation of Col G and Col H suggest that the two target different regions 
in collagen to efficiently degrade substrate (see figure 1B). In chapter 4, a method for collagen 
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degradation synergy between Col G and Col H is proposed based on structures of the enzyme 
and hydrolysis of acid solubilized collagen. The ability of Col G and Col H to bind tightly to and 
degrade collagen fibers makes them molecules of interest for clinical research [7] [8]. Further 
understanding on how Col G and Col H work together would allow for the enzymes to be further 
optimized for clinical research. 
In addition to understanding the structure and mechanism of bacterial collagenases. This 
research also seeks to understand the systems by which collagenase expression is regulated. 
Two-component systems are stimulus response mechanisms found in bacteria and some lower-
level eukaryotes that allow the organisms to sense and respond to different stimulus in the 
environment. Two-component systems consist of a histidine kinase that initially receives a signal 
and a response regulator responsible for transcriptional regulation [9]. Briefly their mechanisms 
involve, a signal being received which then causes the protein to dimerize. ATP then binds to a 
specific region in the histidine kinase and donates a phosphate to a conserved His residue. 
Finally the phosphate is passed (either in a cis or trans method) to a conserved Asp residue 
located on the Response Regulator. Phosphate can also be passed through internal receiver 
(REC) and histidine phosphor-transfer (HPT) domains in what is known as a phosphor-relay 
system. Internalized additional domains allow for extra regulatory checkpoints along the 
phosphorylation pathway [10].  
V. alginolyticus, the system described in chapters 5 and 6 uses the VarS/VarA system to 
regulate the expression of collagenase (see figure 2). Since V. alginolyticus has low 
pathogenicity towards humans it is considered a model system for studying two-component 
systems. In chapter 5, new approach for crystallization of REC domain is proposed. Crystal 
structure of REC domain would help in drug development of anti-biotics that specifically target 
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two-component systems. In chapter 6, a potential cytoplasmic disulfide bridge was discovered in 
VarS HPT domain. Cys residues are excellent sensors for oxidative stress. In response regulator 
AgrA disulfide bond is formed across the active site after treatment with H2O2 [11]. Disulfide 
bond formation prevents response regulator from interacting with DNA. Similarly disulfide bond 
formation in HPT may inhibit phosphate transfer between REC and HPT or HPT and response 
regulator. Investigating this potential redox sensing pathway would reveal how pathogenic 
bacteria are able to avoid host defense systems.  
1.1 Description of tropocollagen structure and hierarchal organization of fibrillar collagen  
Collagen is the main structural protein in connective tissue such as skin, bone, tendon and 
cartilage and its cable-like structure provides mechanical stability [12]. There are 29 different 
types of collagens and they are dividing into groups according to their structure and the role they 
play [13]. Some are fibril forming collagen responsible for ECM and bone formation, some are 
network forming collagens involved in basement membrane function and some are have 
interruptions in their triple helix and are known as fibril-associated collagens with interrupted 
triple-helices (FACIT) collagens [13]. While Col G and Col H target a wide variety of collagen 
substrates the most common type of collagen in humans is the fibril forming collagens (Type I, 
II, III, V, XI) [14] [13]. As stated above, full-length Col G and Col H are used to degrade built 
up fibrillar collagen in Dupuytren’s contracture and Peyronie’s disease [15]. Full-length 
collagenases may also be used in cell isolation for purposes of transplant [16] [17] [18] [19]. In 
addition to this, research into using Col G and Col H non-catalytic segments for targeted delivery 
of biomolecules is underway [20] [21] [22] [23] [24] [25] [26] [27]. Usage require Col G and Col 
H to specifically target fibrillar collagen. To improve Col G and Col H’s use as therapeutics 
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understanding the structure of fibrillar collagen is necessary. The mechanisms behind type I 
collagen formation are described below. 
The most common fibril collagen is type I collagen which consists of two α1 chains and 
one α2 chain rotated together to form a triple helical structure [28]. Type I collagen chains are 
300 nm long and 1.5 nm thick and consist of X-Y-Gly repeats with X and Y most frequently 
being Pro [28]. All single collagen chains come together to form triple helical trimers known as 
tropocollagens (see figure 3A). Prior to triple helix formation Lys residues on each α-chain are 
hydroxylated in the endoplasmic reticulum to form hydroxylysine. Lys residues in both triple 
helical regions and non-triple helical regions of collagen known as the telopeptide are 
hydroxylated [29]. Disulfide bond formation within C-propeptide aligns collagen α-chains to 
initiate triple helix formation and is catalyzed by special subunit of prolyl 4-hydroxylases [29] 
[30]. Collagen triple helix forms within the cell by having the three procollagen chains supercoil 
around each other in a right-handed manner. Small size of Gly at every third residue in an α-
chain allows chains to pack close enough together to form the triple helix [31]. In the cell, post 
translational modification of Pro residues on collagen by prolyl 4-hydroxylases to form (2S,4R)-
4-hydroxyproline (Hyp) is the most common post translational modification in humans [32]. The 
presence of Hyp at Cγ stabilizes the triple helix by changing conformation of the pyrrolidine ring 
of proline at every Y position from endo to exo which in turn promotes packing of the α-chains 
to form triple helix [33]. Once triple helix is formed it is further stabilized by numerous 
amine/carbonyl hydrogen bonds between each strand [28].  
Chaperoned by collagen dedicated Heat shock protein 47, newly formed triple helical 
procollagen is secreted into the extracellular space [29] [34]. N and C-propeptides are then 
cleaved off by specific metalloproteinases to form mature collagen [29]. After secretion, it is 
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thought that mature tropocollagen molecules begin to spontaneously assembly into a quasi-
hexagonal array parallel and longitudinally staggered by a repeat distance of 67 nm known as the 
D period [35]. This assembled array of collagens is known as the micro-fibril. During micro-
fibril formation, Lys and Hyl residues located at the the N and C telopeptides are oxidatively 
deaminated by Lysyl oxidase to form aldehydic forms of the residues [29] [36]. A series of 
condensation reactions then occur at these new residues to form covalent intra and inter-
molecular pyridinoline cross-links in tropocollagen chains which stabilize the micro-fibril [29] 
(see figure 3B). In the N-telopeptide Lys5 from the α2 chain intramolecularly cross-links with 
Lys9 from one α1 chain while Lys9 from the remaining α1 chain intermolecularly cross-links 
with Lys946 from the triple helical region of an α1 chain in an adjacent tropocollagen [37]. 
While at the C-telopeptide Lys1046 from both α1 chains cross-link with Lys106 from the 
collagen triple helix [37]. Multiple exterior tropocollagens on micro-fibrils are cross-linked to 
together to form collagen fibrils. The specific number of micro-fibrils within a fibril is currently 
up for debate.  
Small leucine-rich repeat proteoglycans (SLRPs) are known to exist on the surface of 
collagen fibrils [38]. Glycosamineglycans (GAG) chains are present on the N-terminal domains 
of SLRPs and bind to non-fibril FACIT collagens present in the extrafibrillar space between 
collagen fibrils. In addition to this, GAG chains interact with GAGs from adjacent collagen 
fibrils via electrostatic interactions lead to collagen fiber formation [39]. Collagenases Col G and 
Col H from H. histolytica were evolved to unbundle the hierarchical structure of collagen fibers, 
exposing tropocollagen molecules for hydrolysis. The presence of dual collagenases suggests 
that Col G and Col must synergistically degrade collagen. However, this mechanism of synergy 
is currently unknown. For us to potentially tease out this mechanism understanding the structure 
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of Col G and Col H is necessary. Structural and functional information from Col G and Col H 
domains are described in the next section. 
1.2 Clinical use for full-length Col G and Col H mixtures 
The ability of full-length Col G and Col H to seek out and synergistically degrade 
collagen fibers makes Col G and Col H molecules of interest for clinical research purposes. 
Santyl ointment is a mixture of Col G and Col H and is used as a wound debridement and as 
stated earlier in the chapter mixtures of the enzyme are used in the treatment of Dupuytren’s 
contracture and Peyronie’s disease [15]. Pancreatic islet transplantation was mentioned earlier in 
the chapter. It is an experimental treatment for type I diabetes and pancreatic cancer where 
pancreatic islets are isolated from the patient pancreas or from a donor using a mixture of Col G, 
Col H and neutral protease (normally thermolysin) (see figure 4). Newly isolated islets are 
cultured and then injected into the patients liver where pancreatic function is restored [19]. 
Minimizing the amount of neutral protease used in isolation is important as excess limits islet 
survival and viability in vitro [40]. In order to minimize the amount of protease used the optimal 
ratio of Col G to Col H needed for optimizing the islet yield needs to be found. Currently 
different ratios of Col G to Col H are being investigated on their cell isolation ability but a 
consensus has yet to be reached [41]. In chapter 5, based on what is known about Col G and Col 
H collagen hydrolysis the optimal ratio of Col G to Col H needed for hydrolysis of fibrillar 
collagen is proposed [42] [43]. For the rest of this section potential roles for Hathewaya 
histolytica collagenases are discussed. 
In addition to pancreatic islet isolation, collagenases can be used for the isolation of stem 
cells from adipose fat tissue. Recently a method was proposed by Gentile and Sterodimas for the 
isolation of stem cells from adipose fat tissue using human MMP for purposes of reversing 
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Covid-19 lung damage [44]. Mesenchymal stem cell isolation process may be optimized by 
using bacterial collagenases instead of human MMP. Stem cells may also be isolated from 
synovial fluid [45]. In addition to treating Covid-19, collagenases could be used to isolate 
skeletal muscle stem cells for the purposes of treating muscular dystrophy and age associated 
muscle atrophy [46].   
Collagenases may also have some applications in nano-surgery. In many orthodontic 
procedures minor surgery is required to remove the collagen connecting teeth to underlying bone 
[47]. An inactive version of Col G was loaded onto a calcium impermeable DMPC bilayer. Once 
at the oral cavities Col G is secreted from the liposomes, activated by calcium present in the oral 
cavity and begins to degrade collagen connecting teeth to bone. Once collagen is degraded teeth 
can be maneuvered into correct positions and natural tissue repair functions will regenerate the 
collagen to keep the tooth in its new position [47]. Understanding how Col G and Col H degrade 
collagen would potentially make them more effective as clinical tools. 
1.3 Two-component systems represent novel targets for developing broad spectrum anti-
biotics 
Information from this research into the structures of VarS cytoplasmic domains could be used to 
create broad spectrum anti-biotics. Anti-biotics would target conserved structural motifs in the present in 
all phosphorelay sensor histidine kinases. Anti-biotic resistant bacteria are currently a severe healthcare 
problem for the planet. Recently developed anti-biotics all tend to target the same structures and pathways 
decreasing their effectiveness [48]. Gene expression analysis of drug resistant tuberculosis isolates show 
that two component response systems can enhance drug resistance [49]. One side effect of growing 
antibiotic resistance is the rising occurrence of secondary infections. Tungiasis, is a parasitic disease 
caused by the female sand flea and infection of lesions by a variety of anti-biotic resistant bacteria is very 
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common [50]. Broad spectrum antibiotics that target two component systems would be a way to 
potentially stop these types of secondary infections. Two-component system inhibitors work by binding 
to and inducing aggregation of the histidine kinase domain; information from this research would 
potentially reveal an alternative targets further downstream for anti-biotics to attack [51] [52]. Currently 
there are risks towards depending heavily on broad spectrum anti-biotics to fight an infection since 
bacteria are more likely to develop resistance to these types of anti-biotics. Broad spectrum anti-biotics 
that target two component systems would be more effective than current drug options as the bacteria 
would not have evolved any resistance to the new anti-biotics. Since these potentially novel anti-biotics 
are broad spectrum they would be able to effectively target a large number of bacteria. 
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Chapter 1: Figures 
  
Figure 1: A. Photograph of a patient with Gas gangrene in their right leg before 
amputation. Bacterial collagenases are responsible for the spread of the disease. B. 
Domain map of Col G and Col H from H. histolytica. In order to activate Col G and Col 
H Pro-peptide (gray, Col G: N1 – N110 Col H: N1-N40) must be cleaved. Catalytic 
domain of Col G and Col H are composed of Activator sub-domains (light brown, 
residues 1 – 288) and Peptidase subdomain (dark brown, residues 289 – 559), which 
itself contains a helper subdomain to help the domain fold correctly (dart brown, residues 
560 – 681). PKD domains (single PKD for Col G in yellow, residues 682 – 771; PKD1 
and PKD2 for Col H in blue and green, residues 681 – 771 for PKD1 and residues 772 – 
861 for PKD2) connect catalytic domains of both enzymes to CBDs. CBDs (CBD1 and 
CBD2 for Col G in red and dark red, residues 772 – 891 for CBD1 and residues 892 – 
1008 for CBD2; single CBD for Col H in pink, residues 862 – 981) are responsible for 
binding both enzymes to collagen.   
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Figure 2: Cartoon representation of VarS/VarA two component system. Activation of 
response regulate VarA leads to transcription of sRNA which bind RNA repressor 
proteins and allow for transcription of Collagenase  
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Figure 3: A. Cartoon representation of the hierarchical structure of fiber forming 
collagens. 3 α-chains with composition X-Y-Gly with X and Y most commonly being 
Pro and Hyp pack together to form triple helical tropocollagen. B. Once secreted into the 
extracellular space tropocollagens pack into micro-fibril. Tropocollagen is both intra and 
intermolecularly crosslinked at Lys residues in telopeptide and triple helical regions by 
LOX to give micro-fibril extra tensile strength. Figure 3B is adapted from Yamauchi et 
al. 2012 
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Figure 4: Cartoon outlining pancreatic islet allotransplantation. Islets are injected into liver 
where they begin to release insulin. Islets are isolated using mixtures of Col G and Col H. 
Understanding how Col G and Col H work to degrade fibrillar collagen would help to find the 
optimal ratio needed for isolation. Liver is chosen as site for transplantation as it allows for 
islets to receive sufficient amount of oxygen and nutrition [9]  
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Chapter 2: Ca2+ dependent structural change and proposed collagenolysis mechanism of Col G 
Abstract 
Both Col G and Col H are dependent upon Ca2+ in order to degrade substrate. This 
chapter seeks to understand how Hathewaya histolytica is able to use the difference in Ca2+ 
concentration between bacteria and host to efficiently secrete active Col G. It also seeks to 
understand the specific Ca2+ domain rearrangement that must occur in Col G to fully activate it. 
Through structural analysis of CBD1BD2 linker as well as Small Angle X-ray Scattering 
(SAXS) envelopes of full-length Col G and non-catalytic Col G segments bound to mini-
collagen we seek to understand how the enzyme binds to collagen. Through this we have been 
able to tease out a mechanism by which Col G processively degrades collagen.  
2.1 Introduction 
Hathewaya (Clostridium) histolytica is a gram-positive bacteria that is known to cause 
gas gangrene. The β-exotoxin of this bacteria consist of two enzymes, Col G and Col H, which 
seek out and degrade collagen fibers located in extracellular space. Destruction of collagen 
exposes new nutrient sources for the invading bacteria and helps spread the infection [2]. Both 
Col G and Col H have a similar multi-domain structure consisting of collagen binding domains 
(CBDs; CDB1 and CBD2 for Col G and CBD for Col H), polycystic kidney disease like- 
domains (PKD for Col G and PKD1 and PKD2 for Col H) and a catalytic domain, a zinc 
peptidase from the M9B family that is responsible for collagen hydrolysis (see figure 1) [3]. 
Duplicate CBD for Col G not present in Col H suggest that Col G is a much tighter binder to 
collagen than Col H. One of the goals of this research is to understand the role dual CBDs play in 
collagen hydrolysis for Col G. 
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CBD1 and CBD2 from Col G and CBD from Col H are homologous with each other with 
each CBD having approximately 120 residues and a β-sandwich “jelly roll” conformation 
composed of nine β-strands (see figure 2A) [1]. High-speed AFM video of Col G with a collagen 
“micro-ribbon” and SAXS experiment with disordered mini-collagen shows that the enzymes 
flocks to disordered regions in both collagen fibril and mini-collagen [2] [3]. It is the CBD that 
allows Col G and Col H to initially bind to these disordered regions in collagen. NMR and SAXS 
experiments with mini-collagen revealed that if disordered regions are not present then Col G 
CBD2 binds to the C-terminus of mini-collagen in a unidirectional manner [4].  
Crystal structure of CBD2 revealed a hydrophobic region on the surface of Col G CBD2 
[5]. Site-directed mutagenesis of these surface exposed hydrophobic residues alongside a 
collagen binding assay was able to initially map the collagen binding cleft for Col G CBD2. 
Study revealed that surface exposed aromatic residues are important for binding with a group of 
three Tyr residues; Tyr970, Tyr994 and Tyr996; being the most important [5]. Aromatic rings 
from Tyr residues may interact with the Pro residues of collagen through aromatic CαH-π 
interactions as demonstrated for model collagen like-peptides [6] [7]. Loss of Tyr994 reducing 
binding affinity to immeasurable levels [5]. Tyr994 may alson form a hydrogen bond with main 
chain of tropocollagen which may explain its huge impact on binding [5]. NMR titration 
experiments revealed the presence of other hot spot residues that help to form the protein binding 
interface [4]. Sequence alignment study with Col H revealed that the collagen binding residues 
are highly conserved with Tyr996 from Col G being replaced with Phe964 in Col H [8] [1]. 
Surface plasmon resonance results for Col G and Col H CBDs revealed that CBD2 from 
Col G binds to mini-collagen tighter than CBD from Col H by a factor of 10 [9]. Oddly enough, 
CBD1CBD2 from Col G does not bind to the substrate tighter than CBD2 alone suggesting that 
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for Col G, CBD1 binds to a different collagen substrate than CBD2 [9]. Fibril binding affinity for 
Col H CBD segment was found using a modified pull-down assay [10]. Col H CBD was found to 
have somewhat low affinity, 15.9 μM, and high capacity, 1.01 nmol/mg of collagen [10]. 
Insoluble collagen binding assay for Col G CBDs has yet to be performed however, for 
promoting callus formation bFGF conjugated to different non-catalytic segments from Col G and 
Col H was found to have the most pronounced effect when conjugated to CBD1CBD2 from Col 
G [9]. Currently, it is not entirely known why Col G non-catalytic segments have higher collagen 
binding affinities than Col H non-catalytic segments. Col H CBD is missing some of the collagen 
binding residues present in Col G CBD2 which may explain the difference in binding between 
Col G CBD2 and Col H CBD. The potential role of CBD1 in allowing Col G to bind to collagen 
tighter than Col H will be discussed further on in this chapter.  
Gelatinase, either Col G or Col H missing their non-catalytic domains, was found to be 
able to degrade denatured collagen (gelatin) but not native collagen [10] [11]. The role of CBDs 
in the degradation of collagen fibrils is well reported [8] [11] [1]. In pancreatic islet isolation 
studies mixtures of Col G and Col H are used isolate pancreatic islets from donor tissue [12] [13] 
[14]. When Col G with truncated CBD2 (Col G -∆CBD2) was used in place of wild type Col G 
pancreatic islet isolation was greatly inhibited [12]. The role of CBD2 in Col G processive 
collagen fibril hydrolysis will be discussed further down in this chapter.  
In addition to the conserved hydrophobic residues in the collagen binding cleft, 
conserved Asn, Glu and Asp residues are also found located near the N-terminus of Col G and 
Col H CBDs [1]. Conserved N-terminal residues of Col G and Col H CBDs are able to chelate to 
two Ca2+ ions [1] (see figure 2B). In the presence of EDTA and other chelating molecules, 
binding affinity and collagen degradation activity for both Col G and Col H is significantly 
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lowered [15] [5] [16]. In the presence of excess Ca2+ CBD N-terminal linker changes from an α-
helix to a β-sheet [5]. Change to β-sheet causes the domain to become more rigid protecting it 
from both chemical and thermal denaturation [1] [16]. The change from α-helix to β-sheet at the 
N-terminal linker is also known to prevent linker from protease degradation (see figure 2C) [17] 
[18]. Both PKD and catalytic domains also contain Ca2+ binding regions however, upon binding 
the change in structure for these domains is not as apparent as it is for the CBDs [19] [15]. It is 
speculated that H. histolytica exploit the difference in Ca2+ between host and bacteria to 
efficiently secrete Col G and Col H. Later on in this chapter the full-length structures of Col G in 
high and low Ca2+ concentrations are proposed and the potential domain rearrangements that 
occur upon Ca2+ binding are discussed. 
2.2 Methods 
2.2a. Production and Purification of Col G and Col H segments 
 The expression and purification of wild type Col G CBD1CBD2 and PKDCBD1CBD2 
was performed at Okayama University Graduate School of Medicine Dentistry & Pharmaceutical 
Sciences in the Matsushita lab using previously described methods [10] [20]. Briefly, pGEX-4T-
2 plasmids containing the sequences to be expressed were transformed into E. coli BL21 
competent cells by heat shock. Cells were plated onto LB Agar plates supplemented with 
ampicillin and chloramphenicol and allowed to grow at 37° C. After 24 hours 10 ml of 2-YTG 
broth supplemented with ampicillin was inoculated with a single colony; broth was incubated at 
37° C for 12 hours with agitation. 6 ml of new culture was transferred to 120 ml of 2-YTG broth 
containing ampicillin and the culture was incubated once again at 37° C for 12 hours with 
agitation. Finally, after 12 hours 25 ml of this culture was transferred to into 2 liters of 2-YTG 
containing ampicillin. Cells were incubated until OD600 of 0.7. IPTG was added to the 2-YTG 
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broth and expression was carried out for 4-8 hours. After addition of 20 mL of 100 mM PMSF, 
cells were harvested using centrifugation (7,000 RPM, 4° C, 15 min). Cell pellet was suspended 
in 40 ml of 1X PBS supplemented with 1 mM PMSF and French press (10,000 PSI) was used to 
lyse the cells into centrifugation tubes (20 ml). 1 ml of Triton X-100 was added to each tube and 
tubes were rotated for 30 min. (4° C). Centrifugation was performed twice to clear out cell debris 
(15,000 RPM, 4° C, 30 min).   
The fusion proteins were purified using batch purification with glutathione sepharose 
beads. Junk proteins were eluted with the PBS wash. Fusion proteins were eluted with 50 mM 
Tris pH 8.0 containing 10 mM glutathione. Incubation with thrombin cleaves the GST tag and a 
second-round chromatography with the glutathione sepharose column was used to separate the 
protein from the tag. Q-sepharose ion exchange chromatography was used to further purify the 
proteins. Flow through fractions were pooled and dialyzed into 50 mM Tris, 1 mM CaCl2 pH 7.5. 
Following dialysis, a BCA assay was used to quantify concentration for each sample. 
2.2b. Identifying lower molecular weight contaminants in full length Col G and Col H from 
VitaCyte 
 Full-length Col G was purchased from VitaCyte for structural analysis. 10% SDS PAGE 
gels was ran for Col G to determine if contaminants are present in the samples. Gels were stained 
with comassie blue and destained with 10% Acetic acid/50% Methanol for 24 hrs. Analysis of 
SDS PAGE gel showed the presence of contaminants for Col G. ImageJ densitometry analysis of 
gel revealed that both Col G is sufficiently pure (>93% purity for both Col G ) (see figure 3).  
Bands were excised, washed twice with 25 mM ammonium bicarbonate, destained with 
ammonium bicarbonate/50% acetonitrile, and dried with pure acetonitrile. Then, the proteins 
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were reduced using 10 mM dithiothreitol in 50 mM ammonium bicarbonate for 1hr. at 55°C 
water bath. Proteins were alkylated by adding 10 mM iodoacetamide (in 50 mM ammonium 
bicarbonate). Reaction was carried out for 1 hr. in the dark. Next, gel pieces were washed with 
ammonium bicarbonate, and dried with pure acetonitrile. Enough trypsin gold (Promega, Mass 
spectrometry grade, 10 ng/μl in 25 mM ammonium bicarbonate) was added to cover the gel 
pieces and the mixture was incubated at 4°C for 30 min. After digestion, 100 µl of 25mM 
ammonium bicarbonate was added and the mixture was left overnight at room temperature. 
Solutions were transferred to separate Eppendorf tubes; left over tryptic peptides being extracted 
by vortexing with 100 μl of 50% acetonitrile/5% formic acid for 5 min. Solutions were 
completely evaporated and reconstituted in 50 µl of 0.1% formic acid and mass spectrometry 
analysis was performed. 
2.2c. Mass Spectrometry analysis of Col G and Col H 
Dr. Rohanna Liyanage in the mass spectrometry department at the University of 
Arkansas performed all trypsin digestions and mass spectrometry analysis. The tryptic digests 
obtained from all samples were analyzed by ESI-LC-MS/MS (Electrospray ionization liquid 
chromatography-tandem mass spectrometry) at the State-Wide Mass Spectrometry Facility at the 
University of Arkansas (Fayetteville, AR). Analysis was performed using data-dependent 
acquisition mode (DDA) with collision-induced dissociation (UltraScan mode, one min, 32,500 
m/z per second). Agilent 1200 series micro flow HPLC system in line with Bruker Amazon-SL 
quadrupole ion trop ESI mass spectrometer (QIT-ESI-MS) was used for analyzing tryptic 
digests. Reverse-phase high performance liquid chromatography (RP-HPLC) with a Zorbax SB 
C18 column (150 mm x 0.3 mm, 3.5 μm particle size, 300 Å pore size, Agilent Technologies) 
and a solvent flow rate of 4 μL/min. was used for separating the tryptic digests. Gradient of 5%-
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38% consisting of 0.1% formic acid and acetonitrile was used during elution. Auto MS mode 
was used to choose peaks for MS/MS analysis. Analysis was performed in positive ion mode 
using Bruker captive electrospray source with a dry nitrogen gas temperature of 200 °C with a 
flow rate of 3 L/min with enhanced scanning mode (8,100 m/z per second).  
Peaks were picked in the LC-MS/MS chromatogram using default settings in Bruker Data 
Analysis 4.2 software. Bruker Proteinscape bioinformatics suite coupled with MASCOT 2.1 
(http://www.matrixscience.com) was used to search and match LC-MS/MS data against Col G 
FASTA sequences in the uniprot format (Col G: Q9X721). Scaffold (version Scaffold_4.8.4, 
Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein 
identifications [21]. Scaffold software was used to give high confident peptide identifications 
using identification probability and false discovery rates. Sequence coverage for each band 
revealed that small amounts of Col G lose C-terminal domains during protein expression (see 
figure 3). 
2.2d. Col G SAXS studies 
 Small Angle X-ray Scattering (SAXS) was used to find a low-resolution envelope full 
length Col G as well as Col G non-catalytic segments bound to mini-collagenmini-collagens. All 
mini-collagens were synthesized by Dr. Takaki Koide using Fmoc‐based solid‐phase method on 
Rink amide resin [22]. For Col G, SAXS data was collected for PKDCBD1CBD2 complexed to 
[(POG)10]3 and for the Col G pCa series (pCa = -log[Ca
+2]). In addition to the pCa series for Col 
G, SAXS data for a pCa series of Col G with truncated CBD2 was also collected (-∆CBD2 Col 
G). Data for Col G CBD1CBD2:[(POG)10]3 complex previously collected by Dr. Ryan Bauer 
was processed to help position PKD domain. 
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For the complex, a 5 mg/ml stock of [(POG)10]3 was created by dissolving min-collagen 
powder in 5 mM Acetic Acid. The solution was incubated overnight at 4° C and circular 
dichroism was used to confirm that the triple helix was formed [23]. Then a 1:1 mole ratio of 
mini‐collagen to protein was incubated at 4 °C overnight, and then dialyzed into 50 mM Hepes 
pH 7.5, 100 mM NaCl, 5 mM CaCl2 [8]. For the Col G pCa series, Col G was exchanged into 
pCa 3, 4, 5, 6 and 7 buffers using Amicon Ultra centrifugal units. pCa buffer composition is 
listed in Tables 1 and 2. Different glycerol concentrations (0%, 0.5%, 1.0%, 1.5% and 2.0%) for 
each pCa were tested using continuous native PAGE gel electrophoresis to find the optimal 
amount of glycerol needed to prevent aggregation for each pCa buffer [24]. Glycerol was 
incorporated into pCa buffers by adding double the concentration listed into the HBS-EGTA 
buffer. For Col G and Col -∆CBD2 the following concentrations of glycerol were used Col G 
pCa 7: 1%, Col G pCa 6: 0.5%, Col G pCa 5: 0%, Col G pCa 4: 0%, Col G pCa 3: 0%, Col G -
∆CBD2 pCa 7: 1.5%, Col G -∆CBD2 pCa 6: 0.5%, Col G -∆CBD2 pCa 5: 0.5%, Col G -∆CBD2 
pCa 4: 0.5% and Col G -∆CBD2 pCa 3: 0%. 
 
 
 
Buffers Composition 
HBS-EGTA 10 mM Hepes pH 7.5, 100 mM NaCl, 0.4 mM 
EGTA 
HBS-Ca 10 mM Hepes pH 7.5, 100 mM NaCl, 2.4 mM 
CaCl2 
HBS 10 mM Hepes pH 7.5, 100 mM NaCl 
Table 1 
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2.3 Results and Discussion 
2.3a. Small angle X-ray Scattering of Col G targeting segments 
 To understand Col G Ca2+ dependent structural change and how the enzyme processes its 
substrate SAXS data was collected for the following samples for full length Col G and Col G 
with truncated CBD2 (Col G -∆CBD2) at different Ca2+ concentration and PKDCBD1CBD2 
bound to mini-collagen. In addition to collecting new data, scattering data for PKDCBD2CBD2 
and pCa 3 and pCa 6 and CBD1CBD2:[(POG)10]3 were reprocessed. Previously derived SAXS 
envelope for CBD1CBD2 at pCa 3 was used to help position segments in Col G both free and 
bound to substrate. Due to the formation of air bubbles in the 96 well plate as well as protein 
aggregation; data for only certain pCa levels of Col G and truncated Col G were useable (pCa = -
log[Ca2+]) (Col G: pCa 3, pCa 6; Truncated Col G: pCa 4, pCa 6, pCa 7). 
 SAXS profiles, guinier plots, pair distribution plots and Kratky and plots for Col G 
samples are shown in figures 4, 5, 6 and 7. Guinier plots indicate that aggregation is minimal 
Buffer HBS-EGTA (ml) HBS-Ca (ml) HBS (ml) 
pCa 3 50 50 0 
pCa 4 50 12.493 37.507 
pCa 5 50 8.681 41.319 
pCa 6 50 7.732 42.268 
pCa 7 50 4.541 45.459 
Table 2 
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among samples. According to Kratky plots, all samples are folded with the exception of 
PKDCBDCBD at pCa 6 which appears to be somewhat unfolded (see figure 4D) [25]. Unfolded 
appearance in kratky plot could be due to lack of calcium causing N-terminus of CBD1 and 
CBD2 to become extended [1] [5] [18]. SAXS data for PKDCBDCBD at pCa will need to be 
recollected and reprocessed in order to full confirm its shape. 
Radius of gyration (RG) for a protein is defined as the square root of the average squared 
distance of each scattered x-ray beam from the center of the molecule. At low resolution x-ray 
scattering can be approximated by using the equation ln I(q)= ln I(0) – qRG
2/3 with the slope of 
the line being used to find RG [26]. High value for RG can be used to identify aggregation in a 
protein [26]. Pair distribution plots give the various vectors found in a molecule and are created 
via fourier transformation of initial x-ray scattering data. DMax found via pair distribution plot is 
the maximum diameter present in a molecule [26]. DMax values are a way to visualize 
conformational changes in a sample and are used in the development of SAXS derived 
envelopes. Pair distribution functions when integrated across all r values can give RG. RG value 
found this way is often used as consistency check for RG found via Guinier approximation [26]. 
Porod exponent is calculated from flexibility and volume analysis function in Scatter and is 
based on the rate of decay for scattering intensity in the initial I(q) vs q intensity plot. For an 
ideal folded molecule P = 4 and for an unfolded molecule P = 1 [27]. In order derive SAXS 
envelopes first multiple envelope calculations are averaged and then filtered. To determine if the 
dummy atoms used in each envelope for calculating the average agree with each other 
normalized spatial discrepancy (NSD) values are used. Envelopes are superimposed with each 
other and distance between dummy atoms is used in calculating NSD values; if value is close to 
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zero it indicates high agreement [26]. Q-range is the range of scattering values from initial 
scattering profile used to create pair distribution plot.  
Agreement between experimental scattering profile and theoretical profile from crystal 
structure coordinates for each envelope was found using Crysol from Atsas online server [28]. 
Results are listed in Appendix. The Rg, Dmax, P, NSD and Q-range values for all samples are 
summarized in tables 1 & 2. P values are not listed for non pCa samples due to relevance. Porod 
exponent (P) values for Col G and Col G ∆CBD2 decreased as the pCa increased. 
 
 
 pCa Rg (Å) 
Guinier 
Approx. 
Rg (Å) 
Defined by 
P(r) 
DMax 
(Å) 
Mean 
NSD 
value 
Q-range 
(Å−1) 
CBD1CBD2 3.0 24 24 75 0.714 0.0159 – 
0.3605 
CBD1CBD2 6.0 27 27 128 0.540 0.0236 – 
0.2198 
CBD1CBD2:[(POG)10]3 2.3 29 30 113 0.572 0.0187 –  
0.2801 
PKDCBD1CBD2 3.0 31 30 98 0.653 0.0215 – 
0.2572 
PKDCBD1CBD2 6.0 39 35 120 1.392 0.0151 – 
0.3483 
PKDCBD1 
CBD2:[(POG)10]3 
2.3 38 38 155 0.607 0.0159 –  
0.1965 
Table 3 
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2.3b. Structural analysis of CBD1CBD2 linker  
At physiological concentrations of Ca2+ SAXS revealed that Col G becomes more rigid. 
The solved crystal structure of CBD1CBD2 was analyzed in order to help determine how CBD1 
binds. In the presence of Ca2+ CBD1 is related to CBD2 by a pseudo two-fold rotational 
symmetry. Interdomain interactions consisting of four salt-bridges and three hydrogen bonds 
found in the linker region may restrict freedom of movement for CBD1 and CBD2 (see figure 8) 
[8]. For CBD2 in the presence of Ca2+ N-terminal linker are resistant to trypsin [18]. However 
 pCa Rg (Å) Guinier 
Approx.  
Rg (Å) 
Defined by 
P(r) 
DMax 
(Å) 
P Mean NSD 
value  
Q-range 
(Å−1) 
Col G 3 47 47 150 3.2 0.881 0.0129 –  
0.3654 
Col G 6 46 48 170 2.8 0.776 0.0111 –  
0.2690 
Col G 
∆CBD2 
4 43 42 130 3.4 0.821 0.0129 –  
0.3220 
Col G 
∆CBD2 
6 43 44 143 2.0 0.764 0.0129 –  
0.3220 
Col G 
∆CBD2 
7 42 43 145 1.6 0.710 0.0152 –  
0.2732 
Table 4 
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the C-terminal linker region in CBD1 has been shown to be susceptible to trypsin like activity 
[14].  
The linker between CBD1 and CBD2 is not long enough for CBD1 and CBD2 to bind to 
the same tropocollagen in cis fashion as observed for CNA from Staphylococcus aureus [29]. 
When CBD1 and CBD2 were hypothetically positioned on the same tropocollagen, the distance 
between Glu895 of CBD1 and Lys896 of CBD2 was estimated as 40 Å. When pCa is greater 
than 6, the linker may still not be long enough for tandem CBD to interact with one 
tropocollagen, but it may be dynamic enough to allow for CBD1 and CBD2 to bind to two 
adjacent hexagonally arranged tropocollagen molecules. When pCa is smaller than 4, the 
orientation of CBDs would allow for Col G to wedge between two parallel oriented collagen 
molecules [8].  
2.3c. SAXS derived envelopes for Col G segments bound to mini-collagen 
To construct the PKDCBD1CBD2:[(POG)10]3 complex, the following information was 
used. The rod-like difference in electron density between PKDCBD1CBD2 at pCa 3 and 
CBD1CBD2:[(POG)10]3 (green and pink, respectively) was assigned as [(POG)10]3. Since CBD2 
binds tighter to mini-collagen than CBD1, CBD2 segment was considered to bind [(POG)10]3. 
Binding surface of CBD2 mapped by mutagenesis and collagen-binding studies was positioned 
to interact with [(POG)10]3 [5]. Previous SAXS and NMR work on the binding of CBD2 to mini-
collagen showed that CBD2 binds asymmetrically to the C-terminus of [(POG)10]3 [4] [3]. In our 
complex, we reasoned that the asymmetric binding to be observed by CBD2 segment of 
CBD1CBD2. SAXS envelopes previously determined for CBD2, [(POG)10]3, and 
CBD2:[(POG)10]3 were also used to position CBD2 and [(POG)10]3 in the envelope calculated for 
PKDCBD1CBD2:[(POG)10]3 [4] [3]. In the remaining non-overlapping electron density, PKD 
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was positioned so that C-terminal residue (Asn770) of PKD is as close as possible to N-terminal 
residue (Thr773) of CBD1CBD2 (see figure 9).  
2.3d SAXS derived envelopes for full-length Col G at low and high Ca2+ concentrations  
At Ca2+ concentration inside bacteria (pCa 6) Col G adopts an elongated shape with a 
DMax of 172 Å. In order to identify the position of CBD1CBD2 (PDB: 5IKU), PKD (PDB: 
4TN9) and catalytic domain (PDB: 2Y3U) in Col G pCa 6 the envelopes for PKDCBD1CBD2 
pCa6 and Col G ∆CBD2 pCa 6 were used. To help find the position of CBD1CBD2 and PKD in 
Col G pCa 6 previously collected scattering data for PKD1CBD1CBD2 at pCa 6 was 
reprocessed. Data points with high intensities were removed, as they correspond to radiation 
damage, and the new elongated envelope for PKD1CBD1CBD2 was positioned at the tail end of 
the envelope of Col G pCa 6. In order to create PDB file for CBD1CBD2 at pCa 6 the PDB file 
for CBD1CBD2 bound to Ca2+ was manipulated by Dr. Ryan Bauer (a former graduate student 
in the Sakon lab). N-terminal linkers in CBD1 and CBD2 were changed from β-sheets to alpha-
helix using MiFit to resemble the potential structure of the CBD1CBD2 in the absence of Ca2+ 
[5]. New structure was found to fit SAXS envelope for CBD1CBD2 at pCa 6 [8]. Previously 
derived SAXS envelope for CBD1CBD2 at pCa 6 was used to help determine the position of 
linkers at low Ca2+. CBD1CBD2 pCa 6 was positioned at the tail-end of the Col G envelope and 
PKD was positioned in the remaining PKDCBD1CBD2 pCa 6 electron density. To help confirm 
the position of CBD1CBD2 the envelope for Col G ∆CBD2 pCa 6 was superimposed with the 
full-length enzyme and CBD2 was found in the non-overlapping region between the two (see 
figure 10A).  
The distance from the N-terminus of CBD1CBD2 to the C-terminus of PKD was 20 Å 
(see figure 10B). For CBD1CBD2 at pCa 6 20 residues in the N-terminal linker were deleted due 
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to overlapping with crystal structure for PKD leaving new N-terminal residue as Ala790. C-
terminal residue for PKD is Asn770. 20 residues missing between Asn770 and Ala790 should be 
more than enough to bridge the 20 Å gap between CBD1CBD2 at pCa 6 and PKD. The catalytic 
domain was positioned in the remaining electron density. The distance from the N-terminus of 
PKD to the C-terminus of the catalytic domain was 29 Å. N-terminal residue of PKD crystal 
structure is Gly685 (Glys685 is Lys in sequence from uniprot: Q9X721) and C-terminal residue 
of catalytic domain crystal structure is Gly680 (Ala in uniprot). Missing 5 residues between PKD 
and catalytic domain would at most only make up 7 Å. Positioning domains via multiple SAXS 
envelopes only tells us their relative positions. It could be that position of PKD and catalytic 
domain need to be refined in order to make up the remaining distance between the two. Currently 
experiments are being performed using SASREF from ATSAS online server to refine positions 
of the domains [30].  
At extracellular matrix Ca2+ concentrations (pCa 3) Col G adopts a more defined and 
compact structure with a DMax of 150 Å (see figure 6 and 11). In order to identify the position of 
each segment in Col G pCa 3 the envelopes for PKDCBD1CBD2:[GPRG(POG)13]3, Col G 
∆CBD2 pCa 4 and PKDCBD1CBD2 pCa 3 were used. To determine the location of 
CBD1CBD2, PKDCBD1CBD2:[GPRG(POG)13]3 envelope was superimposed with the envelope 
for Col G pCa 3. CBD2 was positioned in the overlapping region near where mini-collagen is 
known to be. To confirm the position of CBD2 the envelope for Col G ∆CBD2 pCa 4 was 
superimposed with Col G pCa 3 envelope. Previous research has shown that the orientation of 
segments in Col G at pCa 3 and pCa 4 should be nearly identical [8] [5] [16]. CBD2 was found 
in the non-overlapping region. The scattering data for PKDCDB1CBD2 pCa 3 was previously 
collected. Data points corresponding to radiation damage were removed and the newly derived 
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envelope for PKD1CBD1CBD2 was positioned at the end of the envelope. Envelope for 
PKDCBD1CBD2 pCa 3 was superimposed with Col G pCa 3 envelope. The position of 
CBD1CBD2 is known and PKD was positioned in the remaining electron density (see figure 11).  
The distance from the N-terminus of CBD1CBD2 to the C-terminus of PKD was 37 Å. 
For CBD1CBD2 N-terminal residue is Thr773 and for PKD C-terminal residue is Asn770; 2 
residue gap between CBD1CBD2 and PKD would not be enough to cover 37 Å. In crystal 
structure of CBD1CBD2 N-terminal linker is pointing away from the C-terminus of PKD. 
Current position of CBD1CBD2 may just be a crystallographic artifact and PKDCBD1CBD2 
position is different.   Finally, the catalytic domain was positioned in the remaining electron 
density. The distance from the N-terminus of PKD to the C-terminus of the catalytic domain was 
23 Å. For PKD N-terminal residue is Asn685 and for catalytic domain C-terminal residue is 
Gly680; 4 residue gap between PKD and catalytic domain  would not be enough to cover 23 Å. 
Similar to the distance between PKD and catalytic domain for Col G at pCa 6 the position of 
these two domains may not be optimal and further work would need to be done in order to find 
the optimal position for PKD and catalytic domain within the envelope for Col G at pCa 3. 
2.3e. Ca+2 induced domain rearrangement and secretion of Col G 
The difference in Ca2+ concentration inside H. histolytica, which is likely similar to the 
concentration inside Escherichia coli (0.2-0.3 μM; pCa 6.5-6.7) and extracellular matrix of host 
(~1.2 mM; pCa~2.9) could be exploited by H. histolytica to facilitate rapid secretion into the host 
and subsequent activation [31] [32]. Based on the size of the Col G envelope gram positive type 
II secretion systems are the most likely candidates to secrete the enzymes into hosts [33]. 
According to PyMol the widest portion of Col G has a measured width of 75 Å at pCa 3 and 67 
Å at pCa 6. The inside diameter of a type II injectosomes for Vibrio cholerae has a width of 75 Å 
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(see figure 12) [34]. Based on the widths of both the enzyme and the channel it would be 
difficult for Col G to be efficiently secreted at pCa 3. The dimensionless Kratky plots and P 
values for Col G at pCa 3 and pCa 6 shows that at lower Ca2+ concentrations Col G is more 
flexible (see figure 6D and table 4). The increased flexibility and narrower structure for Col G at 
pCa 6 may permit the protein to be secreted through the type II secretion system.  
Type II secretion system proteins are found not only in H. histolytica (Accession: 
VTQ86622) but also in H. proteolytica (Accession: WP_072902510) and multiple other 
Clostridium species (Accession: WP_035784777, AMN33782, KOR55552). Quorum sensing 
may optimize Hathewaya histolytica’s ability for infection. Collagenases would only be secreted 
once a certain number of bacteria have gathered at the potential infection site or if optimal 
conditions for survival are present [35]. This would ensure that a maximum number of 
collagenases are secreted into host tissue in order for the bacterial infection to proceed. 
In Col G there is a major difference in the position and orientation of the PKD and 
catalytic domains between pCa 6 and pCa 3 (see figure 13). This difference in positions may be 
explained by the change in the N-terminal linker from α-helix to β-sheet in CBD1 and CBD2 [5] 
[1]. PKD domains also chelate to Ca2+ ions however, no large structural change is observed 
when Ca2+ chelates to its N-terminus linker [19]. Transition from α-helix to β-sheet at CBD1 N-
terminal linker may cause PKD domain to rotate along the z-axis approximately 90°. This 
hypothetical repositioning of PKD domain may then cause the catalytic domain to be rotated 
along the y axis until the active site cleft of the peptidase sub-domain is aligned with the collagen 
binding cleft of CBD1. Both Col G and Col H activities toward collagen fibrils are significantly 
impaired at low concentration of Ca2+ [20] [5] [16]. The primary function of the PKD domain in 
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Col G may be to position the catalytic domain for collagenolysis and inactivity at low Ca2+ 
concentration is due to the sub-optimal position of the catalytic domain.  
2.3f. SAXS revealed that CBD2 is used to anchor enzyme to collagen and CBD1 may be used 
to feed substrate into active site  
 The opposing positions of the collagen-binding clefts on tandem CBD present unique 
modes for the domain to latch onto collagen fibril. Whereas collagen fibril is built from a 
staggered array of triple-helical tropocollagen, and is water insoluble, synthetic mini-collagen, 
which mimics the tropocollagen structure, is water-soluble and allows solution-based analysis of 
CBD-collagen interaction. Measured dissociation constants for the interaction between the 
individual CBDs and either mini-collagen or fibril tend to agree [20]. Tandem CBD is the 
tightest binder to collagen fibril, and can bind tighter than the sum of CBD1 and CBD2 
individually [20] . However tandem CBD binds mini-collagen about as tightly as CBD2 alone 
[20]. Corroborating this, the SAXS-derived shapes of the CBD1CBD2:[(POG)10]3 complex and 
the PKDCBD1CBD2:[(POG)10]3 complex are consistent with a one-to-one complex, and CBD2 
is positioned to interact with mini-collagen (see figure 9) [8].  
The binding affinities of CBD1 and CBD2 to mini-collagen suggest CBD2 initiates 
collagen-binding. Furthermore, the sequence alignment of multiple CBD binding segments 
suggests this binding strategy is conserved amongst the collagenases possessing tandem CBDs 
[19]. While the binding clefts of both CBDs complement the curved surface of collagen, the 
three most critical tyrosine residues for collagen-binding in CBD2 (970, 994, and 996) are 
conserved amongst CBD2s, while only two tyrosine residues 851 and 875 (equivalent to 970 and 
994) are conserved amongst CBD1s. Gene duplication of CBD required reduced binding affinity 
in the CBD1 to prevent the tandem CBD from binding too tightly to collagen fibril. The tighter 
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binding CBD2 could initiate binding and serves the leading role, while CBD1 plays an auxiliary, 
yet pivotal role in collagenolysis. 
In order to tease out how collagen substrate is being fed into the catalytic domain of Col 
G the envelope for full length Col G was superimposed with the envelope for 
PKDCBDCBD:[(POG)10]3. Analysis of the superimposed structures reveals that CBD1 could be 
used to feed the substrate into the catalytic domain (see figure 14). As previously stated 
structural analysis of the linker between CBD1 and CBD2 even at low Ca2+ concentration 
indicated that it is highly unlikely that CBD1 could bind to the same tropocollagen molecule as 
CBD2 [8]. The orientation of CBD1 and CBD2 in the crystal structure of tandem CBD (PDB: 
5IKU) suggest that Col G may be able to bind to two parallel oriented collagen molecules rather 
than one collagen molecule. Surface Plasmon Resonance results have indicated that CBD1CBD2 
and CBD2 bind to mini-collagen with equal affinities [9]. The binding affinities of CBD1CBD2 
and CBD2 to mini-collagen suggest CBD2 initiates collagen-binding acting as an “anchor” for 
Col G. If the tropocollagen bound to CBD2 were degraded Col G would most likely dissociate 
from collagen fibril. CBD1 with its lower affinity for mini-collagen may be better suited for 
“sliding” the collagen substrate into the catalytic domain. This ability to wedge between 
opposing tropocollagens could also explain the curious ability of CBD1CBD2 to promote fibril 
formation at low concentrations. Col G may promote fibril formation when it is stalled in order 
to provide CBD2 with more points to anchor to collagen fibril [8].  
2.3g. Potential collagenolysis mechanism for Col G  
Col G’s ability to bind to parallel oriented tropocollagen molecules and degrade only the 
substrate corresponding to CBD1 was inferred using SAXS. High-speed atomic force 
microscopy has been used visualize the interplay of Col G and collagen [2]. In the AFM videos 
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Col G was seen to bind to disordered regions of collagen and continuously degrade substrate 
without being released until reaching the N – terminus of collagen fibril [2]. Below we explain 
the mechanism behind Col G ability to processively degrade collagen substrate.  
The approximate 55 Å spacing of binding clefts in tandem CBD may exclude Col G from 
reaching tropo-collagen molecules within the tightly packed D-periodic structure of collagen 
micro-fibril. However, the spacing would allow for Col G to seek either inter-fibrillary spaces or 
crevices on the surface of damaged collagen fibril. The tandem CBD’s role could be to 
intercalate into the disturbed region. High concentration of Col G may prevent fibril formation 
by physically keeping tropocollagen molecules from coming together. The extrafibrillar matrix is 
the region between collagen fibrils and consists of polysaccharides, proteoglycans and non-fibril 
collagens that are necessary for the formation of collagen fibers [36]. The unique tandem CBDs 
of Col G may make it better suited towards cleaving some of auxiliary, non -fibril collagens 
present in the extrafibrillar matrix that hold collagen fibrils together to form fibers [37].  
Subsequent C-terminus to N-terminus movement is thought to be driven by substrate 
hydrolysis. Catalytic module is well suited to be located behind tandem CBD for it is a 
tripeptidyl carboxypeptidase [2]. This domain arrangement will allow for greater ratio of binding 
sites for substrate than product thus it processively moves towards the N-terminus of collagen. 
Each CBD unidirectionally binding to collagen may keep N-side of collagen apart during 
polarized movement. Tandem CBD utilizes collagen molecules as railings so that catalytic 
assembly will remain close to the substrate. As stated earlier SAXS analysis was able to 
determine that CBD1 is used to feed collagen substrate into the catalytic domain. After 
hydrolysis, Col G will begin to move towards the N-terminus. CBD1, PKD domain and catalytic 
domain begin to move first but tighter binding CBD2 remains anchored to its collagen fibril. It is 
 
38 
 
speculated that this exaggerated strain could be useful in dislodging the tighter binding CBD2 
(see figure 15). To support this “walking” mechanism for Col G to move along collagen 
unpublished high speed atomic force microscopy (AFM) video of the enzyme alone shows that 
the enzyme is dynamic and moves as two segments: CBD1CBD2 being one and the catalytic 
domain being the other. It is unknown which segment the PKD domain belongs to (see video 1 in 
Appendix).  
We speculate that PKD domain in Col G may help to move the enzyme along collagen. 
In SAXS envelope for fully active Col G (pCa 3 equivalent to ECM concentration of Ca2+ in the 
body) the PKD domain is rotated approximately 90° perpendicular to both CBD1CBD2 and the 
catalytic domain. This orientation of PKD domain in Col G may make the domain act as a 
torsion spring to help dislodge the enzyme from collagen.  Released energy from hydrolysis may 
cause PKD domain to be exit from its 90° “twisted” orientation releasing stored mechanical 
energy. This release of built up energy may turn cause CBD1 to be pushed towards the N-
terminus. Finally, enough strain is built up in CBD2 that it is eventually dislodged. B-factor 
analysis of Col G PKD domain shows that its midsection is dynamic in the presence of Ca2+ 
which may give support to the idea of PKD domain as a spring [19]. 
 When Col G was stalled, it isolated collagen fibrils and rearranged them to thicken 
neighboring fibrils [2]. Enzymes benefits from destabilizing substrate to carry out hydrolysis, but 
Col G apparently can stabilize its substrate. The tandem CBD can facilitate collagen fibril 
formation but only at low concentration. The benefit for a collagenase’s counterintuitive function 
is speculated. When Col G encountered tropocollagen molecules that are not oriented in parallel, 
tandem CBD may not be able to bind to two tropocollagen molecules to processively hydrolyze 
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its substrate. Col G’s ability to reorient collagen to fibrillar form may allow for efficient 
collagenolysis. Col G’s ability to stabilize collagen could become beneficial in that context.   
2.3h. Structural explanation for successful applications of Col G CBD1CBD2 for localized 
drug delivery 
Currently non-catalytic segments from both Col G and Col H have been successfully 
used in the localized delivery of bFGF to bone fractures in mice models [9] [38] [39] [40] [41]. 
Bone growth was found to occur quickiest when bFGF was linked to either CBD1CBD2 or 
CBD. In study from Sekiguchi et al. 2018, surface plasmon resonance was used to find binding 
information for CBD1CBD2 and CBD2 to mini-collagen. Dissociation constants for 
CBD1CBD2 and CBD2 were found to be virtually identical (CBD2 KD = 4.54 x 10
-5 M; 
CBD1CBD2 KD = 4.46 x 10
-5 M) [9]. In the same study, different Col G and Col H segments 
were linked to bFGF and their ability to heal bone fracture in mice was tested. It was shown that 
bFGF linked to CBD1CBD2 had the highest efficacy for bone repair [9]. To explain the two 
almost contradictory findings from Sekiguhi et al. 2018, in vivo CBD1CBD2 may be wedging 
between parallel oriented tropocollagen either within a micro-fibril or between collagen fibrils 
[42]. In surface plasmon resonance results dissociation constants are nearly identical because 
linker between CBD1 and CBD2 in CBD1CBD2 is not flexible enough to allow CBD1 to bind to 
the same tropocollagen as CBD2. The 55 Å distance between CBD1 and CBD2 may allow for 
CBD1CBD2 to delivery biomolecules directly to damaged collagen; in orgel structure of micro-
fibril loss of three tropocollagen would give a 45 Å space for CBD1CBD2 to bind [43]. 
Anchoring growth factors to damaged regions minimizes the dosage needed and potential side 
effects [40] [44]. CBD1CBD2’s ability to wedge between opposing collagen fibrils makes it bind 
tighter than CBD2 alone, making it ideal for delivery of biomolecules to promote localized 
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affects [20] [9]. Below we speculate on ways that would make CBD1CBD more effective at 
delivering bFGF.  
 Crystal structure of CBD1CBD2 shows that N-terminus of CBD1 is close to the binding 
cleft of CBD1. When wedging between collagen molecules linker between bFGF and CBD1 
needs to be long enough to avoid interacting with the CBD1 binding cleft and neighboring 
collagen micro-fibrils. Based on collagen micro-fibril structure 45 Å should be long enough [43]. 
Repeats of Gly-Gly-Gly-Gly-Ser are commonly used to provide flexibility and help maintain 
stability of linkers in aqueous solvents, while Pro residues are used to prevent linkers from 
becoming too flexible [45]. Research will need to be done to determine the optimal residue 
content needed for linking bFGF to CBD1. Since bFGF promotes cell proliferation directly 
through its receptor it needs be efficiently released from CBD1CBD2 to have the greatest effect 
[46] [47] [48]. To promote the release of bFGF, the active site for HTRA1, MMP or Cathepsin K 
can be inserted into the linker region. These enzymes are involved in osteoclast or osteoblast 
regulation and are likely to be found near the graft site for bFGF-CBD1CBD2. 
2.3i. Preventing loss of CBD2 is necessary for optimization of Pancreatic islet isolation 
 Pancreatic islet transplantation is an experimental treatment for type I diabetes and 
pancreatic cancer in which a blend of Col G and Col H are used to harvest healthy pancreatic 
islets from a deceased donor, or from the recipients own pancreas [49]. Islets are injected into the 
portal vein of the recipient’s liver. Once the islets have entered the liver, they begin to release 
insulin, restoring pancreatic function [49]. Using the liver as the site for transplantation allows 
for an efficient supply of oxygen and nutrition to the transplanted islets [50]. SDS PAGE and 
MALDI-TOF mass spectrometry of Col G purchased from VitaCyte revealed that CBD2 is lost 
for some of the enzyme during expression (see figure 3). While CBD1 has some binding affinity 
 
41 
 
for collagen fibril its affinity is lower than that for CBD2 [51]. Intact Col G is very important in 
the isolation of pancreatic islets and loss of CBD2 negatively impacts the number of healthy 
pancreatic islets isolated [52] [13] [12].   
Peptide cutter from Expasy was used to analyze the linker region between CBD1 and 
CBD2 (residue 881 to 901) revealed that the linker, contains four Lys residues and may be 
susceptible to cleavage by trypsin and clostripain [8] [53]. Mass spectrometry analysis of two 
version of truncated Col G revealed that one version is cleaved on the C-terminus side of Lys896 
and the other is cleaved on the C-terminus side of Lys908 [14]. To explain how Col G may lose 
CBD2 in pancreatic islet isolation, active trypsin may be present. In addition to trypsin, another 
likely candidate for the loss of CBD2 is clostripain. Clostripain is used alongside Col G and Col 
H in pancreatic islet isolation and is responsible for trypsin like activity during isolation [13]. 
While it prefers to cleave the C-terminal side of Arg it will also cleave on the C-terminal side of 
Lys [13]. Mutation of all four Lys residues would potentially make CBD1CBD2 resistant to 
trypsin and clostripain and would increase yield of healthy islets.  
2.4 Conclusion 
SAXS derived envelopes for Col G at low and high Ca2+ concentrations were able to reveal the 
potential domain rearrangement that occurs within the enzyme necessary for activation after being 
secreted into the host. We speculate that the shift in the PKD domain is very important for activation of 
the enzyme and may help convert the chemical energy from hydrolysis into mechanical energy of 
movement. Col G PKDCBD1CBD2 complexed to mini-collagen showed that CBD1 and CBD2 do not 
bind to the same tropocollagen molecule and that PKD domain appears to be primarily responsible for 
positioning the catalytic domain [51]. SAXS derived envelope of active Col G superimposed with 
PKDCBD1CBD2 in a complex with mini-collagen revealed that CBD1 is used to feed collagen substrate 
into the active site of the catalytic domain. Knowledge of the three-dimensional structure of active Col G, 
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at pCa 3, was able to show that CBD2 is necessary for the enzymes polarized movement on collagen 
fibrils and for the processivity seen in the enzyme [47] [51]. Linker between CBD1 and CBD2 may be 
exposed for proteolysis. For Col G to be a more effective medical tool (either for drug delivery or 
collagen degradation) future research should focus on how to best strengthen the linker between CBD1 
and CDB2.  
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Chapter 2: Figures 
 
 
  
Figure 1: Domain map of Col G and Col H from H. histolytica. In order to activate Col G 
and Col H Pro-peptide (gray, Col G: N1 – N110 Col H: N1-N40) must be cleaved. 
Catalytic domain of Col G and Col H are composed of Activator sub-domains (light 
brown, residues 1 – 288) and Peptidase subdomain (dark brown, residues 289 – 559), 
which itself contains a helper subdomain to help the domain fold correctly (dart brown, 
residues 560 – 681). PKD domains (single PKD for Col G in yellow, residues 682 – 771; 
PKD1 and PKD2 for Col H in blue and green, residues 681 – 771 for PKD1 and residues 
772 – 861 for PKD2) connect catalytic domains of both enzymes to CBDs. CBDs (CBD1 
and CBD2 for Col G in red and dark red, residues 772 – 891 for CBD1 and residues 892 
– 1008 for CBD2; single CBD for Col H in pink, residues 862 – 981) are responsible for 
binding both enzymes to collagen   
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Figure 2: A & B. Structural alignment of Col G CBD2 (red), CBD1 (green) and Col H CBD 
(magenta). R.M.S.D. CBD2 to CBD1 = 0.656 Å, R.M.S.D. CBD2 to CBD = 0.609 Å, 
R.M.S.D. CBD1 to CBD = 0.572 Å. A. Key residues responsible for binding to collagen are 
shown as sticks. B. Ca2+ residues are shown as sticks. C. Proteolytic digestion of apo CBD2 
(a) and holo CBD2 (b). from Philominathan et al. 2009. In the absence of Ca2+ CBD2 is 
degraded within 2.5 hrs. for holo CBD2 protein is still present after 3.5 hrs. Legend for SDS 
PAGE wells 1 - Control, 2 - 0.5 hrs., 3 - 1 hrs., 4 - 1.5hrs., 5 - 2hrs., 6 - 2.5 hrs., 7 - 3 hrs., 8 - 
3.5 hrs. 
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Figure 3: A. Greyscale image of Col G SDS PAGE gel with different amounts of protein. Not 
pictured, ImageJ densitometry results used to calculate purity. Rectangle was drawn around all bands 
for 30.3 μg well. Total intensity was calculated and intensity for each band was divided by total 
intensity to give purity. Purity was found to be 94%. Bands were excised for trypsin digest and mass 
spectrometry analysis. FASTA sequences for full-length Col G (uniprot: Q9X721) and was used with 
mass spectrometry data to find the residue coverage for Col G. Results show that small amounts of 
Col G lose C-terminal domains during expression.  
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Figure 4: A. Experimental Scattering profile for PKDCBD1CBD2 at pCa 3 (black) and pCa 
6 (red). B. Guinier plot for PKDCBD1CBD2 at pCa 3 and pCa 6. RG values are calculated 
from the slope of Guinier region using Guinier approximation. C. Normalized pair 
distribution function for PKDCBD1CBD2 at pCa 3 and pCa 6. Extended DMax in pCa 6 is 
due change in secondary structure at N-terminal linker for CBD1 and CBD2. D. 
Dimensionless Kratky plot for PKDCBD1CBD2 at pCa 3 and pCa 6. Plateau for pCa 6 is 
consistent with a protein that is unfolded [13]. PKDCBD1CBD2 pCa 6 envelope may need 
to be recalculated. 
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Figure 5: A. Experimental scattering profile for CBD1CBD2:[(POG)10]3 (black) and 
PKDCBD1CBD2:[(POG)10]3 (red). B. Guinier plot for CBD1CBD2:[(POG)10]3 (black) and 
PKDCBD1CBD2:[(POG)10]3 with RG values calculated from Guinier approximation. C. 
Normalized pair distribution function for CBD1CBD2:[(POG)10]3 and 
PKDCBD1CBD2:[(POG)10]3. Extended DMax in PKDCBD1CBD2:[(POG)10]3 is due to 
addition of PKD domain to complex (difference in DMax is approximately equal to the length 
of PKD domain. D. Normalized Kratky plots for CBD1CBD2:[(POG)10]3 and 
PKDCBD1CBD2:[(POG)10]3 are indicative of folded proteins. 
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Figure 6: A. Experimental Scattering profile for full-length Col G at pCa 3 (black) and pCa 6 
(red). B. Guinier plot for full-length Col G at pCa 3 and pCa 6 with RG values calculated 
from Guinier approximation. C. Normalized pair distribution function for Col G at pCa 3 and 
pCa 6. Extended DMax in pCa 6 is due change in secondary structure at N-terminal linker for 
CBD1 and CBD2. D. Dimensionless Kratky plot for PKDCBD1CBD2 at pCa 3 and pCa 6. 
After the initial “hump” y values for Col G at pCa 6 are higher than those for pCa 3. For a 
flexible molecule as x values approach infinity y values should start to plateau [13]. 
Movement towards plateau may indicate increase in flexibility for the enzyme at pCa 6. 
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Figure 7: A. Experimental Scattering profile for Col -∆CBD2 at pCa 4 (black), pCa 6 (red) 
and pCa 7 (green). B. Guinier plot for Col -∆CBD2 at pCa 4, pCa 6 and pCa 7 with RG 
values calculated from Guinier approximation. C. Normalized pair distribution function for 
Col -∆CBD2 at pCa 4, pCa 6 and pCa 7. Extended DMax at pCa 6 and pCa 7 is due change in 
secondary structure at N-terminal linker for CBD1 and CBD2. D. Dimensionless Kratky plot 
for Col -∆CBD2 at pCa 4, pCa 6 and pCa 7. Plateau for pCa 6 is consistent with a protein 
that is unfolded [13]. Similar to full-length Col G the enzyme appears to become more 
flexible as pCa increases. 
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Figure 8: Crystal structure of CBD1CBD2 (PDB: 5IKU) showing hydrogen bonds and 
salt bridges responsible for stabilizing the linker between CBD1 and CBD2. Distances 
are in Å. 
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Figure 9: Puzzle-like approach to using multiple SAXS envelopes to derive the position of 
domains. For PKDCBD1CBD2 at pCa3 approximate position of domains was found by 
superimposing the envelope with envelope for CBD1CBD2:[(POG)10]3. Using 
PKDCBD1CBD2:[(POG)10]3 envelope the positions for CBD1, CBD2, PKD and [(POG)10]3 
were confirmed. Based on binding data for CBD1CBD2, CBD2 was positioned on the C-
terminus of mini-collagen [3]. CBD1 was placed in region above CBD2 and PKD2 was 
positioned in the remaining electron density. 
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Figure 10: A. SAXS derived envelope for full-length Col G at pCa 6 (in black), Col G -
∆CBD2 at pCa 6 (in pink) and PKDCBD1CBD2 at pCa 6 (in green). PKDCBD1CBD2 
envelope was first superimposed with full-length Col G in order to find where to dock 
CBD1CBD2 pCa 6 structure and PKD. Catalytic domain was then placed into remaining 
electron density. In order to check the position of the domains Col G -∆CBD2 was 
superimposed with envelope for full-length structure. The non-overlapping region is where 
CBD2 was previously placed. B. To check if domains can reasonably link to form full-length 
enzyme the distance between terminal residues for each domain was measured using PyMol. 
For distance from CBD1 to PKD the 20 Å gap can easily be bridged when taking into 
account the 20 residues deleted from N-terminal linker of CBD1. 29 Å gap between PKD 
and catalytic domain cannot easily be made up as only 5 residues are missing between the 
two. The positions of the PKD and catalytic domain may need to be refined further.  
 
53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: A. SAXS derived envelope for full-length Col G at pCa 3 (in black), Col G -
∆CBD2 at pCa 4 (in pink) and PKDCBD1CBD2:[(POG)10]3 at pCa 3 (in green). In order to 
determine the location of CBD2 in envelope for Col G at pCa 3 PKDCBD1CBD2:[(POG)10]3 
envelope was superimposed with pCa 3 evelope. Since CBD2 in CBD1CBD2 is the domain 
that binds to mini-collagen CBD2 was positioned in the overlapping region between 
PKDCBD1CBD2:[(POG)10]3 and pCa 3 envelope [3] [4]. CBD1 and PKD were placed in the 
remaining overlapping electron density. Finally the catalytic domain was placed in the 
remaining electron density. As with pCa 6 Col G envelope Col G -∆CBD2 was used to help 
check the position of CBD2. B. To check if domains can reasonably link to form full-length 
enzyme the distance between terminal residues for each domain was measured using PyMol. 
For distance from CBD1 to PKD the 37 Å gap cannot be easily bridged. The position of N-
terminal linker in CBD1CBD2 may not be correct for PKDCBD1CBD2. 23 Å gap between 
PKD and catalytic domain cannot easily be made up as only 2 residues are missing between 
the two. The positions of the PKD and catalytic domain may need to be refined further.  
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Figure 12: A. Comparing the widest portions of SAXS derived envelopes for Col G at pCa 3 
and pCa 6. B. The interior diameter for the type II injectosome from V. cholerae was found 
to be 75 Å. At pCa 3 Col G would not be able to be secreted efficiently.  
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Figure 13: Secretion of Col G into human ECM may cause a change in the orientation of 
PKD domain which in turn may position catalytic domain for collagen degradation. 
Repositioning is most likely based on change in N-terminal linker for CBD1 and CBD2 from 
α-helix to β-sheet. Bacteria may use the difference in Ca2+ between cytosol and human ECM 
in order to quickly secrete collagenase. Once collagenase has entered host Ca2+ induced 
domain rearrangement quickly activates the enzyme. 
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Figure 14: A. Superimposed structures for full-length Col G at pCa 3 (in black) and 
PKDCBDCBD:[(POG)10]3. Additional [(POG)10]3 was built into the collagen binding cleft of 
CBD1 using Chimera. B. Same structure but rotated 90°. Newly built mini-collagen aligns 
almost perfectly with the active site for catalytic domain. Catalytic domain crystal structure 
(PDB: 2Y6I) is in a complex with peptide like inhibitor (shown in purple).  
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Figure 15: Schematic representation of processive collagenolysis from Col G collagenase. To 
initiate hydrolysis Col G may intercalate between tropocollagens in a damaged micro-fibril 
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Chapter 3: Identifying the role of PKD domains 1 and 2 in Col H collagenolysis 
Abstract 
Col H and Col G differ in the number of Collagen binding domains (CBDs), Polycystic 
kidney disease (PKD) like domains. While structurally the CBDs for Col H and Col G are 
similar the PKD domains for Col H (PKD1 and PKD2) display different surface features than the 
PKD domain for Col G (PKD). Most importantly are the presence of surface aromatic residues 
(PKD1: Tyr689, Phe712; PKD2: Tyr780, His782, Tyr796, Tyr801). Difference in domain 
orientation and surface features for collagenase PKD domains further hint that Col G and Col H 
target different regions in collagen. In this chapter we seek to understand the significance of 
these residues and the role they play in Col H collagenolysis through mutagenesis and Small 
Angle X-ray Scattering (SAXS) 
3.1 Introduction 
Hathewaya (Clostridium) histolytica is a gram-positive bacteria that is known to cause 
gas gangrene. The β-exotoxin of this bacteria consist of two enzymes, Col G and Col H, which 
seek out and degrade collagen fibers located in extracellular space. Destruction of collagen 
exposes new nutrient sources for the invading bacteria and helps spread the infection [2]. Both 
Col G and Col H have a similar multi-domain structure consisting of collagen binding domains 
(CBDs; CDB1 and CBD2 for Col G and CBD for Col H), polycystic kidney disease like- 
domains (PKD for Col G and PKD1 and PKD2 for Col H) and a catalytic domain, a zinc 
peptidase from the M9B family that is responsible for collagen hydrolysis (see figure 1) [3].  
Currently, the specific role of PKD domains in collagen degradation is unknown. Col G 
contains only a single PKD domain while Col H contains two PKD domains, PKD1 and PKD2. 
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Polycystic kidney disease like domains (PKD) adopt a variable immunoglobulin fold (V-set Ig) 
that was first found in polycystic kidney disease protein. Col G and Col H PKD domain crystal 
structures resemble the variable antibody domain and consist of a β-sandwich of seven strands 
stabilized through a hydrogen bonding network (see figure 2A) [4]. Structurally PKD domains 
are thought to assist in protein-protein or protein-carbohydrate interactions [5]. The difference in 
the number of PKD domains as well as the different structural features for Col G and Col H PKD 
domains hints that the two play different roles in degrading collagen fibrils. 
Similar to CBDs PKD domains for Col G and Col H all have conserved Asp and Asn 
residues responsible for binding calcium ions (see figure 2A). In the presence of calcium the 
mid-section of S2 becomes more flexible but for S2A and S2B calcium causes the domains to 
become more rigid [5]. Unlike CBD domains, PKD domains do not undergo significant 
structural changes in the presence of Ca2+ [5]. Col H PKD domains contain surface aromatic 
residue that are found along a prominent ridge that are not present in Col G PKD domain, 
suggesting that at least for Col H the PKD domains help to bind the enzyme to collagen (PKD1: 
Tyr689, Phe712 PKD2: Tyr780, His782, Tyr796, Tyr801) (see figure 2B) [5]. The different 
surface features of Col H and Col G PKD domains show that the two different types of PKD 
domains from Col G and Col H have different functions in collagen degradations.  
The specific role PKD domains play for H. histolytica collagenases is not known. PKD 
domain may enhancing binding capabilities, act as a spacer or swell collagen [3] [6] [7] [8] [9]. 
PKD from Col G does not contain surface aromatic residues which suggests that it does not play 
a role in collagen binding. Binding studies for Col H PKD2CBD with insoluble type I collagen 
indicate that binding occurs in two phases [3]. The first dissociation constant is 2.11 µM and the 
second dissociation constant is 339 nM. The first phase of binding indicates that just the presence 
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of PKD2 causes CBD domain to bind to insoluble collagen tighter. While PKD2CBD has two 
phases of binding PKD2 by itself has negligible binding affinity for insoluble collagen [3]. 
Surface plasmon resonance derived dissociation constants for PKD2CBD and CBD are roughly 
identical [10]. PKD2’s binding ability is only present for higher ordered collagen substrates. 
Currently it is unknown if Col H PKD1 plays a role in collagen degradation. Full length non-
active Col H was found to have the highest affinity for insoluble collagen fibril which suggests 
that the catalytic domain helps contribute towards collagen binding [3]. A collagen binding 
mechanism for full-length Col H has yet to be postulated. Currently it is unknown what role 
PKD1 and PKD2 play in Col H collagenolysis. Binding and structural study results for Col H are 
described below and the role of PKD1 and PKD2 in Col H collagenolysis is discussed. 
Col G PKD domain has no detectable binding to insoluble collagen so its role may be 
purely structural [11]. B-factor analysis of the crystal structure of Col G PKD domain indicates 
that the protein has high flexibility so perhaps the role of PKD is to help position the catalytic 
domain in Col G so that it aligns with the collagen binding clefts of CBD1 or CBD2. PKD1 in 
Col H may play the same role. In addition to assisting in collagen binding and processivity, PKD 
domains may also assist in collagen “swelling”. The ability to widen the distance from one 
tropocollagen molecule to another in a fibril or micro-fibril is known as collagen swelling. Some 
serine proteases have been determined to swell collagen fibers using their PKD domains to assist 
in degradation [8]. Type I collagens bear a net positive charge and interactions with serine 
protease PKD domain is expected to increase this charge. This may cause an increase in 
electrostatic repulsive forces between tropocollagens within a fibril and may result in exposure 
of tropocollagens. Similar to the surface exposed residues in the Col H PKD domains surface 
exposed aromatic residues from PPC domains are necessary for binding and swelling collagen. 
 
66 
 
When these aromatic residues were mutated to alanine swelling was significantly reduced [9]. 
For PPC domains binding is necessary for swelling to occur and this may be the same for Col H 
PKD domains. However, it is currently unknown if clostridium collagenases are capable of 
swelling collagen. 
3.2 Methods 
3.2a. Site Directed Mutagenesis of Col H PKD domains  
Surface exposed aromatics (TYR, HIS and PHE) along a proposed PKD collagen binding 
ridge in PKD1 and PKD2 were mutated to Ser using PCR site directed mutagenesis [5]. Wild 
type genes for PKD1PKD2CBD and PKD2CBD were used as gene templates for PCR. 5’ and 3’ 
pGEX primers carrying the desired mutations were purchased from Eurofins Genomics and used 
to insert mutations into wild type genes similar to experiment from Wilson et al. 2003 [12]. 
Primers are listed in Table 1 and mutated nucleotides are underlined. 
After 30 PCR cycles, the presence of newly synthesized gene product was confirmed 
using gel electrophoresis. PCR products were transformed into E. Coli Dh5α cells by heat shock 
for plasmid replication. The transformation product was then plated onto LB media containing 
ampicillin. After 24 hours a single colony was inoculated into 5 ml of LB-Amp and incubated at 
37° C overnight with vigorous shaking. Plasmids were isolated from cells using ethanol 
precipitation [13]. After transformation, the presence of the desired mutation in the final plasmid 
product was confirmed using Sanger sequencing [14]. DNA concentration was found using 
NanoDrop ND-1000 by measuring the ratio of absorbance at 260 nm to absorbance at 280 nm. 
Finally, each mutant plasmid was then transformed into BL21 competent cells for expression 
using previously described methods [15] [3]. The following expression vectors were constructed: 
PKD2CBD Y780S, PKD2CBD H782S, PKD2CBD Y796S, PKD2CBD Tyr801Ser, PKD2CBD 
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Tyr780Ser His782Ser Tyr796Ser Tyr801Ser (4Ser PKD2CBD), PKD1PKD2CBD Tyr689Ser 
Phe712Ser (2Ser PKD1PKD2CBD) and PKD1PKD2CBD Tyr689Ser Phe712Ser Tyr780Ser 
His782Ser Tyr796Ser Tyr801Ser (6Ser PKD1PKD2CBD). Expression vectors containing 
multiple mutations (4Ser PKD2CBD, 2Ser PKD1PKD2CBD and 6Ser PKD1PKD2CBD) were 
created by performing site directed mutagenesis experiments with primers containing single 
mutations until desired plasmid is formed. For 6Ser PKD1PKD2CBD, PCR annealing 
temperature was lowered to 50°C so that reverse primer for Tyr780Ser His782Ser could anneal 
to template. 
 
Primer Sequence (5’ to 3’) 
PKD2–Y780S-H782S–For  ATATCTATGAGTGTACCTAAATCCGGAGC 
PKD2–Y780S-H782S–Rev  TACACTCATAGATATAACTGGAAGTTTAT 
PKD2–Y796S-Y801S–For  CTGGAAAAGGAACATCTGACCCAGATGGATCTAT 
PKD2–Y796S-Y801S–Rev GATGTTCCTTTTCCAGAGAAAACAACTTTTTGAT 
PKD2–Y780S–For GTTATATCGATGCATGTACCTAAATCC 
PKD2–Y780S–Rev  ATGCATCGATATAACTGGAAGTTTATT 
PKD2–H782S–For  TATATGAGTGTACCTAAATCCGGAGCC 
PKD2–H782S–Rev AGGTACACTCATATATATAACTGGAAG 
PKD2–Y796S–For GTTTTCTCGGGAAAAGGAACATATGAC 
PKD2–Y796S–Rev  TTTTCCCGAGAAAACAACTTTTTGATT 
PKD2–Y801S–For GGAACATCGGACCCAGATGGATCTATC 
PKD2–Y801S–Rev  TGGGTCCGATGTTCCTTTTCCATAGAA 
Table 1 
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3.2b. Production and Purification of Col G and Col H segments 
 The expression and purification of wild type/mutant Col H PKD1PKD2CBD and 
PKD2CBD was performed at Okayama University Graduate School of Medicine Dentistry & 
Pharmaceutical Sciences in the Matsushita lab using previously described methods [3] [15]. 
Briefly, pGEX-4T-2 plasmids containing the sequences to be expressed were transformed into E. 
coli BL21 competent cells by heat shock. Cells were plated onto LB Agar plates supplemented 
with ampicillin and chloramphenicol and allowed to grow at 37° C. After 24 hours 10 ml of 2-
YTG broth supplemented with ampicillin was inoculated with a single colony; broth was 
incubated at 37° C for 12 hours with agitation. 6 ml of new culture was transferred to 120 ml of 
2-YTG broth containing ampicillin and the culture was incubated once again at 37° C for 12 
hours with agitation. Finally, after 12 hours 25 ml of this culture was transferred to into 2 liters 
of 2-YTG containing ampicillin. Cells were incubated until OD600 of 0.7. IPTG was added to the 
2-YTG broth and expression was carried out for 4-8 hours. After addition of 20 mL of 100 mM 
PMSF, cells were harvested using centrifugation (7,000 RPM, 4° C, 15 min). Cell pellet was 
suspended in 40 ml of 1X PBS supplemented with 1 mM PMSF and French press (10,000 PSI) 
Primers Sequence (5’ to 3’) 
PKD1–Y689S–For TTACCTTCGGGCAAGATCAATGGAACT 
PKD1–Y689S–Rev  CTTGCCCGAAGGTAATGAATTTTTGGA 
PKD1–F712S–For  GGCTCTTCGGATCCAGATGGTAAAATA 
PKD1–F712S–Rev  TGGATCCGAAGAGCCTTCACTAGAGAA 
Table 1 Cont. 
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was used to lyse the cells into centrifugation tubes (20 ml). 1 ml of Triton X-100 was added to 
each tube and tubes were rotated for 30 min. (4° C). Centrifugation was performed twice to clear 
out cell debris (15,000 RPM, 4° C, 30 min).   
The fusion proteins were purified using batch purification with glutathione sepharose 
beads. Junk proteins were eluted with the PBS wash. Fusion proteins were eluted with 50 mM 
Tris pH 8.0 containing 10 mM glutathione. Incubation with thrombin cleaves the GST tag and a 
second-round chromatography with the glutathione sepharose column was used to separate the 
protein from the tag. Q-sepharose ion exchange chromatography was used to further purify the 
proteins. Flow through fractions were pooled and dialyzed into 50 mM Tris, 1 mM CaCl2 pH 7.5. 
Following dialysis, a BCA assay was used to quantify concentration for each sample. 
3.2c Circular Dichroism and Tryptophan Emission Spectra of Col H segments  
 Circular Dichroism and Tryptophan fluorescence emission were used to check if 
introduction of Ser mutations along the proposed collagen binding ridge in PKD1 and PKD2 
would alter the structure of PKD1PKD2CBD and PKD2CBD. For both Circular Dichroism and 
Fluorescence experiments proteins were dialyzed into 10 mM Sodium phosphate pH 7.5 1 mM 
CaCl2. Circular Dichroism and Tryptophan emission spectra of PKD1PKD2CBD and 
PKD2CBD proteins were found using a Jasco CD spectrometer at room temperature.  
3.2d. Collagen Fibril Binding Study for Col H segments 
 Binding information for Col H segments was found using a previously described method 
slightly modified [3]. Binding analysis was performed using type I insoluble collagen from a 
Bovine Achilles tendon (Sigma). Briefly, 5 mg of insoluble type I collagen will be added to a .22 
µm micro centrifugal membrane. Collagen was swollen in 200 µl of 50 mM Tris-HCl 150 mM 
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NaCl 5 mM CaCl2 pH 7.5. Collagen-buffer mixture was then incubated for 30 min. at room 
temperature. After incubation, the mixture was centrifuged at 15,000 x G for 30 min. The 
collagen is then resuspended in 100 µl of the wild type or mutant proteins at various 
concentrations (.3 mg/ml - .04 mg/ml). 100 µl of Bovine Serum Albumin at an equal 
concentration to the protein was added. The mixture was incubated for 30 min and then filtered 
with a fresh .22 µm micro centrifugal membrane at 15,000 x G for 15 min. After centrifugation 
the filtrate was collected for densitometry analysis 
3.2e Densitometry analysis of Col H binding segments  
 Filtrate for each concentration from a sample was ran on an 15% SDS PAGE gel for 2 
hrs. at 20 mA. Gels were stained with comassie blue and destained with 10% Acetic acid/50% 
Methanol for 24 hrs. After destaining, Gels were scanned using Epson scanner and were 
analyzed using ImageJ. Greyscale images were used and background was subtracted (light 
background, sliding parabola and disable smoothing). Rectangles were drawn for each lane to 
include both BSA and sample bands. ImageJ densitometry analysis was used to determine the 
amount of protein in each filtrate by constructing a calibration curve with the BSA bands [16]. 
To potentially compensate for improper staining or destaining scaling factors were derived based 
on the multiplication values needed for BSA intensity values to equal theoretical values from 
calibration curve. Derived scaling factors were used for samples whose BSA intensities diverged 
greatly from the calibration curve.  
 The amount of sample bound and the amount of sample in the filtrate was calculated for 
each well by using calibration curve from BSA band intensity. Saturation curves were 
constructed to give the number of binding phases for each sample. For saturation curves, finding 
the binding parameters such as dissociation constants (KD) and number of binding sites (BMax) 
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for proteins with two phases of binding is difficult as the concentration needed to find these 
parameters may not be achievable. To find binding parameters Scatchard plots were constructed 
by plotting concentration of bound sample over sample vs. bound sample. Slope and x-intercept 
were noted to find association constant, K and amount of protein bound to collagen fibril, BMax. 
Individual results were obtained using linear regression and averaged in triplicate. 
3.2f. Identifying lower molecular weight contaminants in full length Col H from VitaCyte 
 Full length Col H was purchased from VitaCyte for structural analysis. 10% SDS PAGE 
gel was run for Col H to determine if contaminants were present in the samples. Gels were 
stained with comassie blue and destained with 10% Acetic acid/50% Methanol for 24 hrs. 
Analysis of SDS PAGE gel showed the presence of contaminants for Col H. ImageJ 
densitometry analysis of gel revealed that Col H is sufficiently pure (>93% purity for both Col 
H) (see figure 3).  
Bands were excised, washed twice with 25 mM ammonium bicarbonate, destained with 
ammonium bicarbonate/50% acetonitrile, and dried with pure acetonitrile. Then, the proteins 
were reduced using 10 mM dithiothreitol in 50 mM ammonium bicarbonate for 1hr. at 55°C 
water bath. Proteins were alkylated by adding 10 mM iodoacetamide (in 50 mM ammonium 
bicarbonate). Reaction was carried out for 1 hr. in the dark. Next, gel pieces were washed with 
ammonium bicarbonate, and dried with pure acetonitrile. Enough trypsin gold (Promega, Mass 
spectrometry grade, 10 ng/μl in 25 mM ammonium bicarbonate) was added to cover the gel 
pieces and the mixture was incubated at 4°C for 30 min. After digestion, 100 µl of 25mM 
ammonium bicarbonate was added and the mixture was left overnight at room temperature. 
Solutions were transferred to separate Eppendorf tubes; left over tryptic peptides being extracted 
by vortexing with 100 μl of 50% acetonitrile/5% formic acid for 5 min. Solutions were 
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completely evaporated and reconstituted in 50 µl of 0.1% formic acid and mass spectrometry 
analysis was performed. 
3.2g. Mass Spectrometry analysis of Col G and Col H 
Dr. Rohanna Liyanage in the mass spectrometry department at the University of 
Arkansas performed all trypsin digestions and mass spectrometry analysis. The tryptic digests 
obtained from all samples were analyzed by ESI-LC-MS/MS (Electrospray ionization liquid 
chromatography-tandem mass spectrometry) at the State-Wide Mass Spectrometry Facility at the 
University of Arkansas (Fayetteville, AR). Analysis was performed using data-dependent 
acquisition mode (DDA) with collision-induced dissociation (UltraScan mode, one min, 32,500 
m/z per second). Agilent 1200 series micro flow HPLC system in line with Bruker Amazon-SL 
quadrupole ion trop ESI mass spectrometer (QIT-ESI-MS) was used for analyzing tryptic 
digests. Reverse-phase high performance liquid chromatography (RP-HPLC) with a Zorbax SB 
C18 column (150 mm x 0.3 mm, 3.5 μm particle size, 300 Å pore size, Agilent Technologies) 
and a solvent flow rate of 4 μL/min. was used for separating the tryptic digests. Gradient of 5%-
38% consisting of 0.1% formic acid and acetonitrile was used during elution. Auto MS mode 
was used to choose peaks for MS/MS analysis. Analysis was performed in positive ion mode 
using Bruker captive electrospray source with a dry nitrogen gas temperature of 200 °C with a 
flow rate of 3 L/min with enhanced scanning mode (8,100 m/z per second).  
Peaks were picked in the LC-MS/MS chromatogram using default settings in Bruker Data 
Analysis 4.2 software. Bruker Proteinscape bioinformatics suite coupled with MASCOT 2.1 
(http://www.matrixscience.com) was used to search and match LC-MS/MS data against Col H 
FASTA sequences in the uniprot format (Col H: Q46085). Scaffold (version Scaffold_4.8.4, 
Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein 
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identifications [17]. Scaffold software was used to give high confident peptide identifications 
using identification probability and false discovery rates. Sequence coverage for each band 
revealed that small amounts of Col H lose C-terminal domains during protein expression (see 
figure 3). 
3.2h. Col H SAXS studies 
 Small Angle X-ray Scattering (SAXS) was used to find a low-resolution envelope for 
both full length Col H enzyme as well as Col H non-catalytic segments bound to different mini-
collagens. All mini-collagens were synthesized by Dr. Takaki Koide using Fmoc‐based solid‐
phase method on Rink amide resin [18].  
For Col H, SAXS data was collected for full length Col H, both wild type and Ser mutant 
versions of Col H segments apo and complexed to [(POG)10]3 and [GPRG(POG)13]3. To analyze 
complexes of mini-collagen with Col H Ser mutants, a 5 mg/ml [GPRG(POG)13]3 stock was 
formed by dissolving 1 mg of the powder in 200 µl of 50 mM Tris pH 7.5, 1 mM CaCl2. Solution 
was heated at 90° C for three minutes, then cooled to room temperature and placed in the 
refrigerator and the triple helix formed overnight. [(POG)10]3 was formed using the same 
method. Circular dichroism was used to confirm that the triple helix formed (see figure 4) [1]. 
Samples for PKD2CBD, 4Ser PKD2CBD, PKD1PKD2CBD, 2Ser PKD1PKD2CBD and 6Ser 
PKD1PKD2CBD complexed to [GPRG(POG)13]3 were prepared by allowing equal molar 
amounts of proteins and [GPRG(POG)13]3 to incubate together at 4° C overnight. After 
incubation, each complex was dialyzed into 50 mM Hepes pH 7.5, 100 mM NaCl, 5 mM CaCl2 
as this buffer was previously found to be suitable for collagenase non-catalytic domains 
complexed to mini-collagen [19]. SAXS data for PKD2CBD in a complex with [(POG)10]3 was 
collected as a control by using the same technique. For free 4Ser PKD2CBD, 2Ser 
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PKD1PKD2CBD and 6Ser PKD1PKD2CBD 50 mM Tris pH 7.5, 1 mM CaCl2 was used as the 
buffer since the proteins are stable in this buffer. For SAXS full length Col H was dialyzed into 
the pCa 3 buffer used for Col G. Full-length Col H was previously found to be stable in high 
Ca2+ buffer [20]. As such this buffer was used for Col H during SAXS 
 For each sample decreasing concentrations were pipetted into a skirted 96 well SAXS 
plate from VWR (30 µl – 20 µl; 5 wells for each sample, 3 containing protein and 2 containing 
matching buffer; concentration should be no lower than 1 mg/ml). Buffer from either the last 
dialysis exchange or the last centrifugation step were used for dilutions and for the matching 
buffer wells. High-Throughput SAXS data was collected at the SIBYLS beamline 12.3.1 
(Advanced Light Source; Berkeley, CA) using the SIBYLS mail-in program [21]. Plate was 
centrifuged at 3700 rpm for 10 minutes at 4°C to remove air bubbles. SAXS data was collected 
at 10°C using a Pilatus 2M detector (Detector distance: 1.5 m, X‐ray wavelength: 1.127 Å). Each 
sample was exposed to the beam for .3 seconds for 33 to 50 exposures.  
Scatter version 3.0 from Bioisis containing ATSAS 2.7.2 software was used to analyze 
scattering data for each sample. Data from the concentration gradient that were not affected by 
either aggregation, radiation damage or detector saturation were scaled to the highest 
concentration in the series to identify concentration dependent behavior [22]. Radius of gyration 
(RG) and maximum diameter (DMax) of each sample was found using Scatter and GNOM. To find 
RG, Guinier peak analysis function in Scatter was used. The q-range used in constructing the 
Guinier plot was found by adding and removing points so that the best fit line in the low q-range 
of data was linear [23] [24]. The q-range was further refined by adding or removing points so 
that the normalized Guinier plot follows that of an ideal, globular particle [24]. To find DMax, pair 
distribution plots were constructed in GNOM [25]. The number of points omitted at the 
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beginning is equal to the number omitted before the start of the q-range. Plots were constructed 
so that they smoothly approached P(r) = 0 (DMax). Porod-Debye (s vs. I*s
4) plots and 
dimensionless Kratky plots (sRg
2 vs. (sRg
2) x I(q)/I(0)) were constructed to analyze protein fold 
and flexibility [26]. 
Ab initio shape reconstruction of each sample was carried out using DAMMIF; 
calculations were repeated twenty-three times and the resulting envelopes were averaged and 
filtered using DAMAVER and DAMFILT [27] [28]. Solved crystal structures for each Col H 
domain (Col H CBD: 3JQW, Col H PKD2: 4JGU, Col H PKD1: 4U7K, Col H/Col G catalytic 
domain: 2Y6I, 2Y3U, 4ARE and 4ARF) were docked into SAXS derived envelopes based 
binding, NMR and previous SAXS data using Chimera [29] [12] [30] [31]. For mini-collagen, 
[(POG)10]3 or [GPRG(POG)13], were built from [(PPG)10]3 template (PDB: 1K6F) and additional 
residues were added to template using PyMol. To help position domains into SAXS derived 
envelopes FASTA sequences from Col H (Uniprot format; Col H: Q46085) was used to orient N 
and C-termini of each domain.    
3.3 Results and Discussion 
3.3a. Introduction of Ser mutations along a proposed PKD collagen binding ridge 
  In Col H PKD domains 1 and 2 surface exposed aromatic residues (PKD1: Tyr689, 
Phe712 PKD2: Tyr780, His782, Tyr796, Tyr801) are present along a potential collagen binding 
ridge [5]. In Col G CBD2 mutation of Tyr residues in collagen binding cleft was found to greatly 
affect binding [12]. Structure based sequence alignment for PKD domains revealed that PKD 
domains in collagenases with only one CBD contain surface aromatics while PKD domains in 
collagenases with two CBDs do not [5]. Conservation of PKD surface aromatic residues in 
collagenases with only one CBD suggest that the domains assist in binding to collagen. In order 
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to investigate if Col H surface exposed aromatic residues are involved in binding to substrate 
PKD1PKD2CBD and PKD2CBD with surface exposed aromatic residues mutated to Ser were 
expressed [5]. The following mutants were expressed and purified PKD2CBD Tyr780Ser, 
PKD2CBD His782Ser, PKD2CBD Tyr796Ser, PKD2CBD Tyr801Ser, 4Ser PKD2CBD, Tight 
binding PKD2CBD, 2Ser PKD1PKD2CBD and 6Ser PKD1PKD2CBD. Circular dichroism 
spectra for all samples indicates that proteins are folded with predominantly beta-sheet structure 
as predicted (see figure 5) [5].  
3.3b. WT PKD2CBD, 4Ser PKD2CBD and single point mutant binding results 
 Previously performed insoluble bovine type I collagen binding experiment for wild type 
PKD2CBD was repeated as a control [3]. While the binding data was not identical to literature 
values Saturation plots showed two phases of binding for the protein. Binding information could 
not be derived from saturation plots so a scatchard plot was created. Scatchard plot confirmed 
that biphasic binding with a tighter binding phase (K2 = 2.75 x 10
6 +/- 1.07 x 106 M, BMax2 = 
0.087 +/- 0.021 nmole/mg of collagen) and a less tight binding phase (K1 = 1.72 x 10
5 +/- 7.33 x 
104 M, BMax1 = 0.523 +/- 0.187 nmole/mg of collagen) (see figure 6) [3]. The reported binding 
information for WT PKD2CBD is as follows K2 = 2.95 x 10
6 M, BMax2 = 0.201 nmole/mg of 
collagen and K1 = 4.74 x 10
5 M, BMax1 = 0.628 nmole/mg of collagen [3]. Difference in BMax 
values between experimental and literature values may be due to variations in substrate. 
To demonstrate that surface aromatic residues on PKD2 play a role in binding to collagen 
the binding experiment was repeated for 4Ser PKD2CBD. Saturation and Scatchard plots for 
4Ser PKD2CBD show only one phase of binding (K = 5.34 x 105 +/- 9.43 x 104 M, BMax = 0.187 
+/- 0.023  nmole/mg of collagen) with the tighter binding phase being lost (see figure 6). 
Knocking out all surface aromatic residues on PKD2 seems appears to keep the domain from 
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interacting strongly with collagen fibril. In order to investigate if there is a key residue 
responsible for binding the experiment was repeated for the following PKD2CBD single point 
mutants, i.e. Y780S, H782S, Y796S and Y801S and saturation and scatchard plots were created 
for each. Among the single point mutants, only H782S and Y796S exhibited a single binding 
phase with roughly identical binding information (for H782S PKDCBD K = 1.07 x 106 +/- 1.92 
x 105 M, BMax = 0.210 +/- 0.026 nmole/mg of collagen and for Y796S PKDCBD K = 1.49 x 10
6 
+/- 2.11 x 105 M, BMax = 0.132 +/- 0.011 nmole/mg of collagen) (see figure 7). Results for 
Y780S and Y801S were biphasic similar to the wild type (Y780S: K2 = 8.83 x 10
6 +/- 2.56 x 106 
M, BMax2 = 0.069 +/- 0.01 nmole/mg of collagen fibril and K1 = 7.62 x 10
4 +/- 1.09 x 105 M, 
BMax1 = 1.34 +/- 0.059 nmole/mg of collagen fibril; Y801S: K2 = 5.90 x 10
6 +/- 3.65 x 106 M, 
BMax2 = 0.056 +/- 0.016 nmole/mg of collagen; K1 = 1.64 x 10
5 +/- 1.85 x 105 M, BMax1 = 0.433 
+/- 0.231 nmole/mg of collagen) (see figure 8). 
3.3c. WT PKD1PKD2CBD, 2Ser PKD1PKD2CBD and 6Ser PKD1PKD2CBD binding results 
 In order to determine if PKD1 plays a role in binding Col H to collagen fibril the binding 
experiment was performed for wild type PKD1PKD2CBD and saturation and scatchard plots 
were made. Binding results were nearly identical to those of the wild type PKD2CBD (biphasic; 
K2 = 3.18 x 10
6 +/- 7.90 x 105 M, BMax2 = 0.057 +/- 0.008 nmole/mg of collagen; K1 = 1.85 x 10
5 
+/- 9.96 x 104 M, BMax1 = 0.235 +/- 0.126 nmole/mg of collagen) (see figure 9). Decrease in BMax 
values from wild type PKD2CBD may be due to steric hindrance from addition of PKD1. PKD1 
does not interact strongly enough with collagen to form a third phase of binding. However PKD1 
may contribute to binding by acting together with PKD2 on collagen fibril. In order to examine 
this, binding experiment was performed for 2Ser PKD1PKD2CBD. For 2Ser PKD1PKD2CBD 
binding is biphasic (K2 = 1.38 x 10
7 +/- 1.22 x 107 M, BMax2 = 0.031 +/- 0.007 nmole/mg of 
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collagen; K1 = 4.26 x 10
5 +/- 2.87 x 105 M, BMax1 = 0.102 +/- 0.014 nmole/mg of collagen) and 
the second phase seems to be much tighter for 2Ser mutant than for wild type PKD1PKD2CBD 
(see figure 9). Tighter binding could be from potential hydrogen bonding between Ser hydroxyl 
group and amine group from collagen α-chains [12]. While plausible, this seems as other 
PKD2CBD Ser mutants do exhibit significantly increased binding to insoluble substrate. To 
determine if CBD alone can anchor full-length Col H to collagen fibril, binding experiment for 
6Ser PKD1PKD2CBD was performed. For PKD1PKD2CBD with all PKD surface aromatics 
knocked out binding was single phased (KD = 5.94 x 10
5 +/- 1.32 x 105 M, BMax = 0.079 +/- 
0.011 nmole/mg of collagen) (see figure 9). Results indicate that CBD by itself may be strong 
enough to anchor Col H to collagen fibril. 
3.3d. Small angle X-ray Scattering of Col H domains  
SAXS data was collected in order to give a three-dimensional shape of Col H domains 
interacting with collagenous peptide. Since SAXS measures solution scattering insoluble 
collagen fibrils cannot be used to model protein/collagen interaction [32]. In order to model the 
interaction between proteins and collagen, complexes with water soluble collagen-like peptides 
(mini-collagen) were formed. Mini-collagen are short peptides with collagen like sequence, 
generally Pro-Hyp-Gly (POG), repeated throughout the peptide that assemble into triple helix 
when dissolved into buffer [33]. [GPRG(POG)13]3 was used as a the mini-collagen for SAXS 
experiments with (POG)10 being used as a control. Collagenase segments have been shown to 
bind readily to mini-collagen and is thought to mimic how enzyme binds collagen α-chains [30] 
[31] [19]. After dissolving mini-collagen in buffer, solution was allowed to equilibrate overnight 
and triple helix formation was confirmed using circular dichroism (see figure 4) [1].  
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Small Angle X-ray Scattering (SAXS) intensity was collected for the following samples; 
PKDCBD, PKD2CBD:[(POG)10]3, PKD2CBD:[GPRG(POG)13]3, 4 Ser PKD2CBD, 4 Ser 
PKD2CBD:[GPRG(POG)13]3, PKD1PKD2CBD, PKD1PKD2CBD:[GPRG(POG)13]3, 2 Ser 
PKD1PKD2CBD, 2 Ser PKD1PKD2CBD:[GPRG(POG)13]3, 6 Ser PKD1PKD2CBD, 6 Ser 
PKD1PKD2CBD:[GPRG(POG)13]3 and full length Col H. For PKD2CBD, 4 Ser PKD2CBD, 
PKD1PKD2CBD, 2 Ser PKD1PKD2CBD and 6 Ser PKD1PKD2CBD scattering data was 
collected to understand how the Col H domains come together in three-dimensional space. SAXS 
data for PKD2CBD was previously collected by Dr. Ryan Bauer and was only reprocessed for 
this experiment. Envelopes for PKD2CBD and PKD1PKD2CBD were used to determine where 
the enzyme is in relation to the mini-collagen. SAXS profiles, guinier plots, pair distribution 
plots and Kratky and porod-debye plots for Col H samples are shown in figures 9 – 14. 
Dimensionless kratky plots indicate that all samples are folded (see figures 10 – 15) [26].  
Briefly, radius of gyration (RG) is a way to give a rough estimate on the shape of the 
molecule and can be used to identify aggregation in a protein [24]. DMax value found from pair 
distribution function gives the maximum diameter present in a molecule [24]. DMax values are 
used in the development of SAXS derived envelopes. NSD values are used to determine the 
agreement between derived envelopes used to calculate an average structure [24]. Q-range is the 
range of scattering values from initial scattering profile used in deriving SAXS envelope. The 
RG, DMax, NSD and Q-range for all samples are summarized in Tables 2. Identical to Col G, 
agreement between Col H scattering profiles and theoretical profiles from crystal structure 
coordinates for each envelope was also found by using Crysol from Atsas online server. Results 
are listed in appendix. 
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3.3e. SAXS derived envelopes for Col H segments free and bound to mini-collagen 
To construct each PKD2CBD:mini-collagen complex the envelopes for each complex 
and for reprocessed PKD2CBD were superimposed with each other. The crystal structures for 
Sample RG (Å) 
Guinier 
Approx. 
RG (Å) 
Defined 
by P(r) 
DMax 
(Å) 
Mean 
NSD 
value 
Q-range 
(Å−1) 
PKD2CBD 26 26 87 0.509 0.0188 – 
0.3319 
PKD2CBD:[(POG)10]3 33 35 145 0.592 0.0129 – 
0.3220 
PKD2CBD:[GPRG(POG)13]3 33 39 180 0.572 0.0111 – 
0.3932 
4 Ser PKD2CBD 25 26 90 0.512 0.0195 – 
0.3528 
4 Ser PKD2CBD:[GPRG(POG)13]3 32.3 37 180 0.545 0.0111 – 
0.3924 
PKD1PKD2CBD 33 35 110 0.686 0.0111 – 
0.3912 
PKD1PKD2CBD:[GPRG(POG)13]3 40 48 220 0.551 0.0109 – 
0.2890 
2 Ser PKD1PKD2CBD 36 36 115 0.778 0.0164 – 
0.2946 
2 Ser 
PKD1PKD2CBD:[GPRG(POG)13]3 
44 50 210 0.605 0.0129 – 
0.3220 
6 Ser PKD1PKD2CBD 33 34 110 0.749 0.0184 – 
0.3570 
6 Ser 
PKD1PKD2CBD:[GPRG(POG)13]3 
40 46 220 0.576 0.0139 – 
0.3751 
Col H 40 41 140 0.798 0.0124 – 
0.3215 
Table 2 
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[(POG)10]3 (PDB: 1K6F) and [GPRG(POG)10]3 (built from (POG)10 code) were positioned in the 
most rod-like regions of the envelopes while CBD was positioned on the C-terminus of the mini-
collagens as determined by previous works for Col G’s CBD2 [30] [31]. Binding surface of CBD 
derived from mutagenesis and collagen binding studies was positioned to interact with the C-
terminus of mini-collagen [12] [30] [34]. PKD2 was positioned in the remaining electron 
density. For WT PKD2CBD with [(POG)10]3 and [GPRG(POG)10]3 it was discovered that PKD2 
hangs off the end of mini-collagen and does not make any contact (see figure 16A). Construction 
of 4Ser:[GPRG(POG)13]3 complex was performed in the same manner as listed with envelope for 
4Ser PKD2CBD being used in place of PKD2CBD (see figure 16B). The results for 4Ser 
PKD2CBD were very similar to that of the wild type. SAXS envelopes for PKD2CBD and 4 Ser 
PKD2CBD may explain surface plasmon resonance results from Sekiguchi et al. 2018. Plasmon 
resonance results for binding to mini-collagen revealed that measured dissociation constants for 
Col H CBD and PKD2CBD are similar (CBD: 75.2 +/- 0.41 x 10-5 M, PKD2CBD: 44.5 +/- 0.55 
x 10-5 M) [10]. When CBD binds to C-terminus of mini-collagen linker to PKD2 must not be 
long enough to allow the domain to interact with substrate. While it is known that Col G CBD2 
binds to C-terminus of mini-collagen with the front facing the N-terminus the directionality of 
binding for Col H is unknown [30].  
In order to construct the complexes for samples involving PKD1PKD2CBD the position 
of PKD1 in free PKD1PKD2CBD was first determined. The positions of CBD and PKD2 in 
PKD2CBD can be inferred based on the envelopes for the wild type complexes. Envelope for 
wild type PKD2CBD was superimposed with golf club shaped envelope for PKD1PKD2CBD. 
CBD was positioned in the “head” of the club with PKD2 following. PKD1 was then positioned 
in the remaining electron density envelope (see figure 17A). PKD1PKD2CBD complexes were 
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constructed by superimposing the reprocessed envelope for PKD1PKD2CBD with the envelope 
for PKD1PKD2CBD:[GPRG(POG)13]3. [GPRG(POG)13]3, CBD and PKD2 were positioned 
based on the results for PKD2CBD:mini-collagen envelopes and PKD1 was placed in the 
remaining electron density (see figure 17A). Both PKD1 and PKD2 do not make contact the 
same mini-collagen as CBD. For both 2Ser and 6Ser PKD1PKD2CBD:[GPRG(POG)13]3 
complexes were constructed using the same method with 2Ser and 6Ser PKD1PKD2CBD 
envelopes used in place of WT PKD1PKD2CBD (see figure 17B). The results for 2Ser and 6Ser 
PKD1PKD2CBD were identical to that of the wild type. 
3.3f. SAXS derived structure of full-length Col H  
In order to investigate how the full length enzyme is able to hydrolyze collagen the 
SAXS derived envelope for full-length Col H at pCa 3 was superimposed with the previously 
solved complexes for PKD2CBD:[GPRG(POG)13]3 and PKD1PKD2CBD:[(GPRG(POG)13]3. 
Envelope for full-length Col H has a globular shape with a protrusion (see figure 16A). Based on 
results from Ohbayashi et al. 2013 CBD was positioned in the “head” region and PKD2 was 
positioned on the protrusion based on how the Col H envelope overlapped with PKD2CBD and 
PKD2CBD:[GPRG(POG)13]3 envelopes (see figure 18A) [20]. Next PKD1 was positioned based 
on how the Col H envelope overlaps with envelopes for PKD1PKD2CBD and 
PKD1PKD2CBD:[GPRG(POG)13]3. Catalytic domain was positioned in the remaining electron 
density. Crystal structure for full catalytic domain of Col H has not been solved, however crystal 
structure for its peptidase domain has been solved (PDB: 4ARF) [35]. Therefore, the crystal 
structure of catalytic domain from Col G (PDB: 2Y3U) was used to find the position of the 
activator domain. Peptidase domain from Col H with peptide like inhibitor was superimposed 
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with Col G collagenase module (R.M.S.D. = 0.878 Å). Col G and Col H catalytic domains are 
homologous and share sequence identity of 48% and sequence similarity of 66% [7] [36] [37].  
N-terminal residue in CBD crystal structure is not present in sequence of Col H CBD. As 
such it was hidden and new N-terminal residue (Val862) of CBD crystal structure and C-terminal 
residue (Asp860) of PKD2 crystal structure are oriented as close as possible distance between the 
two was found to be 14 Å (see figure 18B). The single residue missing between CBD and PKD2 
would not be enough to make up the 14 Å distance. Coloring both CBD and PKD2 Cα by B-
factor showed that N-terminus of CBD has a high B-factor relative to the rest of the domain 
which may make it dynamic enough to make up the distance without interfering with the Ca2+ 
binding residues. For average B-factor of CBD N-terminus Cα B-factors for residues 861 to 867 
were chosen for finding the average B-factor as Glu868 side chain is involved in chelating Ca2+ 
ions. For the PKD2 and PKD1 overlapping residues in PKD2 were hidden so that no residues are 
missing between N-terminus of PKD2 and C-terminus of PKD1. The distance between the new 
N-terminal residue of PKD2 (Leu771) and the C-terminal residue of PKD1 (Asp770) was found 
to be 9 Å. Coloring the Cα atoms for the N-terminal linker of PKD2 and the C-terminal linker of 
PKD1 by relative B-factor reveal that N-terminal linker of PKD2 and C-terminal linker of PKD1 
have high B-factors relative to their respective structure which may allow the two domains to 
connect (see figure 18C). PKD1 was positioned within superimposed envelope for 
PKD1PKD2CBD so that the N-terminal residue of PKD1 (Asn685) was as close as possible to 
C-terminal residue of Col H peptidase domain (Gly681). The distance between the two residues 
was found to be 33 Å. While two residues are missing between C-terminus of peptidase domain 
and N-terminus of PKD1 that would not bridge the 33 Å gap. The C-terminal region of the 
peptidase domain is known as the helper domain and is used to help the catalytic domain fold 
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correctly [7]. In the full-length enzyme, the helper domain may be folded differently than in the 
peptidase domain alone which may help link PKD1 to peptidase domain. Unpublished high-
speed atomic force microscopy (AFM) results from Osaka University for full-length Col H 
reveals that the enzyme is highly dynamic which may help to link the domains (see Appendix 
video 2). Since the method used for positioning domain can only give a relative position CBD, 
PKD2, PKD1 and catalytic domain may not be positioned optimally in SAXS envelope for full-
length Col H. In the future, SASREF from ATSAS online server may need to be used to find the 
best position for each domain in the envelope.   
3.3g. PKD2 Surface Aromatic residues could allow PKD2CBD to wedge between 
tropocollagen molecules  
Mechanism of how PKD’s aromatic side chains can assist in binding tighter with 
collagen fibril is currently unknown. The binding clefts for CBDs from both Col G and Col H 
contain conserved Tyr and Phe residues that constitute ‘hot spots’ for CBD binding to collagen 
[12] [34]. Mutation of these residues in CBD from Col G either obliterated or diminished binding 
to mini-collagen [12]. HSQC-titration of mini-collagen to CBD2 from Col G also demonstrated 
their interaction to mini-collagen [30]. The orientation of aromatic residues in the binding pocket 
of Col H closely resemble those of Col G. Therefore, both Col G and Col H are likely to use 
these same residues to bind to collagen fibril and mini-collagen. The aromatic residues may 
interact with the Pro residues of collagen through aromatic CαH-π interactions as demonstrated 
for model peptides Pro and aromatic residues, i.e. Tyr, Phe and Trp [38] [39].  
While addition of PKD2 by itself cannot bind to collagen, it was shown to enhance 
collagen fibril binding of CBD but not so much to mini-collagen [3] [10]. Catalytic domain by 
itself (gelatinase) does have the ability to degrade acid solubilized collagen and denatured 
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collagen it cannot degrade the ability degrade insoluble collagen fibril [40] [3]. PKD2 has the 
ability to enhance binding of CBD to collagen fibril however, PKD2 and PKD1PKD2 by 
themselves have no affinity for collagen fibril [3]. To explain PKD2’s ability to enhance 
collagen binding for CBD we speculate that PKD2CBD has the ability to wedge between 
adjacent tropopocollagens within a micro-fibril [41]. Previously described unpublished high-
speed AFM results show that free Col H is a highly dynamic enzyme which may allow to wiggle 
between adjacent tropocollagens (see video 2 in Appendix). Wedges work by converting a force 
applied to its blunt end to into perpendicular forces. Blunt end force may be the dynamic 
movement of PKD2CBD which causes PKD2CBD to bind tighter than CBD alone.  
Once PKD2CBD is wedged, aromatic residues on PKD2 may interact to collagen via 
CαH-π interactions [39]. H782 and Y796 play a key-roles in allowing PKD2 to bind collagen 
fibril. In the crystal structure of PKD2 H782 and Y796 are located near the C-terminal linker of 
PKD2 [5]. Once CBD binds to a tropocollagen, H782 and Y796 could provide the initial surface 
for adjacent tropocollagen to bind. While they appear to not be as important for binding, Y780 
and Y801 may also help PKD2 bind to adjacent tropocollagen. These interactions cause 
PKD2CBD to bind even tighter and explains the higher binding affinity phase seen in WT 
PKD2CBD [3].  
3.3h. PKD1 is not involved in allowing Col H to bind to collagen  
While binding results indicate that PKD1 appears to play no role in allowing Col H to 
interact with collagen fibril it could still play a role in collagenolysis. PKD1 could still act as 
either a spacer or collagen “sweller”. PKD1 domain may provide the proper distance between 
CBD and catalytic domain. PKD1 have a similar role to that of PKD domain from Col G. Since 
it has no apparent binding apparent to insoluble collagen or mini-collagen PKD1’s role may be 
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to align the active site of the catalytic domain with the binding clefts of a CBD [6] [7]. Other role 
for PKD domains demonstrated are that PKD domains from some serine proteases have been 
shown to “swell” collagen fibrils by increasing the distance between tropocollagens within a 
micro-fibril [8] [42]. Interactions between serine protease and tropocollagens increase the overall 
positive charge on collagen and electrostatic repulsive forces may cause individual collagen 
fibers to swell [8]. It is currently unknown if PKD, PKD1 or PKD2 can “swell” collagen fibrils. 
Future experiments are being planned to use AFM to measure the distance between microfibrils 
after being treated with either PKD1PKD2CBD or PKD2CBD [8] [42]. 
3.3i. SAXS derived envelope of Col H reveals PKD2 could feed a tropocollagen into catalytic 
domain  
For a brief recap, in this chapter it was discovered that in SAXS experiments to 
visualized PKD1PKD2CBD and PKD2CBD complexed to mini-collagen PKD domains do not 
interact with mini-collagen. However, fibril binding assay wild type and mutant 
PKD1PKD2CBD and PKD2CBD proteins revealed that aromatic residues present on PKD2 
enhance binding of CBD. Below we attempt to use these new pieces of information to tease out a 
mechanism for Col H collagen hydrolysis. 
Superimposed PKD2CBD:[GPRG(POG)13]3 and PKD1PKD2CBD[GPRG(POG)13]3 
complexes with the SAXS derived envelope for full-length Col H reveals that PKD2 could be 
used to feed a tropocollagen molecule into the catalytic domain. Due to binding results for WT 
PKD2CBD and 4Ser PKD2CBD, PKD2 was positioned so that aromatic residues involved are 
pointed away from the tropocollagen CBD is bound to. In PKD2CBD:[GPRG(POG)13]3 
envelope PKD2 is positioned diagonally from CBD at the C-terminus of the mini-collagen. 
However if PKD2 was positioned so that it is side-by-side with CBD the distance from the 
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binding cleft of CBD to the surface aromatic residues of PKD2 would be approximately 15 Å. 
Consequentially, the distance from the center of one tropocollagen molecule to an adjacent one 
in a micro-fibril is approximately 15 Å [43]. A second tropocollagen molecule was positioned 15 
Å from the crystal structure for [GPRG(POG)13]3 so that PKD2 aromatic residues would make 
contact. This second mini-collagen aligns almost perfectly with the active site cleft of the 
catalytic domain (see figure 19). PKD1PKD2CBD:[GPRG(POG)13]3 envelope suggests that 
PKD1 is necessary for positioning the catalytic domain. If it has any involvement in binding its 
contribution may not be large enough to be picked up by the methods used in this study. While 
CBD is key towards anchoring the enzyme, PKD2 surface aromatic residues allow Col H to 
wedge between adjacent tropocollagen molecules in a micro-fibril. PKD2 does not bind to 
tropocollagen by itself however, its potential loose interactions via surface aromatics may allow 
it be fed into the catalytic domain easier. It is possible that mini-collagen bound to CBD may be 
the one being fed into catalytic domain. Based on mechanism teased out form multiple SAXS 
envelopes tropocollagen bound to CBD does not align with active site cleft of peptidase domain. 
Positioning of domains in envelopes could be incorrect. Potential SAXS experiment with 
mutationally inactivated E416D Col H and mini-collagen would help to support or discredit 
current PKD2 focused hypothesis [3]. 
Col G prefers to bind to slightly untwisted regions in collagen and based on sequence 
similarity Col H may do the same [31] [34]. High speed AFM video shows that Col G prefers to 
attack disorder regions in a collagen micro-fibril mimic and the same could be true for Col H 
[44]. Col H would have an easier time wedging between tropocollagens at less tightly twisted 
regions in collagen fibril. While Col G is a processive enzyme there is no evidence to suggest 
that Col H has processive activity. However, processivity cannot be disproven until AFM 
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experiment with Col H is performed [44]. Limited proteolysis of acid solubilized type I, type II 
and type III collagens by Col H shows that the enzyme prefers to initially attack the 
hypersensitive sequence of tropocollagen located about 1/3 of way from N-terminus [45] [46]. 
After initial hydrolysis event Col H processes C-terminal fragment at specific sites [45] [47]. Col 
H’s role in collagen hydrolysis may be to act as an endopeptidase hydrolyzing hypersensitive 
sites in collagen fibrils and micro-fibrils. Hydrolysis at these sites may open up new regions for 
Col G to begin processive hydrolysis.  
3.3j. Col H segments are successful in increasing the systemic effects of Parathyroid Hormone 
 Like Col G segments, Col H segments can be used for localizing the effects of bFGF. For 
localization of bFGF using PKD2CBD is necessary for getting the best results, however Col G 
segment CBD1CBD2 is still the best for using bFGF [48] [49] [50] [10]. For biomolecules that 
have a more systemic effect, such as Parathyroid hormone (PTH), Col H non-catalytic segments 
are required for increasing their efficacy. Since they do not bind as tightly as Col G segments, 
they are more likely to be distribute throughout blood accessible collagen rich tissues such as 
skin and bone [10]. PTH fused to the N-terminus of CBD has been used to promote growth of 
bone and hair in mice [51] [52] [53] [54]. PTH-CBD was found to distribute to both skin and 
bone after intraperitoneal or subcutaneous injection [52]. PTH-CBD is an anabolic agent and 
works by directly targeting bone and skin [55]. Addition of PKD2, PKD2-CBD, was found to be 
less effective than using CBD alone and approximately equivalent to using PTH alone [54]. 
Preferable pharmacodynamics of CBD is potentially the reason for that.  Linker between PTH 
and PKD2 may be too long and is cleaved in vivo before it can interact with its receptor [54].  
 Scatchard plot and saturation plot data has revealed how tight non-catalytic segments of 
Col H bind to collagen. Based on SAXS derived envelopes for PKD2CBD and PKD1PKD2CBD 
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bound to mini-collagen it was discovered that the N-terminal linker of PKD2 and PKD1 domain 
are not involved in binding to collagen. For increasing systemic affects using Col H segments, 
finding the optimal binding affinity for Col H segments is necessary. For WT PKD2CBD, PKD2 
aromatic residues are key to binding the domain to collagen. However, even when these residues 
are knocked out PKD2CBD still has increased affinity for collagen [3]. Fusing PTH to N-
terminus PKD1 in 6 Ser PKD1PKD2CBD or to the N-terminus of PKD2 in 4Ser PKD2CBD 
may be more efficacious than using PTH fused to CBD. In order to make these potential fusion 
proteins affective linker region between PTH and N-terminus of PKD2 may need to be rigid to 
prevent loss of PTH into the serum [54] [55]. 
3.4 Conclusion 
For Col H, site directed mutagenesis of PKD1 and PKD2 coupled with a collagen binding 
revealed that PKD2 surface aromatics play a key role in binding the enzyme to substrate while 
PKD1 plays no apparent role in collagen binding [3]. SAXS derived envelopes of Col H non-
catalytic segments PKD1PKD2CBD and PKD2CBD complexed with mini-collagen revealed 
that PKD2 works similar to CBD1 in Col G and allows Col H to intercalate between adjacent 
tropocollagens within a micro-fibril [19]. Superimposing full-length Col H envelope with the 
previous non-catalytic envelopes revealed that PKD2 is used to feed substrate into the catalytic 
domain. In order to support proposed mechanism of hydrolysis of Col H more data is needed. 
FRET imaging and High-speed AFM could potentially be used to visualize Col H on 
reconstituted collagen fibrils. Observing Col H on collagen fibril may reveal if micro-fibril 
wedging hypothesis is plausible. Understanding how Col H binds substrate would reveal best 
ways to link PTH for delivery. 
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Chapter 3: Figures 
 
  
Figure 1: Domain map of Col G and Col H from H. histolytica. In order to activate Col G 
and Col H Pro-peptide (gray, Col G: N1 – N110 Col H: N1-N40) must be cleaved. 
Catalytic domain of Col G and Col H are composed of Activator sub-domains (light 
brown, residues 1 – 288) and Peptidase subdomain (dark brown, residues 289 – 559), 
which itself contains a helper subdomain to help the domain fold correctly (dart brown, 
residues 560 – 681). PKD domains (single PKD for Col G in yellow, residues 682 – 771; 
PKD1 and PKD2 for Col H in blue and green, residues 681 – 771 for PKD1 and residues 
772 – 861 for PKD2) connect catalytic domains of both enzymes to CBDs. CBDs (CBD1 
and CBD2 for Col G in red and dark red, residues 772 – 891 for CBD1 and residues 892 
– 1008 for CBD2; single CBD for Col H in pink, residues 862 – 981) are responsible for 
binding both enzymes to collagen   
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Figure 2: A. Structural alignment for Col G PKD (yellow), Col H PKD2 (green) and Col H 
PKD1 (cyan). R.M.S.D. PKD to PKD2 = 0.619 Å, R.M.S.D. PKD to PKD1 = 0.639 Å and 
R.M.S.D. PKD1 to PKD2 = 0.490 Å. Residues responsible for Ca2+ chelation are shown as 
sticks. B. Surface aromatic residues for PKD2 (Tyr780, His782, Tyr796 and Tyr801) and 
PKD1 (Tyr689 and Phe712) lie along a proposed collagen binding domain.   
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Figure 3: Greyscale image of Col H SDS PAGE gel with different amounts of protein. Not 
pictured, ImageJ densitometry results used to calculate purity. Rectangle was drawn around 
all bands for 30.3 μg well. Total intensity was calculated and intensity for each band was 
divided by total intensity to give purity. Purity was found to be 96%. Bands from were 
excised for trypsin digest and mass spectrometry analysis. FASTA sequences for full-length 
Col H (uniprot: Q46085) was used with mass spectrometry data to find the residue coverage 
for Col H. Results show that small amounts of Col H lose C-terminal domains during 
expression.  
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Circular Dichroism Spectra for 
[GPRG(POG)13]3
Figure 4: Circular dichroism spectrum for [GPRG(POG)13]3. Maximum at 225 nm and 
minimum at 198 nm is consistent with triple helical collagen [1]. 
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Figure 5: A. Circular dichroism spectra for PKD2CBD, 4 Ser PKD2CBD, V778Y K785Y 
PKD2CBD, Y780S PKD2CBD, H782S PKD2CBD, Y796 PKD2CBD, Y801S PKD2CBD. 
V778Y K785Y PKD2CBD is a potential tight binding mutant of PKD2CBD. V778Y K785Y 
PKD2CBD did not express well, only enough protein was produced for Circular dichroism. 
B. Circular dichroism spectra for PKD1PKD2CBD, 2 Ser PKD1PKD2CBD and 6 Ser 
PKD1PKD2CBD. Raw data was plotted on Excel and smoothed with exponential smoothing 
function. 
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Figure 6: A. Saturation plot for PKD2CBD (black) and 4 Ser PKD2CBD (green) with bovine 
type I insoluble collagen fibril. Wild type PKD2CBD appears to still have two phases of 
binding while 4 Ser PKD2CBD lost a phase B. Scatchard plots for PKD2CBD and 4 Ser 
PKD2CBD also shows that 4 Ser PKD2CBD has lost a phase of binding. While uncertainty 
for scatchard plots are generally high plots should still be able to give association constant 
within an order of 10. 
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Figure 7: A. Saturation plot for H782S PKD2CBD (black) and Y796S PKD2CBD (green) 
with bovine type I insoluble collagen fibril. H782S PKD2CBD and Y796S PKD2CBD both 
show single phase in saturation plots. B. Scatchard plots for H782S PKD2CBD and Y796S 
PKD2CBD both confirm single phase of binding and were used to estimate association 
constant. In PKD2 crystal structure H782 and Y796 are closest to C-terminal linker to CBD. 
These two residues might provide the initial surface for binding to collagen fibril.  
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Figure 8: A. Saturation plot for Y780S PKD2CBD (black) and Y801S PKD2CBD (green) 
with bovine type I insoluble collagen fibril. Y780S PKD2CBD and Y801S PKD2CBD both 
show two phases in saturation plots. B. Scatchard plots for Y780S PKD2CBD and Y801S 
PKD2CBD both confirm single phase of binding and were used to estimate association 
constant. Results seem to give support to H782 and Y796 being responsible for binding in 
PKD2. 
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Figure 9: A. Saturation plot for PKD1PKD2CBD (black) 2 Ser PKD1PKD2CBD (green) 
and 6 Ser PKD1PKD2CBD (blue) with bovine type I insoluble collagen fibril. 
PKD1PKD2CBD and 2 Ser PKD1PKD2CBD both show biphasic binding in the saturation 
plot while 6 Ser PKD1PKD2CBD shows only a single phase. B. Scatchard plots for 
PKD1PKD2CBD, 2 Ser PKD1PKD2CBD and 6 Ser PKD1PKD2CBD confirm binding 
phase information and were used to estimate association constant 
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Figure 10: A. Experimental Scattering profile for PKD2CBD (black), PKD2CBD:[(POG)10]3 
(red), PKD2CBD:[GPRG(POG)13]3 (green). B. Guinier plot for PKD2CBD, 
PKD2CBD:[(POG)10]3, PKD2CBD:[GPRG(POG)13]3. RG values are calculated from slope of 
Guinier region using Guinier approximation. C. Normalized pair distribution function for 
PKD2CBD, PKD2CBD:[(POG)10]3, PKD2CBD:[GPRG(POG)13]3. Extended DMax values are 
from addition of mini-collagen D. Dimensionless Kratky plot for PKD2CBD, 
PKD2CBD:[(POG)10]3, PKD2CBD:[GPRG(POG)13]3. Plateau like region for 
PKD2CBD:[GPRG(POG)13]3 may be due to extended mini-collagen used for complex 
making the structure appear more rod-like. 
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Figure 11: A. Experimental Scattering profile for 4 Ser PKD2CBD (black) and 4 Ser 
PKD2CBD:[GPRG(POG)13]3 (red). B. Guinier plot for 4 Ser PKD2CBD and 4 Ser 
PKD2CBD:[GPRG(POG)13]3. RG values are calculated from slope of Guinier region using 
Guinier approximation. C. Normalized pair distribution function for 4 Ser PKD2CBD and 4 
Ser PKD2CBD:[GPRG(POG)13]3. Extended DMax values are from addition of mini-collagen 
D. Dimensionless Kratky plot for 4 Ser PKD2CBD and 4 Ser PKD2CBD:[GPRG(POG)13]3. 
Plateau like region for 4 Ser PKD2CBD:[GPRG(POG)13]3 may be due to extended mini-
collagen used for complex making the structure appear more rod-like. 
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Figure 12: A. Experimental Scattering profile for PKD1PKD2CBD (black) and 
PKD1PKD2CBD:[GPRG(POG)13]3 (red). B. Guinier plot for PKD1PKD2CBD and  
PKD1PKD2CBD:[GPRG(POG)13]3. RG values are calculated from slope of Guinier region 
using Guinier approximation. C. Normalized pair distribution function for PKD1PKD2CBD 
and PKD1PKD2CBD:[GPRG(POG)13]3. Extended DMax values are from addition of mini-
collagen D. Dimensionless Kratky plot for PKD1PKD2CBD and 
PKD1PKD2CBD:[GPRG(POG)13]3.  
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Figure 13: A. Experimental Scattering profile for 2 Ser PKD1PKD2CBD (black) and 2 Ser 
PKD1PKD2CBD:[GPRG(POG)13]3 (red). B. Guinier plot for 2 Ser PKD1PKD2CBD and 2 
Ser PKD1PKD2CBD:[GPRG(POG)13]3. RG values are calculated from slope of Guinier 
region using Guinier approximation. C. Normalized pair distribution function for 2 Ser 
PKD1PKD2CBD and 2 Ser PKD1PKD2CBD:[GPRG(POG)13]3. Extended DMax values are 
from addition of mini-collagen D. Dimensionless Kratky plot for 2 Ser PKD1PKD2CBD and 
2 Ser PKD1PKD2CBD:[GPRG(POG)13]3.  
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Figure 14: A. Experimental Scattering profile for 6 Ser PKD1PKD2CBD (black) and 6 Ser 
PKD1PKD2CBD:[GPRG(POG)13]3 (red). B. Guinier plot for 6 Ser PKD1PKD2CBD and 6 
Ser PKD1PKD2CBD:[GPRG(POG)13]3. RG values are calculated from slope of Guinier 
region using Guinier approximation. C. Normalized pair distribution function for 6 Ser 
PKD1PKD2CBD and 6 Ser PKD1PKD2CBD:[GPRG(POG)13]3. Extended DMax values are 
from addition of mini-collagen D. Dimensionless Kratky plot for 6 Ser PKD1PKD2CBD and 
6 Ser PKD1PKD2CBD:[GPRG(POG)13]3.  
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Figure 15: A. Experimental Scattering profile for Col H B. Guinier plot for Col H. RG values 
was calculated from slope of Guinier region using Guinier approximation. C. Normalized pair 
distribution function for Col H. D. Dimensionless Kratky plot for Col H.  
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Figure 16: A. SAXS derived envelope for PKD2CBD bound to [GPRG(POG)13]3 and 
[(POG)10]3. Position of domains was determined by superimposing envelope for PKD2CBD 
with docked crystal structures with envelopes for PKD2CBD bound to [GPRG(POG)13]3 and 
[(POG)10]3 contrary to fibril binding results PKD2 does not appear to bind to mini-collagen B. 
SAXS derived envelope for 4 Ser PKD2CBD bound to [GPRG(POG)13]3 envelope appears 
identical to that for PKD2CBD bound to mini-collagen 
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Figure 17: A. SAXS derived envelope for PKD1PKD2CBD bound to [GPRG(POG)13]3. 
Position of domains was determined by superimposing envelope for PKD1PKD2CBD with 
docked crystal structures with envelopes for PKD1PKD2CBD bound to [GPRG(POG)13]3. 
Similar to results for PKD2CBD bound to mini-collagen PKD1 and PKD2 do not appear to 
bind to mini-collagen B. SAXS derived envelope for 2 Ser PKD1PKD2CBD and 6 Ser 
PKD1PKD2CBD bound to [GPRG(POG)13]3. The envelope appears identical to that for 
PKD1PKD2CBD bound to mini-collagen 
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Figure 18: A. SAXS derived envelope for full-length Col H. Domains were positioned by 
superimposing envelope for PKD2CBD and PKD1PKD2CBD. Catalytic domain was 
positioned in remaining electron density. B. Figure A with envelopes removed. C. Zoomed in 
region between CBD/PKD2 and PKD2/PKD1 with Cα B-factors colored (Red: relative high 
B-factor, Blue: relative low B-factors). B-factors may allow the domains to link together to 
form the full-length enzyme.  
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Figure 19: A. Teasing out collagen binding mechanism for Col H. Envelope for Col H was 
superimposed with envelopes for PKD1PKD2CBD (pink) and PKD2CBD (yellow) bound to 
[GPRG(POG)13]3 as well as with PKD1PKD2CBD (red) and PKD2CBD (blue) alone. Based 
on PKD2 wedging hypothesis a second [GPRG(POG)13]3 was built near PKD2 so that it 
makes contact with PKD2 residues. Distance from first mini-collagen to the second was 
found to be 15 Å the same as the distance between tropocollagens within a micro-fibril. Col H 
may use PKD2CBD to wedge between tropocollagens in a micro-fibril for hydrolysis. B. 
Figure A rotated 90°. Second [GPRG(POG)13]3 aligns almost perfectly with active site of Col 
H peptidase domain (in orange). 
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Chapter 4: Working hypothesis of Col G/Col H collagenolytic synergy for purposes of Cell 
isolation 
Abstract 
While it is known that both Col G and Col H are needed to most effectively degrade 
collagen fiber, the optimal ratio between the two is not agreed upon. This chapter focuses on the 
degradation of type I collagen fiber from Col G and Col H. In order to isolate different cells type 
I collagen fibers, which are abundant in all tissues, would need to be degraded [5]. This chapter 
seeks to understand the steps that H. histolytica takes to degrade each level of hierarchical 
collagen and expose micro-fibrils. Based on time course hydrolysis of acid solubilized bovine 
type I collagen a method of synergistic hydrolysis of collagen micro-fibril by Col G and Col H 
was speculated. Optimal ratio between Col G and Col H can improve cell isolation yields for 
transplant.  
4.1 Introduction 
4.1a. Clinical applications for Col G/Col H mixtures  
The ability of full-length Col G and Col H to seek out and synergistically degrade 
collagen fibers makes Col G and Col H molecules of interest for clinical research purposes. 
Santyl ointment is a mixture of Col G and Col H that is used as a wound debridement and they 
are also used in the treatment diseases characterized by a buildup collagen fibrils (Dupuytren’s 
contracture and Peyronie’s disease) [6]. Pancreatic islet transplantation was mentioned earlier in 
the chapter. It is an experimental treatment for type I diabetes and pancreatic cancer where 
pancreatic islets are isolated from the patient pancreas or from a donor using a mixture of Col G, 
Col H and neutral protease (normally thermolysin) (see figure 1). Newly isolated islets are 
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cultured and then injected into the patients liver where pancreatic function is restored [7]. 
Minimizing the amount of neutral protease used in isolation is important as excess limits islet 
survival and viability in vitro [8]. In order to minimize the amount of protease used the optimal 
ratio of Col G to Col H needed for optimizing the islet yield needs to be found. Currently 
different ratios of Col G to Col H are being investigated on their cell isolation ability but a 
consensus has yet to be reached [9]. Based on what is known about Col G and Col H collagen 
hydrolysis, in this chapter the optimal ratio of Col G to Col H needed for hydrolysis of fibrillar 
collagen is proposed [4] [10].  
In addition to pancreatic islet isolation, collagenases can be used for the isolation of stem 
cells from adipose fat tissue. Recently a method was proposed by Gentile and Sterodimas for the 
isolation of stem cells from adipose fat tissue using human MMP for purposes of reversing 
Covid-19 lung damage [11]. Mesenchymal stem cell isolation process may be optimized by 
using bacterial collagenases instead of human MMP. Stem cells may also be isolated from 
synovial fluid [12]. In addition to treating Covid-19, collagenases could be used to isolate 
skeletal muscle stem cells for the purposes of treating muscular dystrophy and age associated 
muscle atrophy [13]. Knowing the optimal ratio of Col G to Col H necessary for collagen fiber 
degradation would improve the many clinical applications for H. histolytica collagenases. Below 
a method for unbundling collagen fibers by H. histolytica is proposed based on the known 
structures and collagen hydrolysis patterns for Col G and Col H.  
4.1b. Proposed method for Hathewaya histolytica unbundling collagen fibers  
 Collagen fiber are the largest ordered structure of tropocollagen molecules possible. 
Collagen fibers within the interstitial matrix give structural support to cells and keep them 
tethered to basement membranes from different organs. For Col G/Col H mixtures to be effective 
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at cell isolation and collagen degradation in treating Dupuytren’s contracture and Peyronie’s 
disease collagen fibers must be unbundled [6] [14] [5]. For a brief reminder on type I collagen 
hierarchy, three alpha propeptide chains (two α1 and one α2) intertwine to form triple helical 
tropocollagen. Orgel et al. 2006 posits a micro-fibril structures where five to six tropocollagens 
molecules are packed together in a super-twisted, right-handed quasi-hexagonal pattern called a 
micro-fibril (see figure 2). As tropocollagens are twisted together individual tropocollagens are 
longitudinally staggered throughout the micro-fibril by 67 nm to create D-period gaps [15].  
Tropocollagens within a micro-fibril are both inter and intra molecularly cross-linked at 
Lys residues located at the N and C-telopeptide regions by Lysyl oxidase (LOX), cross-links 
provide additional strength to tropocollagen and micro-fibril [16]. In order to hydrolyze 
tropocollagens within a micro-fibril telopeptide region must be cleaved off. Intermolecular cross-
linking at the telopeptides is known to play a key role in collagen fibril formation [17]. In order 
to form collagen fibril from micro-fibril LOX catalyzes cross-linking at Lys residues from 
tropocollagen molecules on the exterior of the micro-fibril [18]. Finally, collagen fibrils are 
linked together by proteoglycan bridges to form collagen fibers (see figure 3) [19]. While 
proteoglycan bridges are hydrolyzed in acid solubilized collagen for MMPs proteoglycan bridges 
prevent the enzyme from cleaving collagen fibers [20]. It may be the same for bacterial 
collagenases. Below a brief description on the mechanism by which proteoglycan bridges 
promote collagen fiber formation is described.  
Small leucine-rich repeat proteoglycans (SLRPs) are a specific type of proteoglycan that 
is thought to promote fiber formation. In SLRP knockouts mice, collagen fibrils are highly 
disorganized, and some connective tissue function is lost [21]. SLRPs are two part constructs 
with one N-terminal variable domain containing sulfonated Tyr or acidic amino acids and one 
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core protein domain that is rich with Leu repeats [21]. The core protein domain of decorins bind 
to D-period gaps in collagen via covalent interactions most likely to 3HYP repeats found at the 
C-terminus of type I tropocollagen [22] [2] [23]. Glycosaminoglycans (GAG) chains are present 
on the N-terminal domain of SLRPs and affect collagen fiber formation by binding to non-fibril 
collagens, FACIT collagens, that exist in the collagen matrix between fibrils [21]. They also 
interact with GAG from adjacent collagen fibrils via electrostatic interactions [24]. This ability to 
bridge multiple collagen fibrils through FACIT collagens and electrostatic interactions results in 
the association of several collagen fibrils forming fibers. 
It has previously been shown that a crude mixture of Col G and Col H has the ability to 
unbundle collagen fibers from sea cucumber [24]. Collagenase type I from Worthington 
biochemical was used during this experiment. Type I from Worthington is a mixture of Col G 
and Col H and contains trace amounts caseinase, clostripain and trypsin. TEM imaging revealed 
that collagen treated with this mixture began to unbundle and proteoglycans connecting fibrils 
were lost [24]. SDS-PAGE analysis of collagen fiber incubated with this crude mixture for 
various intervals was used to visualize the hydrolysis of proteoglycans over time. SDS-PAGE gel 
was stained with alcian blue-periodic acid stiff, which is used to stain sugars, revealed the 
presence of a diffuse sugar band appearing from 87 kDa to 55 kDa. As the incubation time 
increased this band became denser and wider, implying that over time more GAG is released 
from solubilized collagen fiber [24]. In addition to SDS-PAGE, DMNB assay also revealed that 
the amount of GAG present in the supernatant of samples treated with Col G/Col H mixture 
increases over time [24].  
Despite these results, it is currently unknown if the collagenases Col G or Col H can 
hydrolyze the proteoglycan bridge or if the added caseinase, clostripain and trypsin do the 
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hydrolysis. Clostripain and trypsin have been previously shown to efficiently hydrolyze 
choindroitin sulfate aggregates from rats [25]. Currently it is unknown if caseinase has any 
activity towards proteoglycans involved in fiber formation. We speculated that clostripain is 
primarily responsible for degradation of proteoglycan bridge. Clostripain is a cysteine protease 
with a preference for hydrolysis on the C-terminal side of Arg and Lys [26]. Arg rich SLRPs 
have been found in a variety of collagens [27]. The protease was initially isolated from C. 
histolyticum (now H. histolyticum) and found in all Clostridium species. Core protein domain for 
SLRPs are resistant to degradation from most enzymes, including clostripain, suggesting that if 
cleavage is to occur it must be cleaved off at the variable N-terminal domain [28]. For 
Clostridium species clostripain’s role in virulence is not entirely understood. In C. perfringens α-
clostripain structural gene ccp was mutationally inactivated. In mice models of myonecrosis, 
inactivation of the ccp gene was found to have no affect on the progression of the disease 
indicating that clostripain may not play a major role in the progression of gas gangrene but it 
may be one of many enzymes that assist in initially unbundling collagen fibers for Col G and Col 
H to attack [29]. 
4.1c. Col G may be responsible for dismantling Extrafibrillar Space between collagen fibers  
 Once proteoglycan bridges are dismantled collagen fibers are only partially exposed. 
However, in the interstitial space, where Col G and Col H primarily work, there exists a complex 
connective matrix between collagen fibers. This region must be properly degraded before 
collagen fibrils are fully exposed. This extrafibrillar space consists of polysaccharides, 
proteoglycans and auxiliary collagens that are necessary for the formation of collagen fibers (see 
figure 4) [30]. The tandem CBDs of Col G bare larger bore size and may make uniquely suited 
towards cleaving some of auxiliary, non-fibril collagens present in the extrafibrillar matrix that 
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hold collagen fibrils together to form fibers [31]. Below we speculate how Col G dismantles this 
region 
 Type V collagen is a key component of the extrafibrillar matrix and associates with type I 
collagen to form heterotypic fibrils [2]. It has three different α-chains α1, α2 and α3 that come 
together in different combinations with (α1)2α2 being the most common for forming heterotypic 
fibrils [2]. This isoform has the normal triple helical regions of collagen however, at the N-
terminus there is a propeptide domain that is important in interacting with the extrafibrillar 
matrix. In heterotypic collagen fibrils, type V collagen is in the interior and due to the presence 
of a kink region between the N-terminal propeptide and the triple helical region it is thought that 
the propeptide is projected through the D-period gap region [2] [32]. Once the propeptide is 
projected through the D-period gap it is able to interact with different non-fibrillar (FACIT) 
collagens in extrafibrillar space (see figure 5) [32] [33]. Immunoelectron microscopy has been 
able to reveal the presence of type VI collagen, a FACIT collagen, in the banded regions of 
collagen fibers from the extracellular matrix of chicken embryo and human fibroblast [34]. This 
interaction with the extrafibrillar space is thought to be important for fiber formation; in mice 
with gene for type V collagen knocked out fiber formation was significantly inhibited [35].  
In addition to fiber formation, Type V collagen is important for connecting cells to 
basement membranes. Type V collagen N-terminal propeptide interacts with type VI collagen 
which then interacts with type IV collagen, a key component of basement membranes [2] [30]. 
This ability to act as a sort of “bridge” between heterotypic collagen fibrils and basement 
membranes makes type V collagen very important in anchoring cells to basement membranes. 
SDS-PAGE analysis and mass spectrometry have revealed that type V collagen is a substrate for 
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Col G but not for Col H [31]. Unlike digestion of type I collagen which occurs from the C-
terminus; digestion of type V collagen was found to occur near the N-terminus [36] [37] [31].  
This ability to hydrolyze type V collagen near the N-terminus may hint towards Col G’s 
role in cell isolation. Col G’s dual CBDs may allow the enzyme to wedge between a heterotypic 
collagen fibril containing type V collagen and the type IV/VI basement membrane collagens it is 
connected to. While both type IV and type V collagens are substrates for Col G it is currently 
unknown if type VI collagen is for Col G [38] [31]. Type VI collagen contains triple helical 
regions similar to fibril collagens suggesting that it to can be processed by H. histolytica 
collagenases [39]. If type VI collagens are resistant to Col G, the enzyme still may be able to 
bind to heterotypic collagen fibril in ECM and position its catalytic domain to optimally process 
the N-terminal propeptide from type V collagen. In heterotypic collagen fibrils the only portions 
of type V collagen that would be available for processing are the N-terminal propeptide and the 
hinge region. Once this bridge between heterotypic collagen fibrils and tissue basement 
membranes is cut isolation could be performed more easily. Below a method for collagenolytic 
synergy between Col G and Col H is proposed. 
4.2 Methods 
4.2a. Time Dependent Hydrolysis of Bovine Type I Collagen by Col G and Col H 
Experiments regarding time dependent hydrolysis of Bovine Type I collagen were 
performed by Dr. Keisuke Tanaka at the Nippi Research Institute of Biomatrix in Toride, Japan. 
Analysis of data was done at the University of Arkansas. To prevent formation of gelatin all 
steps were performed at 4°C unless stated otherwise. Briefly, 12.5 μl of acid solubilized bovine 
type I collagen (2 mg/ml) was mixed with 50 μl of a 2X collagenase buffer (100 mM Bis-Tris-
HCl pH 7.5, 0.4 M NaCl, 10 mM CaCl2), 36.5 μl of MilliQ water and 1 μl of Col G or Col H (0.1 
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mg/ml). Final concentration of collagen and collagenase was 0.25 mg/ml and 0.001 mg/ml 
respectively. Mixture was incubated at 30°C and samples were collected at 0, 0.5, 1, 3, 5 and 21 
hrs. respectively. The reaction for each sample aliquot was stopped by adding 15 μl of 2X SDS 
PAGE sample buffer. After all samples were collected, ther were boiled at 100°C for 3 min and 
30 μl of each sample were applied to a 4-20% gradient Tris-Glycine gel and gel electrophoresis 
was performed. 
 Gels were stained with comassie blue and destained with 10% Acetic acid/50% Methanol 
for 24 hrs. After destaining, gels were scanned and ImageJ software was used to perform 
densitometry analysis for Col G and Col H [40]. Greyscale images were used and background 
was subtracted (light background, sliding parabola and disable smoothing). Rectangles were 
drawn for each well to include γ, β11 variant, β11, β12, α1, α2 and any potential fragments from 
hydrolysis [41]. Densitometry peaks were integrated. To help reveal how Col G and Col H 
process different regions in collagen, the intensity for each band was plotted over the course of 
21 hrs. Relative mobility of each band relative to protein ladder was used to help determine the 
molecular weight for each band.  
4.3 Results and Discussion 
4.3a. Hydrolysis of γ and β collagens by Col G and Col H gives an initial increase in α1 and 
α2 chains 
Fragments resulting from hydrolysis of acid solubilized bovine type I collagen from Col 
G and Col H over 21 hours were separated by SDS-PAGE and analyzed. Since the bands for β11 
and β12 could not be separated, intensity was quantified for a single β11/β12 band. For Col G 
and Col H bands corresponding to γ, β11 variant, β11/β12, α1 and α2 as well as any collagen 
fragments were assigned based on past study (see figure 6A & 7A) [4]. Cross-link of two α1 
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chains forms β11 collagen and cross-link of α1 chain with α2 chains forms β12 collagen and 
cross-link of three α chains (commonly α1α1α2) forms γ collagen [41]. Background from gels 
were subtracted using imageJ and rectangles were drawn around each lane to quantify band 
intensities. For Col G and Col H total intensity for each band was plotted over time (see figure 
6B & 7B).  
β11 variant intensity appears to be negligible for both Col G and Col H. For both Col G 
and Col H, the intensities for the γ and β11/β12 bands decrease over the course of the 
experiments while the intensities for α1 and α2 collagens increase during the first 30 minutes 
then decrease over the rest of the experiment. For Col G at 3 hrs. bands were almost fully 
hydrolyzed and for Col H bands were still present after 21 hrs. For Col G, as the hydrolysis 
experiment proceeded the ratio of α1 band intensity to α2 band intensity changes from 2:1 to 
closer to 1:1 (2.30:1 at 0 hr., 1.15:1 at 0.5 hr., 1.37:1 at 1 hr.). For Col H, the ratio of α1 to α2 
stays closer to 2:1 (2.14:1 at 0 hr., 1.76:1 at 0.5 hr., 1.60:1 at 1 hr., 1.49:1 at 3 hr., 1.83:1 at 5 hr.) 
(see figure 6B & 7B). For Col G, only one additional fragment was present outside of the normal 
six isoforms for type I collagen (see figure 6A) [41]. This additional fragment appeared after 30 
min. and quickly disappeared at 1 hr. Due to its low intensity and short lifespan it is not included 
in plot for hydrolysis of acid solubilized collagen by Col G. For Col H six fragments emerged at 
different times after hydrolysis. Molecular weight of Col H fragments were calculated by using 
relative mobility of protein ladder to create a calibration plot (see figure 7C) [42]. What the the 
appearance of these bands mean for a potential collagen hydrolysis mechanism for Col H is 
discussed further on in the chapter. 
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4.3b. Col G collagenolysis starts at C-terminus and ends with hydrolysis of both N & C 
telopeptides  
To understand the increase in the release of α2 chains the formation of tropocollagens 
and their packing within a micro-fibril must be considered. While acid solubilized type I 
collagen is not identical to collagen micro-fibril hydrolysis of solubilized substrate may give hint 
to how H. histolytica collagenases degrade insoluble collagen substrate. During collagen fibril 
formation tropocollagens are packed in parallel and staggered by a repeat distance of 67 nm 
known as the D-period [16]. Inter and Intra molecular covalent crosslinks located at regions near 
the N and C-terminal known as telopeptides (see figure 3B) [16]. At the C-telopeptide Lys 
residues from both α1 chains are intermolecularly crosslinked with α1 chain Lys in the triple 
helical region of an adjacent tropocollagen. There are no Lys residues in the C-telopeptide of the 
α2 chain [16]. While at the N-telopeptide Lys from one α1 chain intermolecularly crosslinks with 
Lys in the triple helical region of an adjacent tropocollagen [17]. Lys on the other α1 chain 
intramolecularly crosslinks with Lys in the N-telopeptide of the α2 chain [17].  
N-telopeptide is thought to be the main region in collagen involving α2 cross-linking [17] 
[16]. Initial increase in intensity for α2 band and decrease in intensity for γ, β11 and β12 bands 
must be from hydrolysis of N-telopeptide. For the amount of α2 chain to be increased in the 
SDS-PAGE during the first 30 mins. Col G must hydrolyze the N-telopeptide. Hydrolysis would 
release α2 chain as the intramolecular crosslink between Lys from α1 and Lys from α2 would be 
degraded and release of α1 chains would be slowed due to the presence of intermolecular 
crosslinks at the C-telopeptide region. Previously it has been shown that Col G cannot bind to 
telopeptide regions but it is still able to have the region efficiently released [43] [44]. Based on 
previous results it is believed that Col G is also involved in the hydrolysis of the C-telopeptide 
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[44]. However, the intensity increase in α1 from hydrolysis would be difficult to pick up due to 
α1 being cross-linked at both the C and N-telopeptides. 
SAXS and NMR data show that CBD2 from Col G prefers to bind to loosely wound 
regions of tropocollagen and will bind so in a unidirectional manner [45] [37]. Previous high 
speed AFM video of Col G revealed that the enzyme flocks to disordered regions in collagen 
micro-fibril mimic [36]. MMP binding site in collagen is roughly one quarter distance from the 
C-terminus of collagen [46]. Low hydroxyproline content near the C-terminus suggest that this 
region is unstable as it has been reported to locally “melt” [47]. Similar to its preference for 
disrupted regions in collagen micro-ribbon Col G may prefer the partially unwound region at the 
C-terminus since less energy would be needed for unwinding substrate before hydrolysis [45]. 
While processing collagen; polarized movement occurs as Col G moves from the C-terminus to 
the N-terminus. Saddle like shape of catalytic domain active site, tight binding of CBD2 and 
lower collagen affinity of CBD1 allows Col G to processively degrade substrate [1]. A 
mechanism for this processivity was previously proposed and below we attempt to reconcile this 
mechanism with known information on Col G and collagen micro-fibril structure with new 
information pertaining to the enzymes ability to hydrolyze N-telopeptide regions in acid-
solubilized collagen [1]. Using all of this information we attempt to tease out how Col G 
hydrolyzes collagen micro-fibril in vivo. 
Col G would still attack disordered regions in the micro-fibril (either from damage or at 
the C-terminus) of the collagen and wedge between two parallel oriented tropocollagens. Once 
wedged the enzyme would proceed to move towards the N-terminus of one tropocollagen 
molecule while processively degrading substrate [36]. C-terminus of tropocollagen CBD2 is 
bound to is staggered, with the N-terminus of an adjacent tropocollagen molecule overlapping 
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(see figure 3B). This overlapping from the D-periodicity of the micro-fibril would position the 
enzyme so that it may effectively cleave off the N-telopeptide from the adjacent tropocollagen.  
Proteolysis experiments on procollagen from human skin revealed that bacterial 
collagenase cleave at the border between telopeptide and triple helical regions of collagen and at 
the border between procollagen and telopeptide for both C and N-telopeptides [44]. Amino 
propeptide is thought to fold over on the triple helical portion of collagen increasing the stability 
of the tropocollagen chain [44]. Hydrolysis of the propeptide/telopeptide region by Col G 
decreases the stability of the tropocollagen which may make it more susceptible to hydrolysis by 
Col H. Loss of telopeptide would loosen the collagen fibril which in turn would make it easier 
for Col H to bind and hydrolyze at its specific sites [4] [10].  
4.3c. Non-processive endopeptidase, Col H hydrolyzes specific regions in acid solubilized 
collagen    
 Hydrolysis of acid solubilized type I collagen with Col H revealed six additional 
fragments in addition to the six main isoforms of acid solubilized type I collagen (γ, β11 variant, 
β11, β12, α1 and α2) (see figure 7A). Understanding the Col H hydrolysis pattern in type I 
collagen would help to reveal the role it plays in synergistic degradation of collagen. Molecular 
weights of all Col H bands are estimated using relative mobility of SDS-PAGE bands (see figure 
&C) [41]. After 0.5 hr. fragments 1 (approximately 110 kDa), 2 (approximately 95 kDa), 3 
(approximately 83 kDa) and 4 (approximately 53 kDa) appear. After 3 hrs. fragments 5 
(approximately 61 kDa) and 6 (approximately 42 kDa). Over the full 21 hrs. intensity for 
fragment 1 stays consistently low and that intensity for fragments 2 and 3 increase up until 5 hrs. 
after which they begin to decrease. Intensities for fragments 5 and 6 both increase for the full 21 
hrs. of the experiment and the band for fragment 6 appears to shift from approximately 42 kDa to 
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37 kDa. Fragment 5 plateaus at 800 units and fragment 6 increases drastically up to 4200 units 
(see figure 7B).  
Results from acid solubilized collagen hydrolysis with Col H appear to agree closely with 
acid solubilized collagen hydrolysis results from French et al. 1987. In results for French et al. 
1987 intensity for γ bands is not given [4]. It is unknown why γ band intensities are not given. 
Based on the ordered decrease in intensity for γ, β11/β12, α1 and α2 bands in acid solubilized 
type I collagen Col H does not hydrolyze telopeptides before initially attacking three quarters 
region near the N-terminus of collagen. After initial hydrolysis 35 kDa N-terminal fragment and 
62 kDa C-terminal fragment are produced. In results from French et al. 1987 N-terminal 
fragment forms a 70 kDa dimer (F’1/F’2) [4]. Assuming that bands from the latest results are 
running at larger molecular weights we speculate that fragment 2 (approximately 95 kDa) from 
bovine hydrolysis is equivalent to F’1/F’2 from rat tail collagen hydrolysis. In acid solubilized 
collagen intermolecular cross-links are most likely hydrolyzed although based on some 
intermolecular cross-linking may still be taking place. In acid solubilized collagen, aggregates 
could also be either non-staggered or staggered by a 4D distance [48]. Intramolecular cross-
linking between α1 and α2 chains at the N-telopeptide would explain the presence of N-terminal 
35 kDa dimer [16]. Based on the molecular weights and rate at which intensities increase for 
fragments 3 and 4 these two bands may be analogous to 62 kDa C-terminal fragment (F’3/F’5) 
and 35 kDa N-terminal fragment (F’7/F’8) monomers from the initial hydrolysis with Col H [4]. 
 The approximately 100 kDa fragment 1 from the latest bovine type I collagen hydrolysis 
results is not present in the experiment from French et al. 1987 [4]. Fragment 1 could be from 
hydrolysis of 4D staggered acid solubilized substrate. C-terminal 62 kDa fragment could cross-
link with Lys residues in triple helical region of N-terminal 35 kDa fragment in adjacent 
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tropocollagen and the resulting product would be approximately 100 kDa [48]. Fragment 1 could 
also be from both inter and intramolecular cross-linking present in non-staggered N-terminal 
fragment from initial hydrolysis with Col H [4] [48]. More research will need to be performed to 
determine the identity of fragment 1. At 3 hrs. the appearance of fragments 5 (approximately 61 
kDa) may be from further processing of the 62 kDa C-terminal fragment and is analogous to 
(F’9/F’10) from French et al. 1987 [4].  Fragment 6 (approximately 42 kDa) is not present in 
results from French et al. 1987. However, it the French group later discovered that N-terminal 
fragment from initial Col H hydrolysis is further processed and Fragment may be from further 
processing of N-terminal fragments [10].  
In rat type I collagen Col H initially hydrolyzes the bond between Arg396 and Gly397 
across all α-chains to form the 35 kDa and 62 kDa fragments [10]. 62 kDa fragment is next 
hydrolyzed near the newly formed N-terminus at the bond between Hyp405 and Gly406 to form 
a 58 kDa fragment [10]. 58 kDa fragment is then processed at two sites closer to the C-terminus 
to give 36 kDa, 32 kDa and 26 kDa fragments [10]. Hydrolysis for bovine type I collagen and rat 
type I collagen are expected to be similar and indeed they were. Col H hydrolysis strategy is 
thought to be conserved across fibril collagens based on the presence of conserved hyperreactive 
sites in all type I, II and III collagens [10]. 36 kDa, 35 kDa, 32 kDa and 30 kDa may be too small 
to be efficiently separated using gel electrophoresis. In addition to the F’9, F’10 fragment 6 may 
be a combination of the 36 kDa, 35 kDa, 32 kDa and 30 kDa fragments which would explain the 
significant increase in intensity over time (see figure 7B).  
While comparison of acid solubilized bovine type I collagen hydrolysis and rat tail type I 
collagen hydrolysis revealed that Col H mechanism for acid solubilized collagen hydrolysis is 
conserved. It is currently unknown how Col H hydrolyzes collagen micro-fibrils. Based on acid 
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solubilized collagen hydrolysis results as well as structure/function results we attempt to tease 
out a hydrolysis mechanism. The size of envelopes for Col H segments complexed to mini-
collagen as well as the orientation of the domains in the full-length enzyme suggests that Col H 
may be best suited for wedging between tropocollagens within a micro-fibril. PKD2 is most 
likely used similar to CBD1 in Col G. Col H may scan the surface of collagen micro-fibrils for 
loosely wound regions to wedge between. Once found the 15 Å distance between PKD2 and 
CBD may position Col H to clip tropocollagens from within a micro-fibril. Micro-fibril binding 
results support this ability as addition of N-terminal domains causes an increase in binding 
affinity consistent with wedging [49]. Unpublished high-speed AFM video of free Col H reveals 
that the enzyme is highly dynamic which may make it easier for the enzyme to intercalate within 
the interior of a micro-fibril (Appendix video 2). Once bound Col H would then be able to cleave 
all three chains in tropocollagen. Hydrolysis of tropocollagen at its interior would create a 
potential new site for Col G to begin hydrolysis. The slow speed for Col H hydrolysis of acid 
solubilized type I collagen with suggests that not all hyperreactive sites for the enzyme are 
immediately available for hydrolysis. Hydrolysis with Col G may be required first to loosen the 
collagen fibril. Synergy between Col G and Col H is discussed further in the next section. 
4.3d. Description of collagen degradation synergy between Col G and Col H 
Studies from Orgel et al. on the structure of type I collagen fibrils revealed that 
tropocollagens are arranged to form a supertwisted discontinuous right-handed micro-fibril [15]. 
Tropocollagens within micro-fibril are stabilized through intramolecular and intermolecular 
cross-links at both the N and C-telopeptides (see figure 3B) [15]. Okuyama group disagrees with 
Orgel fiber diffraction structure based on low resolution, number of reflections and occupancy 
and they suggest that position of chains remains speculative [50]. As it is still the most accepted 
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model for collagen micro-fibril all proposed methods for collagen hydrolysis are based on the 
Orgel model. For solubilized collagen, Col G and Col H have the ability to degrade substrate 
alone however for insoluble collagen micro-fibril perhaps both enzymes are required. Currently 
the mechanism of synergy between Col G and Col H is currently unknown. Depending on the 
target cell being isolated, different mixtures of Col G and Col H may be required. Previous 
research into the isolation and recovery of pancreatic islets show that poorly isolated cells have 
shorter survival periods post culture and are less likely to survive upon transplant into the 
recipient’s liver [51]. Understanding the mechanism by which the enzymes work together to 
degrade collagen may reveal the most optimal ratio of Col G to Col H necessary for the isolation 
of cells. Below a method of synergy between Col G and Col H is proposed based on current and 
previous research results.  
In a micro-fibril, due to the quasi-hexagonal packing of tropocollagens in the micro-fibril 
Col H proteolysis sites on the exterior tropocollagens are more easily accessible for hydrolysis 
than those in the interior. In a collagen fibril, multiple micro-fibrils are cross-linked, so the initial 
proteolysis sites on tropocollagens within a micro-fibril are thought to be buried. In addition to 
Col H proteolysis sites binding sequences for MMP1, MMP13, von Willebrand factor, 
glycoprotein VI, integrins and fibromodulin are also predicted to be at least partially buried 
within the core of a collagen fibril [52]. Yet, cellular functions regarding these binding sites are 
still carried out [52]. This suggest that collagen micro-fibril be have dynamic character in vivo.  
Dividing a 300 nm long tropocollagen molecule by the D-period allows one to divide a 
micro-fibril into five segments (D1-D5) which repeat throughout the fibril [52]. To further 
understand which segments in a collagen fibril are solvent exposed molecular dynamic 
simulations were performed on previously derived model of collagen fibril with boundaries 
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placed to replicate the supramolecular arrangement of collagen [15] [53]. Solvent accessible 
surface area (SASA) calculations were performed for each segment in a collagen fibril using a 
1.4 Å probe and a 5 Å probe. 1.4 Å probe, which is roughly the size of a water molecule, had a 
high SASA for all segments in the collagen fibril indicating that even the buried tropocollagen 
molecules are sufficiently hydrated [52]. For the 5 Å probe, SASA was measured for both sides 
of the collagen fibril (A & B) (see figure 8A). For side A SASA for D5 and D4 at the C-terminus 
were both high but on side B SASA is significantly lower [52]. On side A SASA for both D3, D2 
and D1 is low but on side B SASA for D3 and D2 increase slightly while D1 increases 
significantly. For Col H the initial proteolysis site is located at segment D2. Low SASA for D2 at 
both side A and B suggests that the collagen fibril needs to be initially unwound to expose the 
proteolysis site for Col H [52]. 
It is believed that Col G is necessary for exposing the main proteolysis site for Col H. 
Previous NMR and SAXS results revealed that the enzyme binds unidirectionally to the C-
terminus of mini-collagen in the absence of undertwisted regions [37] [45]. D5 segment (C-
terminus) of tropocollagen within microfibril is predicted to be packed less tightly on side A 
[52]. Based on B-factor analysis of collagen-like peptide C-terminus of tropocollagen is thought 
to be less structured [54]. Col G will wedge between two adjacent tropocollagens at the D1 
segment of a collagen fibril and begin to precessively degrade the substrate while moving 
towards the N-terminus of the collagen fibril [36]. As the enzyme moves towards the N-terminus 
Col G may work similar to DNA helicase as the collagen fibril becomes slightly unwound. As 
the fibril becomes slightly unwound proteolysis site for Col H at segment D2 may become more 
solvent accessible allowing it to be cleaved by Col H. Col H hydrolysis results for acid 
solubilized bovine and rat tail type I collagen reveals that the enzyme is a non-processive 
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endoprotease that cleaves only at select sites in the substrate to produce multiple fragments [4] 
[10]. After initially cleaving near the N-terminus to produce the 35 kDa and 62 kDa fragments 
Col H further processes the C-terminal 62 kDa fragment to produce a 59 kDa, 36 kDa, 32 kDa, 
30 kDa and 26 kDa fragments [10]. N-terminal 35 kDa fragment is also processed further to give 
a 33 kDa fragment which suggests that the enzyme does not have polarized movement along the 
collagen fibril and simply cleaves at specific sites [10]. This “hit and run” method of hydrolysis 
for Col H would provide newly exposed regions for Col G to bind to and begin degrading 
tropocollagens on the exterior of the collagen fibril (see figure 8B). The collagen degrading steps 
for Col G and Col H are then repeated to hydrolyze the tropocollagens located in the interior of 
the collagen fibril.  
4.3e. Endo/Exo synergy found in cellulose hydrolysis 
This method of synergy for Col G and Col H is conserved in a wide variety of enzymes. 
Synergy between Col G and Col H is similar to endo/exo synergy seen for degradation of a 
variety of biopolymers such as mucin, chitin and cellulose [55] [56]. Since cellulose degradation 
is the most well understand, it’s hydrolysis will be described in further detail. However, 
hydrolysis of mucin and chitin occurs in a similar manner with exoprocessive enzymes 
hydrolyzing from chain ends and the non-processive endoglucanases hydrolyzing randomly in 
the interior of the polysaccharide chain.  
The main component of cell walls, cellulose is the most abundant polysaccharide in 
nature and consists of linear chains of multiple glucose units linked through a β-1-4 glycosidic 
bond [57]. Cellulose consists of numerous chains packed together to form fibril like structures 
similar to collagen which makes both difficult to breakdown. Sugars from the breakdown of 
cellulose are a potential alternative fuel source so the study of cellulose hydrolysis is of great 
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importance [58]. A group of enzymes including cellobiohydrolases (CBHs), endoglucanases and 
β-glucosidases work together using endo/exo synergy to efficiently degrade cellulose [57]. CBHs 
are analogous to Col G as they degrade cellulose processively from the chain ends. 
Endoglucanases are analogous to Col H as they are non-processive and attack at locations in the 
interior of cellulose chains [57]. Product inhibition of CBH is prevented by β-glucosidase 
hydrolyzing cellobiose into two glucose units [57].  
Endoglucanase targets amorphous regions of cellulose and which opens up new starting 
points for CBH. CBH stalls and is released from substrate when reaching these regions [57]. 
Hydrolysis by CBH may in turn reveal new amorphous regions for endoglucanases to target. 
Similar to endoglucanase, Col H may initially target and cleave amorphous, solvent exposed 
regions in collagen fibrils. This may be supported by Col H’s preference towards collagen like 
peptides over triple helical collagen [59]. In collagen fibril Col G is thought to stall in regions 
where fibril is disorganized. Small amounts of Col G promote fibril formation so stalling may be 
due to the enzyme reforming substrate so that hydrolysis can continue [1]. Collagen fibril serves 
as a “railing” for Col G and the same may be true for cellulose fibril with CBH targeting 
segment. When “railing” is damaged the enzyme can no longer continue on the substrate. 
Hydrolysis of the damaged “railing” would thus prevent the enzyme from being released. Based 
on the different domain orientations between bacterial collagenases and cellulases endo/exo 
synergy shared between both enzymes is the result of convergent evolution. 
4.3f. Finding the optimal ratio of Col G to Col H for cell isolation 
Finding the optimal ratio of Col G to Col H is important for improving the yield of viable 
cells during isolation of pancreatic islets and stem cells for purposes of transplantation [9] [7] 
[51] [60]. Pancreatic islet transplantation is an experimental treatment for pancreatic cancer as 
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well as diabetes while stem cell transplantation may be a potential treatment for a variety of 
diseases [7] [11] [13]. Auto transplant of cells into a recipient are more likely to succeed as it 
would prevent an immune response. Previous research into the optimal ratio of Col G to Col H 
for collagenase synergy revealed that synergy between the two peaks at 25% Col G:75% Col H 
[9]. Synergy was calculated for multiple ratios of Col G to Col H by dividing the collagen 
degradation activity (CDA) for the Col G/Col H mixture by the sum of the CDA for Col G and 
Col H individually [61] [9]. While the two enzymes may be working together the best at this 
ratio in terms of CDA this ratio was one of the worst. The best ratio for CDA was found to be 
90% Col G:10% Col H. This ratio gives the lowest synergy, however this may be due to Col G 
being the primary workhorse for collagen degradation [9]. In one study focusing on the isolation 
of pancreatic islets from human tissue the best digestion results were obtained with mixture 
containing the maximum amount of Col G [62]. Of the two enzymes Col G must play the 
primary role in collagen degradation. However, study measuring collagen degradation activity 
(CDA) of different mixtures of Col G and Col H show that when less Col G is present in the 
mixture Col H can play a more effective role in collagen degradation [9].  
Measuring CDA in different mixtures of Col G ∆CBD2 with Col H helped to tease out 
Col H’s ability to degrade collagen. For Col G ∆CBD2 two different forms were used; one where 
CBD2 was lost by cleavage at Lys896 and one by cleavage Lys908 [9]. Previously it was 
described how CBD2 is necessary for the processivity of Col G [1]. Upon loss of CBD2 
pancreatic islet isolation by Col G is inhibited [7]. For both forms of Col G ∆CBD2:Col H 
mixtures experimental CDA increases as the amount of Col H is increased with CDA peaking at 
25% Col G ∆CBD2:75% Col H [9]. For Col G ∆CBD2 cleaved at Lys896 synergy between the 
two enzymes increases as the amount of Col H increases. However, for Col G ∆CBD2 cleaved at 
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Lys908 synergy decreases as the amount of Col H increases. The differences for synergy 
between the two forms of Col G ∆CBD2 are thought to be from differences in purity for the two 
Col G -∆CBD2 [9]. 
If the amount of Col G in the collagenase mixture is low Col H may take more of a lead 
role in hydrolysis. Initial hydrolysis by Col H separates tropocollagen into multiple fragments. 
Shorter fragments have lower melting temperatures [63]. Type I collagen has previously been 
found to be somewhat thermally unstable at body temperature [47]. Col H may hydrolyze 
collagen into smaller fragments that are more likely to melt away at body temperature 
disassembling the collagen fibril. This method would not be very affective as the initial 
proteolysis site for Col H may not always be available which would explain the low CDA value. 
Review from McCarthy et al. 2018 states that as long as excess collagenase is present the 
ratio between Col G and Col H is not important and the type of neutral protease present in the 
cocktail is what controls the rate of cell isolation [64]. Collagenase is proposed to loosen up the 
ECM revealing protease sensitive sites on ECM proteins key to anchoring cells [64]. However, 
excess neutral protease used for cell isolation has been found to decrease cell survival and 
viability post isolation and neutral protease by itself has cannot isolate cells from ECM [8] [64]. 
Replacement of neutral protease (usually thermolysin) with clostripain was found to greatly 
increase cell survival post isolation [8]. Previously in this chapter it was speculated that 
clostripain degrades the proteoglycan bridges between collagen fibrils within a fiber. It is 
currently unknown if it may play another role in dissociation of ECM.  
The presence of excess collagenase during cell isolation can cause an immune response 
and while the neutral protease is necessary as a supplementary enzyme too much can 
significantly affect cell survival and viability. These findings suggest that for promoting survival 
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after cell isolation finding the optimal ratio between Col G and Col H is ideal. Based on the 
proposed mechanism for the synergy between Col G and Col H we believe that the optimal ratio 
for Col G to Col H in cell isolation should be approximately 3:1 (see figure 8B). Hydrolysis by 
Col H essentially separates the tropocollagen molecule into three large fragments. For efficient 
hydrolysis, each fragment should have its own Col G molecule. Previous results for digestion of 
human pancreas have shown that a 1:1 mixture of Col G to Col H is most effective however, the 
most Col G heavy ratio that was tested was a 2:1 Col G to Col H ratio. In cell isolation, the non-
fibrillar collagens withing the extrafibrillar space must be dismantled before tropocollagens can 
be exposed for hydrolysis. Col G with its dual CBDs is thought to be best suited in wedging 
between a heterotypic collagen fibril and the non-fibril type VI collagen it is connected to via the 
type V collagen propeptide. It may also wedge between the type VI collagen and the type IV 
collagen of the cell basement membrane. Hydrolysis of this connection between the basement 
membrane and the collagens of the interstitial space is necessary for efficient cell isolation [2] 
[31]. Due to this slightly more Col G may be needed in the collagenase mixture than the 3:1 
ratio. 
4.4 Conclusion    
Using derived structural and binding information for Col G and Col H as well as collagen 
hydrolysis information, both new and old, a method for collagenolytic synergy between Col G 
and Col H was derived and an optimal ratio of Col G to Col H for the best cell isolation results 
was proposed [4] [10]. Based on Col H hydrolyzing at three specific locations in a tropocollagen 
for optimal hydrolysis three molecules of Col G will be needed for each molecule of Col H. 
Fragment pattern for hydrolysis of collagen suggests that enzyme is a non-processive 
endopeptidase. This ratio will need to be tested to see if it leads to a higher yield pancreatic islet 
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than what has previously been shown. Much about Col H hydrolysis is still unknown such as the 
further processing of the 35 kDa N-terminal fragment seen in types I, II and III collagens [10]. 
Further research into the structure and function of Col G and Col H is necessary in order to 
further optimize the use of Col G/Col H mixtures for medical purposes. 
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Chapter 4: Figures 
  
Figure 1: Cartoon outlining pancreatic islet allotransplantation. Islets are injected into liver 
where they begin to release insulin. Liver is chosen as site for transplantation as it allows for 
islets to receive sufficient amount of oxygen and nutrition [3]  
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Figure 2: Head-on representation of Orgel micro-fibril. Tropocollagens are packed into a 
quasi-hexagonal structure with the center-to-center distance being 15 Å.  
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Figure 3: A. Cartoon representation of the hierarchical structure of fiber forming 
collagens. 3 α-chains with composition X-Y-Gly with X and Y most commonly being 
Pro and Hyp pack together to form triple helical tropocollagen. B. Once secreted into the 
extracellular space tropocollagens pack into micro-fibril. Tropocollagen is both intra and 
intermolecularly crosslinked at Lys residues in telopeptide and triple helical regions by 
LOX to give micro-fibril extra tensile strength. Figure 3B is adapted from Yamauchi et 
al. 2012 
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Figure 4: Cartoon representation of basement membranes. Col G, with its dual CBDs 
may be able to intercalate between fibrillar collagens to degrade FACIT and 
microfibrillar collagen holding collagen fibers together [1]. 
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Figure 5: A. Representation of heterotypic collagen fibrils containing type V collagen. B. 
Chart showing the role type V collagen plays in keeping cells bound to basement membranes 
and maintaining tissue matrix scaffold. Figures were adopted from Mak et al.. 2016 [2].  
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Figure 6: A. SDS PAGE results from Col G hydrolysis of bovine type I acid solubilized collagen B. 
Monitoring band intensity from A. over time. Initial increase for α1 and α2 chains is from hydrolysis 
of γ collagen (two α1 and one α2 chains forming a trimer) and β11/β12 collagens (two α1 chains or 
one α1 and one α2 chains forming a dimer). At one hour ratio of intensity between α1 and α2 moves 
from 2:1 to approximately 1:1 indicating an increase in the release of α2 chains. In order to promote 
release of α2 chain N-telopeptide must be cleaved off by Col G prior to hydrolysis.  
 
143 
 
 
  
Figure 7: A. SDS PAGE results from Col H hydrolysis of bovine type I acid solubilized collagen. 
Multiple fragments is indicative of a non-processive endoprotease. B. Monitoring band intensity from 
A. over time. Results tend to agree with French et al. 1987 with the exception of fragment 5 [4] C. 
Relative mobility from SDS PAGE was used to calculate molecular weight for each fragment. 
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Figure 8: A. SASA calculations from Hoop et al. 2017 [11]. Calculations revealed that on side 
A of micro-fibril D5 (C-terminus) is solvent exposed. D2 (near Col H initial hydrolysis site 
for acid solubilized collagen) on side B is slightly exposed and may become more solvent 
accessible after Col G starts to unwind micro-fibril. B. Cartoon representation of proposed 
collagen hydrolysis synergy. C-terminus of micro-fibril is packed less tightly than the rest of 
the molecule. Col G binds and begins hydrolysis while moving toward N-terminus. As the 
enzymes moves, it would begin to partially unwind the micro-fibril exposing the initial 
hydrolysis site for Col H. After the initial hydrolysis Col H cleaves at two regions further 
toward the C-terminus (red arrow) [14]. Based on the proposed hypothesis for collagen fibril 
degradation synergy this research speculates that the optimal ratio for isolation of pancreatic 
islets is 3:1 Col H to Col G.  
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Chapter 5: Vibrio alginolyticus REC domain consists of two domains with two-fold symmetry 
connected by a flexible linker 
Abstract 
 Currently attempts at crystallization of REC domain have proven to be non-successful. In 
this chapter we sought to understand why attempts have proven unsuccessful. Homology model 
of REC domain from Itasser revealed a two-domain structure (I and II), with both domains 
containing a Rossman fold, connected by 21-residue flexible linker. Circular dichroism and 
Tryptophan fluorescence emission spectra gave support to the homology model. Limited 
proteolysis revealed that the linker region is susceptible to hydrolysis. While the structures for 
subdomains I and II are structurally homologous (R.M.S.D. = 1.9 Å) subdomain I from REC is 
missing key residues present in the active site of subdomain II. The potential origin of two 
domain REC incorporated into VarS sensor histidine kinase is also investigated in this chapter. 
5.1 Introduction 
In general, two-component systems are comprised of a sensor protein (Histidine Kinase) 
and a corresponding response regulator. Since each particular system is specialized to respond to 
a specific environmental signal there may be multiple systems present in a single cell [2]. Upon 
receiving a signal in the periplasmic region, the sensor kinase forms a dimer and phosphate is 
transferred from ATP to a conserved histidine. There are two different classes of histidine 
kinases (see figure 1A and 1B). Class I kinases, of which VarS is a member, have the CA and 
dHp domains directly linked to each other. In Class II kinases the CA domain is separated from 
the domain containing the phosphorylated histidine by a hinge like domain important for 
signaling [3]. There are two types of Class I kinases [3]. The first type is known as a simple two 
component in which the phosphate bound to the histidine in the CA domain is immediately 
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transferred to a response regulator. The second type of two-component system is known as a 
phosphorelay, in which the phosphate at the CA domain is first transferred to a conserved 
aspartate located on an intermediate receiver (REC) domain and then transferred to a conserved 
histidine located on the histidine phosphor-transfer (HPT) domain before finally being 
transferred to a response regulator 
REC domains are approximately 120 residues long with a Rossman like fold consisting 
of five-stranded parallel β-sheet structure with each β-sheet connected by an α-helix [2]. REC 
domains are known as the common regulatory module for all response regulators [4]. These 
domains fold easily, are stable and compact and undergo conformation changes upon 
phosphorylation [5]. In response regulators binding at the N-terminal REC domain causes the 
protein to dimerize which allows it to bind to DNA [5]. REC domains have a small set of highly 
conserved residues located within the active site. The most conserved residue of course being the 
phosphate accepting Asp. High energy acyl phosphate may provide energy coupling to drive a 
conformational change within REC [2]. In addition to the phosphate accepting Asp, the 
following key residues in the active site are conserved; an Asp residue in the adjacent β-sheet, 
two additional Asp or Glu residues in the active site that coordinate a Mg2+ and a conserved Lys 
residue that forms a salt bridge with the phosphate bound to the active site [2]. In addition to the 
active site residues Phe/Tyr are highly conserved on β-sheet 5 while Ser/Thr are highly 
conserved on β-sheet 5. In activated response regulators Phe/Tyr interact with DNA binding 
effector domain while Ser/Thr help to coordinate the conserved aromatic residues [2].  
Some response regulators contain two REC domains. The first domain contains Asp 
residue which receives Phosphate while the second domain has the Rossman-like fold 
characteristic of the first domain, however it is non-functional suggesting that second domain 
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may have arisen from gene duplication event [1] [6]. In PleD presence of secondary REC adaptor 
domain helps in intra and intermolecular dimer formation via hydrophobic interactions and salt 
bridge formation with the first domain [1]. PleD dimer is involved in the formation of cyclic di-
guanosine monophosphate (c-di-GMP), an important signaling molecule from two GTP 
molecules. Dimer formation in PleD allows GTP loaded DGC domains from both subunits to 
come together and catalyze the formation of c-di-GMP [1]. Addition of REC adaptor domain 
may help promote dimer formation however, there are multiple DGC domains at the C-terminus 
of only one REC domains indicating that adaptor domain is not necessary [1].  
Nearly 25% of histidine kinases incorporate an internal REC domain to form phosphor-
relay histidine kinases. REC domains are incorporated into histidine kinases at the C-terminus of 
the dHp domain via gene fusion [7]. Currently crystal structure of internal REC domain from 
VarS has yet to be solved. Solving structure would help to continue understand the different 
structural nuances of sensor histidine kinases. Based on the number of residues in the protein, 
REC from VarS is predicted to be a multi-domain protein. Understanding how the multi-domain 
structure of REC evolved as well as understanding how gene fusion between VarS and REC 
occurred would help explain the structural differences between the two domains. Understanding 
these structural differences would help in planning new approach for crystallization of the 
domain. 
5.2 Methods 
5.2a. Expression and Purification of VarS REC domain 
The genes for REC has been previously identified and isolated [8]. In order to construct 
the expression vector for REC the gene was ligated into the pHSG398T plasmid using EcoRI and 
HinDIII. Plasmid was then transformed into E. coli BL21 cells for expression. Nickel-affinity 
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chromatography was used to purify the expressed protein. Once purified the protein was dialyzed 
into 1 x PBS for an extra round of purification as well as for storage. Production and purification 
of REC domain was accomplished by Dr. Takehiko Mima at Okayama University of Medicine 
as the Sakon lab at the University of Arkansas does not have access to gene for VarS from V. 
alginolyticus. 
5.2b. Itasser Homology Modeling of REC 
 Due to difficulty in crystallization of REC and HPT domains homology modeling was 
used to give a probable structure of the proteins based on sequence homology in proteins whose 
structures have been solved. Random mutagenesis using a transponson based system alongside 
sequence alignment studies were used to find the nucleotide and amino acid sequences for REC 
(residue 535 – 781) [8]. Modeling was accomplished by inputting sequence into the Itasser 
(Iterative Threading Assembly Refinement) program developed by the Zhang lab at the 
University of Michigan [9]. For REC, homology model for sub-domain I was produced by 
deleting coordinates in the original Itasser derived homology model that correspond to sub-
domain II and the linker region. Homology model for REC sub-domain II was produced in the 
same manner with coordinates corresponding to sub-domain I being deleted.  
5.2c. Circular Dichroism and Tryptophan Emission Spectra of REC Domain 
 Circular Dichroism and Tryptophan Fluorescence emission were used to check if 
expressed REC domain secondary structure and fold matched the Itasser homology models. For 
both Circular Dichroism and Fluorescence experiments proteins were dialyzed into 30 mM 
Hepes pH 7.5, 50 mM KCl, 1 mM TCEP. For Circular Dichroism experiments best results are 
obtained when the protein is in a low salt buffer. For the CD experiment proteins were diluted 
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with the new buffer to 1.5 ml with a final concentration of 0.2 mg/ml. For Tryptophan emission 
experiments proteins from the CD experiments were diluted with buffer as needed. Circular 
Dichroism and Tryptophan emission spectra of REC domains was found using a Jasco CD 
spectrometer at room temperature. 
5.2d. Limited Proteolysis of REC domain 
 Proti-Ace screen from Hampton Research was used for proteolysis of REC domain 
because it contains multiple enzymes that could potentially target the dynamic loop region [10]. 
Initial digestion was performed as described in the kit. Briefly, 100 µl of deionized water was 
added to each Protease in the kit to create a 1 mg/ml stock. From each 1 mg/ml stock a 1:1000 
dilution was performed (0.001 mg/ml); each protease was diluted with pre-supplied 10 mM 
Hepes pH 7.5, 500 mM Sodium chloride dilution buffer. 10 µl of REC (1 mg/ml) were mixed 
with 10 µl of each 1:1000 protease stock and incubated at 37° C for 1 hour. After 1 hour the 
reaction was stopped by adding SDS-PAGE sample buffer to each sample and the samples were 
ran on a 15% SDS PAGE gel for analysis. 
5.2e. Time Dependent Proteolysis of REC Domain with Elastase 
 Time Dependent digestion of REC was performed identical to initial proteolysis however 
the concentration of Elastase was increased 1:100 dilution (0.01 mg/ml). 30 µl of REC was 
mixed with 30 µl of the 1:100 dilution of elastase and the reaction was incubated for 1 hour at 
37° C. Every 10 minutes 7.5 µl of the mixture was aliquoted and the reaction was stopped by 
adding an equal amount of SDS sample buffer. Samples were frozen to prevent potential 
disulfide bond cross linking from occurring. The samples were run on a 15% SDS PAGE gel to 
visualize the appearance of a new sub-domain.  
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5.2f. Identifying if multi-domain structure is present in crystal structures of related REC 
domains 
To identify if the multi-domain structure from the REC homology is conserved in related 
proteins, the homology model was loaded onto the DALI server and matched against the full 
Protein Databank [11]. The structures with the top ten Z-scores were chosen and superimposed 
with the REC homology model using PyMol to identify if multi-domain structure with flexible 
linker is conserved in solved crystal structures of related REC domains. Only non-redundant 
structures were chosen from the Protein Databank. Conserved structural elements other than 
linker were noted as well. To investigate the origin of both sub-domains from REC homology 
model the newly created homology models for REC sub-domain I and II were loaded onto DALI 
server and matched against the full Protein Databank Non-redundant structures with the top ten 
Z-scores were chosen for both domains I and II and superimposed with PyMol.  
5.3 Results and Discussion 
5.3a. Description of Itasser derived REC domain model 
 Due to difficulties with crystallization Itasser was used to construct a model of REC 
domain using homologous structures as a template [9]. This model revealed a structure that 
consists of two domains (I and II) with a pseudo two-fold symmetry similar to receiver domain 
in PleD response regulator [1]. Domain I and II both have a Rossman fold common amongst 
REC domains [12]. Domain I contains four α-helices and five β-sheets and domain II contains 
five α-helices and five β-sheets. The domains are connected by a 21-residue linker (residues 114-
133) that is predicted to highly flexible based on B-factors from the homology model [13]. In 
addition to the loop connecting domain I and II the following regions in the model are also 
predicted to be highly flexible: residues 64-69 connecting α-helix b to β-sheet D and residues 
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100-114 which make up α-helix d. The active site of REC is found in domain II. Key Mg2+ 
chelating Asp residues 140 and 141 are found on the loop connecting β-sheet A’ and α-helix a’. 
Asp184, which receives the phosphate from the HisKa domain, is found nearby Asp140 and 
Asp141 on β-sheet C’ (see figure 2). Key Lys residue 236, responsible for stabilizing phosphate 
via salt bridge is found on the loop connecting β-sheet E’ and α-helix e’ [2]. Intriguingly, LTKP 
motif containing Lys236 is the only site responsible for phosphate transfer conserved in both 
domain I and II. 
5.3b. Circular Dichroism and Tryptophan Emission Spectra support REC homology model 
structure 
 Circular dichroism and tryptophan emission spectra were found to give support to the 
REC homology model. Circular dichroism spectrum was normalized and smoothed using 
exponential smoothing function from excel so that noise at lower wavelengths is minimized. 
However, data below 195 nm was still too noisy to be read. Starting at 250 nm REC spectrum 
decreases smoothly until reaching approximately 230 nm where the ellipticity decreases more 
rapidly. Rapid decrease continues until a minimum at 208 nm is reached and then ellipticity 
increases until a maximum at 195 nm is reached (see figure 3A). For a protein that is primarily α-
helical circular spectra contains local minima at 223 nm and 208 nm and a protein that is 
primarily β-sheet has minimum at 218 nm and a maximum at 195 nm [14]. Circular dichroism 
spectra for REC domain is consistent with a protein whose secondary structure contains both α-
helices and β-sheets.  
Since REC domain contains only a single Trp residue; Trp emission spectrum was used 
to determine if the protein is folded identical to the Itasser derived homology model. Absorbance 
wavelength was 280 nm and the emission wavelength for the protein peaked at 343 nm (see 
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figure 3B). This is consistent with Trp61 being exposed to solvent [15]. Trp that is fully exposed 
to solvent has an emission wavelength maximum at 350 nm. In the homology model the Trp61 is 
found on α-helix b near the loop connecting α-helix b to β-sheet D. Interactions between Trp61, 
Ile6, Leu33, Asn36, Val43, Leu45, Val57, Pro60, Met68 and Pro70 form a hydrophobic pocket 
that may need to be stabilized if crystallization of REC will occur (see figure 4). In addition to 
protein dynamics and flexibility, amino acid composition plays a large role in crystallization. 
The presence of hydrophobic residues on the surface of a molecule would cause entropy of the 
solvent to become more negative. Hydrophobic effect of Trp61 causes water molecules in the 
solvent to become more ordered [16]. Mutation of Trp61 to Tyr may keep this proposed 
hydrophobic pocket stable however the presence of a hydroxyl group from Tyr would keep water 
molecules from associating together due to the hydrophobic effect.  
5.3c. Proteolysis of REC domain confirms the existence of flexible loop in the protein 
 Limited Proteolysis of REC domain was performed to better probe the existence of 
dynamic loop connecting domain I and II. After one hour the digestion was stopped, and all 
samples were run on a 15% SDS PAGE gel. The loop contains Arg131 which is a potential site 
for trypsin. The loop contains the residues Ala122, Leu120 and Leu132 for elastase to potentially 
attack. Chymotrypsin and subtilisin have previously been known to cleave the c-terminal side of 
Leu. Papain could potentially cleave the same site in the loop as trypsin. Endoproteinase Glu-C 
cleaves the peptide bond c-terminal to Glu which there are three of present in the loop region 
(Glu115, Glu128 and Glu130). Only chymotrypsin, elastase and subtilisin were able to digest 
REC domain after 1 hour (see figure 5A). Molecular weight of wild-type REC domain is 
approximately 28 kDa and on the gel undigested REC shows up at approximately 35 kDa. REC 
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domain is most likely running larger on the 15% due to the protein not being fully unfolded or 
basic amino acids (Arg and Lys) interfering with SDS binding to the protein [17]. 
After digestion, the new band appearing at approximately 27 kDa for elastase appeared to 
be most stable as it lacks the long smear trail seen in the new bands for α-chymotrypsin and 
subtilisin. Time dependent proteolysis of REC with elastase was performed with a fresh batch of 
REC domain to better isolate the new lower molecular weight species seen in the initial 
digestion. After 10 minutes, a new band appeared between 27 kDa and 17 kDa. After 60 minutes, 
this band is still present which indicates that this new species must be stable (see figure 5B).  
Potential high molecular weight contaminants are present in the initial proteolysis and 
time dependent proteolysis experiments. These contaminants are most likely from the initial 
expression and purification of REC domain from E. coli but could be the result of soluble REC 
aggregates from Cys disulfide bond formation. REC domain contains 3 Cys residues. The 
apparent molecular weight of the contaminants (80 kDa and 100 kDa) are not consistent with 
that of a REC dimer however it may be consistent with a REC trimer (REC monomer is 
approximately 27 kDa). Band will need to be digested and analyzed to identify the contaminant. 
If bands are the result of soluble REC aggregates, protein will need to be purified to remove 
aggregates and proteolysis experiment will need to be repeated. 
5.3d. Flexible loop between domain I and II is inhibiting Crystallization of REC domain 
 Protein crystals form when over time proteins in solution come together through 
intermolecular contacts [16]. The formation of these intermolecular contacts, like all things, is 
driven by change in Gibbs free energy (∆G°) [16]. Briefly, a reaction with a negative value for 
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∆G° is likely to proceed spontaneously. For protein crystallization the Gibbs free energy 
equation can be written as  
∆G°Crys = ∆H°Crys – T(∆S°Protein + ∆S°Solvent) 
It has been theorized that a change in ∆H°Crys is not important for crystallization which means 
that crystallization by change in ∆S° [16]. Imposing order upon a three-dimensional biomolecule 
results in the loss of six translational and rotational degrees of freedom per molecule and results 
in a massive negative change in entropy for ∆S°Protein and is only slightly compensated by newly 
created vibrational degrees of freedom [18]. To overcome this negative ∆S°Protein ordered water 
molecules are released into the solvent as protein crystal contacts form to give a large positive 
value for ∆S°Solvent [16]. 
 Highly dynamic and flexible regions in proteins (such as loops) would cause ∆S°Protein to 
have a large negative value. As such, proteins with more ordered structures and less flexible 
regions are more likely to form quality crystals for x-ray crystallography. In the context of REC 
domain, removal of the loop region (crystalize just the active site domain) or truncation of the 
loop region may allow the protein to crystallize easier. To determine if this multi-domain 
structure connected by a flexible loop region is conserved in proteins related to REC domain, the 
homology model was loaded onto the DALI server and matched against the full Protein 
Databank [11].  
The structures with the top 10 Z-scores were chosen and aligned using PyMol and it was 
found that all but two of the structures contained only the active site domain [19] [20] [21]. 
Figures are summarized in figure 6A. For the other two structures the loop region is present, but 
it is highly truncated (see figure 6B and 6C). Chosen structures superimposed with homology 
 
160 
 
model of REC nicely; all with R.M.S.D values < 1 Å [22]. The active site triad key for 
phosphorylation in REC domains is highly conserved in all the structures (see figure 6D) [2]. In 
addition to the active site acidic residues, key Lys residue responsible for forming a salt bridge 
with active site phosphate is conserved in all DALI structures [2].  
In the REC homology model Leu134, Leu153, Val157, Val160, Leu180 and Leu247 
appear to form hydrophobic pocket at the N-terminus of domain II. This pocket appears to be 
conserved throughout the DALI structures with homologous residues being in place of the Leu 
and Val residues (see figure 6E). To make crystallization of REC domain easier a truncated 
version of the protein containing just domain II was expressed. To keep the N-terminal 
hydrophobic pocket stabilized the new N-terminus was made to be Leu134. REC domain 
containing just domain II was found to express rather poorly. Currently it is unknown if lowering 
the temperature during expression or if increasing the expression time would prevent the 
formation of inclusion bodies. 
If expression levels for REC domain containing only domain II cannot be improved, 
shortening of the loop between domain I and II may provide an alternative method for decreasing 
∆S°Protein and increasing the chance of crystallization (see figure 2) [16]. Based on the B-factors 
for the loop region we predict that deletion of residues 117 to 129 from the loop region would 
sufficiently decrease the ∆S°Protein while still leaving enough residues to efficiently link the two 
domains. Glu115 and Leu132 lie at either end of the loop between domain I and II with 7.9 Å 
distance between the two. The addition of Ser116 and Arg130 to both sides of the loop would be 
enough to sufficiently bridge the 7.9 Å gap between the two domains. 
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5.3e. Gene duplication may be responsible for two REC sub-domains 
The primary known function of most REC domains is to act as a phosphorylation 
mediated switch for response regulators [12]. While REC domains are commonly attached to 
DNA binding domains they are also found on a variety of output domains including enzymatic, 
RNA-binding and ligand binding domains [5]. However, some REC domains are not attached to 
any output domain and exist independently. Approximately 50% of response regulators in 
Archaea consist of only a single REC domain with no output domain [12]. Currently it is 
unknown how REC domains began to be incorporated into different histidine kinase forming 
Phospho-relay two component systems. Incorporation of the REC domain into a histidine kinase 
would present an additional regulatory checkpoint for environmental stimulus response that is 
not present for the response regulator [2]. REC domains in response regulators and phosphor-
relays have similar structures and can contain either one or two sub-domains [1] [2]. In response 
regulators binding at the N-terminal REC domains causes the protein to dimerize which allows 
the C-terminal effector domain to bind to DNA [5]. It is currently unknown if internal REC 
domains from histidine kinase forms a dimer as well. Below we investigate the potential origin 
of REC domain incorporation into histidine kinases. 
In REC homology model residues corresponding to domain II and the linker region were 
deleted to create a model for just domain I. For domain II, this process was repeated with domain 
I and linker region being deleted. The newly derived homology models for domain I and II from 
REC were loaded onto the DALI server and matched against each other. Structures for domains I 
and II were found to be highly conserved with an R.M.S.D = 1.9 Å (see figure 7A). The 
homology model of REC domain I is missing the key Asp residue that is phosphorylated during 
histidine kinase signaling. Rec domain I is also missing one of the acidic residues necessary for 
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Mg2+ chelation. However, as stated earlier in the chapter key Lys residue responsible for 
stabilizing the phosphate is conserved in domain I (see figure 7B) [2]. REC domain II was found 
to contain all the necessary motifs necessary for phosphate transfer. 
In addition to being matched against each other, the two derived homology models for 
REC domain I and II were matched against the full Protein Databank. For both domain I and II 
the structures with the top 10 Z-scores were chosen and aligned using PyMol. For REC domain I 
it was found that the structures superimposed well with the of domain I homology model, all 
with R.M.S.D. values < 2.5 Å (see figure 7C). For REC domain II it was found that the 
structures superimposed well with R.M.S.D. values < 1.9 Å (see figure 7D). However, the 
percent sequence identity for domain II was much higher than that for domain I. For domain II, 
the chosen structures had percent sequence identities higher than 30% while for domain I chosen 
structures had percent sequence identities < 20%. Domain II of REC had a higher sequence 
identity when matched against the entire Protein Databank compared to domain I, which 
indicates that domain II must be more closely related to this single domain common ancestor 
[11]. Due to this domain II must have evolved in REC before domain I. 
DALI results for REC homology model revealed that structures containing two REC 
domains are from PLED like response regulators with GGDEF effector domains [1]. The 
presence of dual REC domains in PLED response regulators may give a hint to the origin of 
REC domain from VarS. Based on their presence on a variety of output domains response 
regulatory REC domains may have evolved from single domain response regulators from 
Archaea [23]. Incorporation of REC domain would give early bacterial ancestors the ability to 
affectively respond to different stimuli and promote survival via phosphate transfer [23]. It is 
currently unknown by which horizontal gene transfer mechanism this single domain common 
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ancestor was incorporated into prokaryotes. It is speculated that many eukaryotic or archaeal 
systems evolved through horizontal gene transfer [24]. Archaea like single domain response 
regulators are still used in prokaryote signal response. E. coli CheY protein which regulates 
chemotaxis is a known relative of single domain response regulators [23].  
While REC domains consist of approximately a single domain with approximately 120 
residues PleD-like REC domains contain two sub-domains and approximately 240 residues. 
Gene duplication may explain the presence of dual REC domains in PleD like response 
regulators. In two component systems from the tomato plant, gene duplication events primarily 
occur in the cytoplasmic response regulator [25]. After gene duplication, pre-existing functions 
are not as likely to be conserved which may explain domain I’s lack of residues involved in 
phosphate transfer [6]. PleD-like response regulators may have evolved two REC domains two 
assist in dimer formation of GGDEF effector domains (see figure 8). Crystal structure of PleD 
reveals that REC-like adaptor domain assist in homodimer formation which is essential for 
GGDEF dimer formation. Dimer formation is necessary to promote formation of cyclic di-
guanosine monophosphate (c-di-GMP) from two molecules of GTP [1]. To explain the presence 
of two domains in VarS, gene for PleD-like response regulator may have been incorporated into 
gene for VarS histidine kinase via gene fusion as genes for PleD family of response regulators 
are found in V. alginolyticus. [7]. REC-like adaptor domain assists in dimer formation for PleD 
and may assist in dimer formation for VarS [1]. REC domain could only be incorporated into the 
gene for VarS by insertion at the C-terminus as insertion at the N-terminus would disrupt the 
transmembrane region of the new protein causing it to be unable to fold correctly [26]. Once 
being incorporated into VarS, REC must have lost GGDEF effector domain over time.   
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Incorporation of REC domain into the histidine kinase may explain some of the 
differences in residue content between domain I and II. Hydrophobic pocket present in domain I 
is also present in domain II however the pocket in domain II is not as hydrophobic. Trp61 from 
domain I is His65 in domain II, Met68 from domain I is Asn72 in domain II and Pro70 from 
domain I is Asp74 in domain II. The other residues that make up the hydrophobic pocket are 
homologous for both domains. Presence of surface exposed Trp residues is highly unlikely 
however, in the full length VarS histidine kinase surface exposed hydrophobic pocket could be 
buried. After being incorporated into the VarS histidine kinase domain I may have evolved to 
select for more hydrophobic residues in this pocket (see figure 4). This increase in 
hydrophobicity may allow this pocket in domain I to serve as a contact point for REC with the 
HATPase domain. Increased hydrophobic contacts between HisKA and REC domain may keep 
the VarS sensor histidine kinase folded correctly. Just like the increase in hydrophobic residues 
for domain I can be explained by REC being incorporated into the gene for VarS so to can the 
decrease in phosphate transfer motifs be explained. In domain I active site phosphate accepting 
Asp residue is not present. In domain II Asp140 is replaced with Glu7 in domain I while Asp141 
is replaced with Pro8. Residues responsible for phosphate transfer in domain I may have been 
lost due to pressure to prevent phosphate transfer into domain I. If phosphate were to be 
transferred into domain I it may not be able to be affectively transferred further downstream.  
Prevention of phosphate transfer would stop bacteria from responding to outside 
stimulus. For different bacteria this would lead to different outcomes. In Vibrio alginolyticus this 
would prevent the bacteria from efficiently degrading substrate stopping the uptake of necessary 
nutrients for survival. Understanding how evolution leads to differences between the two 
domains in REC is key to the development of strategies for crystallization of the domain. 
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Crystallization of REC domain is necessary for the development of broad-spectrum antibiotics 
that would target conserved structural motifs in REC domains from different species. Drug 
resistant “superbugs” are a growing problem due to incorrect use of anti-biotics. Recently 
developed anti-biotics all tend to target the same structures and pathways decreasing their 
effectiveness [27]. Gene expression analysis of drug resistant tuberculosis isolates have shown 
that two component response systems can enhance drug resistance [28]. Targeting certain two 
component systems may be an efficient way to increase drug sensitivity of bacteria. 
5.4 Conclusion 
In V. alginolyticus, Itasser derived homology model of REC domain reveals a structure with two 
sub-domains connected by a flexible linker. Circular dichroism and tryptophan emission spectra provided 
support to the model and limited proteolysis confirmed the presence of flexible linker. Based on the two-
domain structure of REC a theory on the evolution of VarS incorporated REC domain from PleD-like 
response regulator via horizontal gene transfer and gene fusion was proposed. Based on its role in the 
REC-like adaptor domain, non-active site domain in REC may help promote dimer formation in VarS 
during signal activation of the sensor histidine kinase [1]. Crystallization efforts for REC domain have so 
far been unsuccessful. In order to crystallize REC domain flexible linker was removed. Expression 
plasmid containing REC sub-domain II (sub-domain II contains the active site) was transformed 
into E. coli and the protein was expressed. However, expression level for the protein was poor. If 
expression levels for REC sub-domain II cannot be improved REC domain with a shortened 
linker may need to be expressed [16]. Based on the REC homology model it is speculated that 
deletion of residues 117 to 129 from the linker should still allow the C-terminus of sub-domain I 
to be efficiently linked with the N-terminus of sub-domain II. 
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Chapter 5: Figures 
Figure 1: A. Cartoon representing two classes of histidine kinases. B. Cartoon showing the 
differences between simple two-component system and a phosphorelay.  
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Figure 2: Itasser derived homology model of REC domain. B-factors are colored using PyMol 
(regions in blue are highly ordered, regions in red are highly disordered). Key Asp residues 
for Phosphorylation are colored yellow and surface exposed Trp61 is colored red.  
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Figure 3: A. Circular dichroism spectrum for REC domain. A minimum at 208 nm and a 
maximum at 195 nm is consistent with a protein that contains both α-helices and β-sheets. B. 
Trp emission spectrum for REC domain. Maximum at 343 nm is most likely due to Trp 
residue being surface exposed 
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Figure 4: Hydrophobic pocket from REC sub-domain I. Pocket may give a contact point for 
the domain to be incorporated into full-length VarS. 
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Figure 5: A. Initial proteolysis of REC domain using Proti-ace kite from Hampton research. 
Digestion from Elastase appears to produce a stable product. B. Time dependent proteolysis 
of REC domain using Elastase. Stable product appears after 10 mins. 
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Figure 6: A. Table summarizing DALI results for REC domain B. REC domain homology 
model superimposed with multi-domain DALI structures. C. REC domain homology model 
superimposed with single domain DALI structures. D. Superimposed active site region for 
REC domain and all DALI results. E. Superimposed hydrophobic region at the N-terminal 
region of domain II for REC domain and all DALI structures.    
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Figure 7: A. Superimposed structures for REC sub-domain I (green) and REC subdomain (II) 
magenta B. Active site region from A. zoomed in. Sub-domain is missing the majority of 
residues necessary for phosphate transfer C. Superimposed DALI results for REC sub-domain 
I.  D. Superimposed DALI results for REC sub-domain II. Smaller R.M.S.D. values (in table) 
indicate REC sub-domain II is more closely related to REC common ancestor. 
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Figure 8: Cartoon representation of the role the adaptor domain plays in activating PleD-like response 
regulators. Adaptor domain was most likely kept after being incorporated into gene for VarS. Cartoon 
is from Wassman et al. 2007 [1]. 
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Chapter 6: Potential role of conserved Cys in Vibrio alginolyticus HPT domain for regulation of 
collagenase expression under oxidative stress 
Abstract 
 While attempting to study the structure for the cytoplasmic region of full length VarS 
histidine kinase (residues 197 – 932) it was discovered the protein was partially degraded and 
only appeared to be in its native state due to the presence of two disulfide bonds in the histidine 
kinase (Cys697/Cys789 and Cys883/Cys892). Due to the location of Cys883/Cys892 disulfide 
bridge within the HPT domain (residues 797 – 932) its potential role as a redox sensitive 
regulator for collagenase expression was investigated using homology modelin, Pz-peptidase 
assay and qRT-PCR. qRT-PCR revealed that sRNA2 transcription is only slightly downregulated 
in the presence of Menadione. Potential role of Cys883/Cys892 will need to be investigated 
further.  
6.1 Introduction 
Two-component systems serve as a basic stimulus response mechanism allowing 
organisms to sense and respond to different environmental changes. A brief outline of their 
mechanism is as follows; first a signal is received which causes the protein to dimerize, next 
ATP donates a phosphate to a conserved His residue, finally the phosphate is passed (either in a 
cis or trans method) to a conserved Asp residue located on the Response Regulator. Response 
regulator then leads to either the expression or repression of certain genes through transcription 
of sRNA which binds to repressor proteins [3]. VarS, histidine kinase pair from the VarS/VarA 
two component system, is a phosphor-relay type histidine kinase where the phosphate is passed 
through an internal REC domain and then a C-terminal HPT domain before finally passing it on 
to the VarA response regulator. The VarS/VarA system or closely related systems are used to 
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control virulence factors for a variety of bacteria. V. cholera uses a system closely related to 
VarS/VarA to control the expression of ToxR, a transcriptional activator that is essential for V. 
cholera virulence [4]. S. aureus uses the YycG/YycF two-component regulatory system to 
control the expression of genes involved in cell wall metabolism, membrane bound transport 
systems and pathogenicity [5]. 
The majority of HPT proteins are all α-helical and contain a conserved four helical 
bundle as the minimal core structure (see figure 1) [2] [6]. In most HPT domains this bundle is 
assembled as a monomer but in some cases, such as for ChpT from C. crescentus and Spo0B 
from B. subtilis it can be assembled as a dimer [2] [7]. The two forms do not have detectable 
sequence similarity and are most likely not evolutionary related but are examples of convergent 
evolution [2]. Outside of the conserved four helical bundle HPT domains can have different 
lengths or contain different structural elements [2]. The solvent exposed Histidine located on the 
second αB accepts phosphate from REC domain and transfer it to response regulator leading to 
gene transcription and protein expression. Below the general structure for phosphor-relay HPT 
domains is described.  
Ypd1 from S. cerevisiae is a monomeric HPT domain used in regulating S. cerevisiae 
response to osmotic stress [8]. Due to the many studies on the structure of Ypd1 it is considered 
a model HPT protein [2] [6]. HPT from V. alginolyticus has sequence similarity with Ypd1 from 
S. cerevisiae indicating that its four-helix bundle is assembled as a monomer (see figure 1). 
Structure function analysis of Ypd1 indicate that several residues located near the key His 
residue that are important for phosphate transfer. Alanine substitution of Lys67 was found to 
have the greatest effect on phosphate transfer [2]. Basic amino acids are found to be highly 
conserved at this position in the HPT family. In REC domains conserved basic residues in the 
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active site help to coordinate phosphate binding by forming a salt bridge with oxygen from the 
phosphate [6]. Conserved basic residues may be playing the same role for HPT. Conserved Gly 
four residues from the phosphate accepting His residue towards the C-terminus was also found to 
be important for phosphate transfer. Mutation of this Gly residue to Gln results in reduced levels 
of phosphorylation [9]. Substitution of Gly68 from Ypd1 with bulkier residues inhibits transition 
state formation with response regulator Sln1 [10]. Crystal structure of Ypd1:Sln1 complexed 
with beryllium fluoride ion revealed that conserved hydrophobic and hydrogen bond interactions 
on three α-helices from the four helix bundle are necessary for forming the complex [1]. There is 
high sequence similarity at these same positions for the HPT domain of V. alginolyticus. 
Internalized REC and HPT domains do not have any effect on phosphate transfer or response 
regulator output but simply allow for extra regulatory checkpoints along the phosphorylation 
pathway. Intermediate REC and HPT domains can be targeted by specific phosphatases for an 
additional gene transcription regulation step [6].  
During host invasion V. alginolyticus is thought to encounter oxidative stress 
environments, either from reactive oxygen species (ROS) from host immune system or H2O2 
diffused from intestinal epithelial cells [11] [12]. Host immune systems generate ROS to kill 
invading pathogens [11]. ROS can damage bacteria in multiple ways; by disrupting oxidative 
phosphorylation, by damaging the bacterial membrane through lipid peroxidation, by oxidizing 
purines in DNA preventing replication and by protein carbonylation [13] [14] [15]. ROS sensing 
can be used by bacteria to adopt to and avoid host immune system [16]. To conserve energy 
needed for oxidative stress repair pathways bacteria may have evolved methods to sense 
intracellular ROS and up/down regulate expression of different proteins. Cys residues have high 
redox sensitivity which makes them excellent sensors for oxidative stress. In this chapter it is 
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discussed whether HPT disulfide bond between Cys883 and Cys892 discovered using mass 
spectrometry helps to downregulate expression of collagenase during oxidative stress. In certain 
response regulators intramolecular disulfide bond formation creates steric hindrance between the 
protein and DNA preventing sRNA transcription and perhaps a similar mechanism is occurring 
for VarS HPT [3] [17] [16]. Disulfide bond could also be intermolecular. In RegB from R. 
capsulatus, a histidine kinase responsible for many cellular processes, conserved Cys in dHp 
domain forms intermolecular disulfide bond in the presence of oxidizer. This Cys is highly 
conserved in RegB analogs however, Cys from RegB is not found in an analogous position in 
VarS (see figure 2) [18]. RegB is a simple histidine kinase while VarS is a phosphorelay-type 
histidine kinase. Currently it is unknown if this redox sensing Cys motif is present in 
phosphorelay-type histidine kinase. 
6.2 Methods 
6.2.a. Expression and Purification of VarS HPT domain and Cytoplasmic VarS 
The gene for HPT has previously identified and isolated [19]. In order to construct the 
expression vector for HPT the genes was ligated into the pHSG398T plasmid using EcoRI and 
HinDIII. Plasmid was then transformed into E. coli BL21 cells for expression. Nickel-affinity 
chromatography was used to purify the expressed protein. Once purified the proteins were 
dialyzed into 1 x PBS for an extra round of purification as well as for storage.  
The cytoplasmic region of VarS (residues 197-932) was expressed and purified as 
follows. A DNA fragment encoding VarS197-932 was inserted in a pET-16b expression vector. 
Plasmid for N-terminal His10-tagged VarS197-932 was transformed into E. coli BL21(DE3) cells 
and expressed by IPTG. Newly expressed VarS197-932 was purified by affinity chromatography 
with Ni-NTA agarose. VarS197-932 protein was further purified by ion exchange chromatography 
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with Q sepharose. Once purified, the protein was dialyzed into the following buffer for storage 
30 mM HEPES pH 7.5, 50 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, 40% glycerol, 
10% ethylene glycol. Proteins were shipped from Okayama University. Production and 
purification of all HPT and VarS197-932 was accomplished by Dr. Takehiko Mima at Okayama 
University of Medicine since the Sakon lab at the University of Arkansas does not have access to 
the gene for VarS from V. alginolyticus. 
6.2b. Itasser Homology Modeling of HPT 
 Due to difficulty in crystallization of HPT domain homology modeling was used to give a 
probable structure of the proteins based on sequence homology in proteins whose structures have 
been solved. Random mutagenesis using a transponson based system alongside sequence 
alignment studies were used to find the nucleotide and amino acid sequences for HPT (residue 
797 to 932) [19]. Modeling was accomplished by inputting sequence into the Itasser (Iterative 
Threading Assembly Refinement) program developed by the Zhang lab at the University of 
Michigan [20]. Homology model for REC sub-domain II containing linker to HPT domain was 
produced with Itasser using REC sub-domain II sequence with linker to HPT to identify if 
Cys697/Cys789 disulfide bond is possible in vivo. 
6.2c. Circular Dichroism and Tryptophan Emission Spectra of HPT Domain 
 Circular Dichroism and Tryptophan Fluorescence emission were used to check if 
expressed HPT secondary structure and fold matched the Itasser homology models. For both 
Circular Dichroism and Fluorescence experiments proteins were dialyzed into 30 mM Hepes pH 
7.5, 50 mM KCl, 1 mM TCEP. For Circular Dichroism experiments best results are obtained 
when the protein is in a low salt buffer. For the CD experiment proteins were diluted with the 
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new buffer to 1.5 ml with a final concentration of 0.2 mg/ml. For Tryptophan emission 
experiments proteins from the CD experiments were diluted with buffer as needed. Circular 
Dichroism and Tryptophan emission spectra of HPT was found using a Jasco CD spectrometer at 
room temperature. 
6.2d. Identifying Apparent Molecular Weight of VarS197-932 
 Size exclusion chromatography (G-200 sephadex) with reference proteins were used to 
determine the apparent molecular weight of VarS197-932. 1 g of G-200 sephadex was mixed with 
60 ml of elution buffer (30 mM Hepes pH 7.5 50 mM KCl) and swollen at 90° C for 5 hrs. The 
slurry was degassed by bubbling with inert N2 gas for 10 min and gravity flow was used to pack 
the column. Blue Dextran (MW: 2,000 kDa) was eluted to find the void volume of the column. 
Gravity filtration was used to run the following reference proteins through the column; Bovine 
Gamma Globulin (MW: 150 kDa), Bovine Serum Albumin (MW: 66.5 kDa) and Lysozyme 
(MW: 14 kDa). All reference proteins were eluted through the column in triplicate. VarS197-932 
was eluted through column normally and after being incubated with TCEP. VarS197-932 was 
treated with TCEP by incubating equal volumes of protein with 10 mM TCEP for 1 hr. at 4°C. 
As the protein elutes from the column 0.5 ml volumes were collected and a micro-bradford assay 
was used to determine when each protein was eluted. Absorbance at 625 nm was used to reveal 
when blue dextran was eluted. Log (MW) vs Ve/Vo was plotted, and the linear trend line was 
used to find the apparent molecular weight of VarS197-932. 
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6.2e. Identification of VarS197-932 disulfide bonds using trypsin digestion coupled with MALDI 
– TOF 
 12% SDS PAGE gels were used to check if addition of TCEP causes VarS197-932 dimer to 
dissociate into the monomer. Protein samples were run in the absence and presence of .2 M 
TCEP. For the reduced sample equal volumes of 2 mg/ml VarS197-932 and .2 M TCEP were 
incubated together at room temperature for 30 minutes before electrophoresis. In the non-
reduced sample .2 M TCEP was replaced with an equal volume of water. 
Dr. Rohanna Liyanage in the mass spectrometry department at the University of 
Arkansas performed all trypsin digestion and mass spectrometry analysis. 5 µl of VarS197-932 was 
digested in its native state (without reducing agent) by adding 10 µl Mass Spectrometry grade 
trypsin (Promega) at a concentration of 10 ng/µl in ammonium carbonate buffer. Mixture was 
incubated overnight at 37°C. After incubation 100 µl of 5% Formic Acid (FA) in 60% 
acetonitrile was added to quench trypsin and break down ammonium bicarbonate. Digest 
mixtures were then dried and reconstituted in 50 µl of 0.1% FA. A HPLC-20A/LC-30A, coupled 
to a Shimadzu electro spray ionization quadrupole ion trap-time of flight mass spectrometer (LC-
ESI-IT-TOF-MS) was used to obtain high resolution accurate intact masses of the digestions 
with less than 10 ppm error.  The digest was subjected to LC separations using a Bio wide Pore 
C18 reverse phase column (4.6 mm × 15 cm, 5 μm) (Supelco, St. Louis, MO) with a solvent flow 
rate of 0.8 mL/min in 0.1% formic acid/acetonitrile gradient of 5–100%, over a 60 min period. 
Shimadzu LC-MS solution version 3.81 was used to process peaks to obtain mass spectra for 
each chromatographic peak. Then the monoisotopic mass obtained from the isotopically resolved 
high resolution multiple charged ions were matched against the Insilco tryptic digest masses 
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obtained by Bruker Daltonics sequence editor software version 3.2 (Bruker Daltonics GmbH) 
based on all possible disulfide linkages. 
6.2f. Identification of conserved structural and sequential elements in related HPT domains 
 To identify if structural elements within the VarS HPT homology model are conserved 
homology model was loaded onto DALI server and matched against the entire Protein Databank. 
Non-redundant structures with the top ten Z-scores were chosen and aligned with the HPT 
homology model using PyMol to identify key structural elements. The presence of Cys residues 
were noted for each structure from DALI. If a structure contained multiple conserved Cys 
residues the distance between Cα’s was noted. To identify conserved sequence motifs for the 
DALI structures FASTA sequences were aligned using Clustal omega online server [21]. The 
positions of conserved hydrophobic, basic and acidic residues near the active site His residue 
were noted [2]. The positions of Cys residue for each FASTA sequence were also noted.  
6.2g. Effect of VarS Cys883Ser mutation on Pz-peptidase activity 
 All experiments regarding the effects of VarS C883S mutation on Pz-peptidase activity 
were performed by Dr. Takehiko Mima at Okayama University. A gene expression vector 
possessing wild type VarS and a gene expression vector possessing the mutant VarS C883S were 
transformed into a V. alginolyticus VarS deletion mutant. A gene expression vector possessing 
no VarS gene was used as a negative control. Expression vector for VarS C883S was constructed 
using site directed mutagenesis with expression vector for wild type VarS being used as the 
template.  
The primers used for mutagenesis were (5’-TCATATTCCGGAGTGCCTAGGCTGAA) 
and (5’-CACTCCGGAATATGAGCTACTGCCGT) with underlined regions corresponding to 
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the new S883 residue. Introduction of mutation was confirmed by Sanger sequencing. Newly 
transformed cells were grown in NZ1/2SW medium (1% NZ amine, 1.67% sea salts) containing 
0.2% gelatin at 25°C. Expression of collagenase was induced by adding 50 μl of overnight 
culture to each well of a 96 well plate containing 50 μl of an insoluble collagen solution and 
incubating at 37°C for 2 hrs [19]. After induction collagenase activity of bacterial culture was 
measured colorimetrically using 4-phenylazobenzyloxy-carbonyl-Pro-Leu-Gly-Pro-D-Arg (Pz-
peptide, Sigma-Aldrich) as described by Wünsch and Heidrich [22]. 
6.2h. Effect of Oxidative stress on expression of sRNA2 
 To measure the potential effect of oxidative stress on the activity of V. alginolyticus wild 
type cells were grown as previously described [19]. When the OD600 of culture reached 0.5, 25 
μM menadione or 2 mM H2O2 were added, and the cultures were incubated for an additional 2 
hrs. or 7 min. respectively. Total RNA was isolated using RNeasy Protect Bacteria Mini kit 
(Qiagen), and reverse-transcribed with a ReverTra Ace qPCR RT Master Mix (TOYOBO, Japan) 
according to the manufacturers’ instructions. The relative sRNA quantity was measured using a 
KAPA SYBR Fast qPCR kit (NIPPON Genetics, Japan). qRT-PCR was carried out using a CFX 
Connect Real-Time PCR Detection System (BioRad), and data were analyzed using the supplied 
software. Expression levels for sRNA2 were normalized to that of 23S rRNA. (5’-
AAGCCTAATGGACGAGGTATCTTCA-3’) is the sRNA2 forward primer used and (5’-
ATCCTGACGGGCGAACTCTATC-3’) is the reverse primer used. 23S rRNA forward primer 
(5’-TTACCTACTCTTGACATC-3’) and (5’-GACTTAACCCAACATTTC-3’) 23S rRNA 
reverse primer were used to quantify the amount of 23S rRNA. All experiments regarding the 
effect of oxidative stress on sRNA2 expression were performed by Dr. Takehiko Mima at 
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Okayama University of Medicine as the University of Arkansas does not have access to qRT-
PCR thermocycler. 
6.3 Results and Discussion 
6.3a. VarS cytoplasmic domains are cleaved off during expression from E. coli  
 Initially, size exclusion chromatography was used to identify if the full length VarS 
histidine kinase undergoes dimerization in vitro similar to other histidine kinases [23]. Due to the 
molecular weight of the VarS197-932 (monomer: 82 kDa, dimer: 164 kDa) 1 g of G-200 sephadex 
was swollen in 30 mM Hepes pH 7.5, 50 mM KCl. Blue dextran was eluted through the column 
in triplicate and the void volume (Vo) of the column was found to be 4.5 ml. Bovine Gamma 
Globulin (MW: 150 kDa), Bovine Serum Albumin (MW: 66.5 kDa) and Lysozyme (MW: 14 
kDa) were also eluted in triplicate and elution peaks were averaged for each standard to give the 
average elution volume (Ve). Log(MW) vs. Ve/Vo for the three standards was plotted to make a 
calibration curve with the equation y = -0.8476x + 6.3074 where y is the Log(MW) of the 
standards and x is the Ve/Vo for each standard. For VarS197-932 elution peak for the protein was 
found at 4.5 ml (see figure 3A). When this value is entered into the calibration curve equation an 
apparent molecular weight of 257 kDa is given. To investigate whether disulfide bond formation 
is responsible for soluble aggregate formation VarS197-932 was treated with TCEP and 
chromatography experiment was repeated in duplicate. For TCEP treated VarS197-932 elution peak 
was found at 5 ml which gives an apparent molecular weight of 204 kDa (see figure 3B). SEC 
derived molecular weights are inaccurate when compared to known molecular weight calculated 
from Expasy ProtParam tool (monomer: 82 kDa, dimer: 164 kDa). 0.5 ml fractions collected for 
both native and TCEP treated VarS197-932 were most likely too large to give an accurate 
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molecular weight for VarS197-932 and the standards. However, this experiment was able to reveal 
that the protein undergoes a conformational change after treatment with TCEP. 
 In order to investigate this conformational change SEC elution fractions from the reduced 
protein were ran on a 12% SDS PAGE gel alongside native VarS197-932 and TCEP treated 
VarS197-932 (see figure 4A). Native VarS197-932 sample ran as a single band with a MW of 
approximately 80 kDa while the addition of TCEP caused the appearance of three bands with 
approximate MW of 80, 58 and 25 kDa. TCEP treated SEC VarS197-932 samples from 4.5, 5.0 and 
5.5 ml fractions all ran as single bands with MW of approximately 58 kDa. While it was not 
discovered if full length VarS is a dimer in vitro it was discovered that VarS197-932 was partially 
degraded during its expression from E. coli and that intramolecular disulfide bonds were keeping 
the protein together (see figure 4B). For a protein that exist in the cytosol, a primarily reducing 
environment, the ability to form disulfide bonds is an intriguing discovery [24].  
6.3b. ESI Mass Spectrometry analysis revealed Cys residues involved in formation of disulfide 
bridges   
To determine the location of disulfide bonds within VarS197-932, ESI mass spectrometry 
experiment was planned. VarS197-932 was digested by trypsin in its native state and the presence 
of disulfide bridges were confirmed by mass spectrometry analysis. After LC-MS, 
chromatographic peaks were processed to obtain the monoisotopic masses for multiple charged 
ions. The experimentally obtained masses were matched against in silico obtained digest masses 
from Bruker daltonics sequence editor version 3.2 based on all possible disulfide linkages. ESI 
mass spectrometry experiment was performed as a collaboration by our lab and Dr. Rohana 
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Liyanage in the statewide mass facility at the University of Arkansas. Mass spectrometry 
analysis was able to confirm the presence of two disulfide bridges in native VarS197-932.  
 The first disulfide bridge was found to be formed between Cys697 in the REC domain 
and Cys789 in the linker region between REC and HPT domains. Region containing disulfide 
bridge was hydrolyzed with trypsin at Arg690, Lys710, Arg758 and Lys795. Chromatographic 
peak corresponding to the two tryptic peptides was analyzed and mass spectra for +6 and +7 
charged ions (m/z) were used to confirm the existence of this disulfide bridge. +6 and +7 spectra 
were chosen as they were the easiest to interpret. The percent difference between experimental 
and theoretical mass spectra for +6 and +7 ions were found to be less than 0.1% (see figure 5 and 
6).  
The second disulfide bridge was found to be formed between Cys883 and Cys892 in the 
HPT domain. Region containing disulfide bridge was formed by hydrolysis with trypsin by at 
Lys875, Lys887, Lys889 and Arg900. Chromatographic peak corresponding to the two HPT 
tryptic peptides was analyzed and mass spectra for +3 and +4 charged ions (m/z) were used to 
confirm the existence of this disulfide bridge. +3 and +4 spectra were chosen as they were the 
easiest to interpret. The percent difference between experimental and theoretical mass spectra for 
+3 and +4 ions were also found to be less than 0.1% (see figure 7 and 8). 
Linker database reveals that Cys residues are unlikely to be present in linker region of 
multi-domain proteins. Itasser derived homology model of REC domain containing the 
additional residues from the linker region revealed that Cα distance between Cys697 and Cys789 
is approximately 25 Å which is not within the appropriate distance for disulfide bond formation 
(see figure 9) [25]. Since Cys697/Cys789 distance is being estimated from homology model the 
position of linker α-helix could be incorrect and may be much shorter. Using nomenclature from 
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chapter 3, loop connecting β-sheet E to linker α-helix may be oriented so that linker α-helix 
comes closer to Cys789. While this may be occurring in vitro, it would not be beneficial for the 
enzyme if this disulfide bond is occurring in vivo. Cys789 is located near the active site of REC 
domain and if linker α-helix were brought near enough that Cys697/Cys789 disulfide bond could 
form it would potentially block active site from accepting phosphate. Disulfide bond could be the 
result of intermolecular interactions. Sensor histidine kinases form dimers both in vivo and in 
vitro [26] [23]. Dimer is formed primarily by hydrophobic interactions and currently it is 
unknown if these interactions are strengthened by disulfide bond formation [27]. Based on the 
location of both Cys residues lying within the HPT sub-domain and their proximity to the key 
His residue in the primary structure of HPT the disulfide bond between Cys883 and Cys892 was 
analyzed further (see figure 10). 
6.3c. Description of Itasser derived HPT domain homology model 
 Similar to REC domain, troubles with crystallization of HPT forced the use of homology 
modeling to derive a structure for the domain. Sequence for HPT was uploaded to the Itasser 
server and model was computed based on crystal structures of homologous proteins [20]. The 
Itasser derived homology model of HPT revealed a structure that consists of five α-helices; the 
core of the protein is arranged in a four helix bundle motif with the remaining two α-helices at 
the N-terminus of the model (see figure 11A). Four helix bundle motifs are highly conserved 
amongst HPT domains [2]. 20 residue N-terminus of the homology model is predicted to be 
highly flexible based on Cα B-factors [28]. Some hydrophobic regions in the N-terminus are 
predicted to be solvent exposed. For crystallization of HPT domain to be successful, truncation 
of N-terminus may be required [29]. Other than the N-terminus the model is predicted to be quite 
ordered. In the homology model solvent exposed His874 is located on α-helix c with key 
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phosphate coordinating Lys875 and hydrophobic residues necessary for interaction with REC 
domain are also on this helix. Hydrophobic and polar residues necessary for complex formation 
with REC are conserved throughout helices b and d as well [1]. Cys883 is located on the loop 
connected α-helix c to α-helix d and Cys892 is located on α-helix d. In homology model 
disulfide bond between Cys883 and Cys892 is not predicted to occur.  
6.3d. Circular Dichroism and Tryptophan Emission Spectra support HPT homology model 
structure 
Circular dichroism (CD) and tryptophan emission spectra were used to support the HPT 
homology based structure. Raw data for circular dichroism spectrum was normalized and 
smoothed using exponential smoothing function in excel. Noise at low wavelengths due to 
excess salt in the buffer was minimized from this method however, data below 195 nm was still 
too noisy to be read. Ellipticity from HPT spectrum decreased rapidly until reaching 220 nm and 
then the ellipticity began to decrease slowly until a minimum was reached at 206 nm. After the 
minimum was reached ellipticity began to increase until reaching the maximum at 195 nm (see 
figure 11B). HPT CD spectrum is indicative of a protein that is primarily α-helical which is 
consistent with known structure for other HPT domains and with the homology model [30] [2].  
Since HPT domain contains only a single Trp residue the Trp emission spectrum was 
used to determine if the protein was folded identical to the Itasser derived homology model. 
Absorbance wavelength was 280 nm and the emission wavelength for the protein peaked at 340 
nm. Similar to REC domain the emission spectrum is consistent with Trp27 being at least 
partially exposed to the solvent (see figure 11C) [31]. In the homology model Trp27 is located 
on α-helix b near the potentially dynamic loop connecting α-helix a to α-helix b. Hydrophobic 
interactions between Trp27, Ala30, Leu31, Ala41, Lys42, Leu45, Tyr133 and Leu134 and 
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electrostatic interaction between Trp27 side chain nitrogen and side chain carboxy group from 
Glu38 and form a pocket that may need to be stabilized for potential crystallization attempts of 
HPT. 
6.3e. Sequence and Structural alignment reveal that Cys892 is highly conserved across HPT 
domains 
To determine if Cys883 and Cys892 are conserved in structural homologs of HPT 
homology model Itasser derived HPT domain was loaded onto DALI server and matched against 
the entire Protein DataBank [32]. The structures with the top 10 Z-scores were chosen and 
aligned using PyMol (see figure 12A and B). Structures from DALI search are listed in table 1. 
Chosen structures from DALI were found to have lower percent sequence identity that those 
chosen from the non-redundant database. Structures were found to align well with the homology 
model all with R.M.S.D. less than or equal to 3.2 Å. For the DALI structures percent sequence 
identity with HPT homology model was not higher than 20% with the exception of E. coli HPT 
protein from BarA (45%) and Shewanella HPT domain (38%). For the itasser HPT homology 
model the flexible N-terminus is found only in two of the DALI structures, that for S. cerevisiae 
Ypd1 (PDB: 5KBX) and that for E. coli HPT protein from BarA (PDB: 3IQT). When searching 
the homology model across the entire Protein Databank Cys883 and Cys892 were found to be 
only partially conserved. Some structures contain both Cys residues at locations identical to that 
of the homology model. Most of the structures contain only one or no conserved Cys residues. 
Clustal omega server was used to align the FASTA sequences from DALI structures with the 
sequence for VarS HPT domain (see figure 12C) [33]. In structures with only one Cys residue it 
was found that the position for Cys892 was more conserved than that for Cys883. The position 
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of key Gly residues as well as hydrophobic, polar, basic and acidic residues near phosphorylated 
His were noted (see figure 12C).  
6.3f. Potential cytoplasmic Cys883/Cys892 disulfide bond does not affect Pz-peptidase activity  
 To investigate if the disulfide bond between Cys883 and Cys892 in VarS could modulate 
the function of VarS Dr. Takehiko Mima at the University of Okayama mutated Cys883 to Ser 
and Pz-peptidase activity of V. alginolyticus mutant was checked compared to the wild type [19]. 
Experiment was performed at the University of Okayama due to our lab not having the proper 
materials for growing mutant V. alginolyticus strains and being closed due to Covid-19. 
Overnight cultures for wild type and mutant V. alginolyticus were incubated with insoluble 
collagen solution to induce expression of Vibrio collagenase [19] [34]. Pz-peptidase activity of 
newly expressed collagenase was measured over 25 hrs. for each culture [19] [22]. V. 
alginolyticus culture containing expression vector with no VarS gene did not express 
collagenase. However, for V. alginolyticus containing expression vector for wild types and 
Cys883Ser mutant Pz-peptidase activity was found to be roughly the same for both (see figure 
13). These results appear to indicate that disulfide bond between Cys883 and Cys892 most likely 
does not exist in native V. alginolyticus and potential Cys883/Cys892 disulfide bond is not 
involved in collagenase expression.   
6.3g. Menadione effects the expression of sRNA2 responsible for Vibrio collagenase expression  
 Results from previous section revealed that disulfide bond between Cys883 and Cys892 
is not necessary for the catalytic mechanism behind phosphate transfer in VarS. However, Cys 
residues may still serve as regulatory sensors for oxidative stress in the cell [35]. To test if 
collagenase expression pathways are turned off in the presence of oxidative stress V. 
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alginolyticus wild type cells were grown by Dr. Takehiko Mima at the University of Okayama as 
previously described and incubated normally or with oxidizing agent (25 mM menadione or 2 
mM H2O2) [19]. qRT-PCR was used to quantify the amount of transcribed sRNA2. Like section 
4.6, experiment was performed at University of Okayama as our lab does not have access to wild 
type V. alginolyticus cells or to a real time PCR detection system. It was found that addition of 
25 mM menadione leads to an approximate 30% down regulation in sRNA2 transcription levels 
while addition of 2 mM H2O2 does not cause any change in sRNA2 transcription (see figure 12). 
Unexpectedly it was also discovered that sRNA2 transcription is turned on for V. alginolyticus in 
just L-broth. More experiments will need to be performed to determine if trace elements in L-
broth are responsible for activating VarS sensor histidine kinase. 
6.3h. Protein disulfide isomerases are not necessary for correctly folding HPT 
The presence of disulfide bonds in the region of VarS that is expected to be in the 
cytoplasm is an unexpected finding. Cytosol in prokaryotes and eukaryotes is a highly reducing 
environment which normally prevents disulfide bond formation [36]. Reducing environment in 
bacterial cytosol is mostly maintained by superoxide dismutase, glutathione peroxidase, 
thioredoxin/thioredoxin reductase pathway and the glutathione/glutaredoxin pathways. Pathways 
most likely evolved to prevent reactive oxygen species (ROS) damage within the cell Superoxide 
dismutase and glutathione peroxidase work to directly reduce ROS to water [37]. Thioredoxin 
and glutathione work to reduce cytosolic protein disulfide bonds from ROS. After reducing 
disulfide bond conserved Cys residues are oxidized and must be reduced by thioredoxin and 
glutaredoxin before they can act on another protein [36].  
While Cys residues can be present in proteins within the reducing cytosol of bacteria 
usually they are involved in oxidative stress repair pathways similar to thioredoxin/thioredoxin 
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reductase and glutathione/glutaredoxin. For some proteins, disulfide bond formation is necessary 
for allowing the protein to fold properyly [38]. Protein disulfide isomerases (PDI) are proteins 
that catalyze the formation of disulfide bonds necessary for proteins secreted into the 
extracellular space [39]. While primarily they exist in the periplasm, some PDIs catalyze the 
formation of disulfide bonds from proteins located in the cytoplasm [40] [41]. Pz-peptidase assay 
for V. alginolyticus Cys883Ser revealed that a potential cytoplasmic disulfide bond between 
Cys883 and Cys892 in VarS is not important for maintaining function to regulate expression of 
collagenase (see figure 13). Since function is maintained for both the wild type and mutant V. 
alginolyticus structure function relationship suggests Cys883 and Cys892 do not form a disulfide 
bond in native V. alginolyticus and PDIs are not needed in folding of the HPT subdomain of 
VarS. It could be that Cys883 and Cys892 may be forming a disulfide bond only in vitro. 
However, it seems unlikely that evolution would allow for VarS to conserve Cys residues that 
play no discernable role in protein function. VarS must have been evolutional pressured to keep 
Cys883 and Cys892 indicating that these residues must play a critical role in the histidine kinase. 
For multiple redox proteins and transcription factors Cys residues serve as oxidative stress 
sensors and lead to promotion of redox processes within the cell [35] [36] [16] [42] [17]. For 
VarS Cys883 and Cys892 may play the same role.  
6.3i. Cys883/Cys892 disulfide bond partially downregulates sRNA2 expression during 
oxidative stress 
Previously it was thought that two component systems and oxidative stress sensing 
pathways are independent events [16]. However, Cys residues, with their high redox sensitivity, 
within sensor histidine kinases could potentially serve as internal oxidative stress sensors [43]. In 
the presence of oxidative stress disulfide bond formation may stop or slow down phosphate 
 
195 
 
transfer in histidine kinase allowing the bacteria to focus more energy towards turning on 
oxidative stress repair pathways. Bacteria using disulfide bonds to sense oxidative stress is not 
without precedent. In S. aureus transcription of arg gene leads to the expression of quorum 
sensing AgrC histidine kinase as well as its response regulator AgrA and the precursor to AgrC 
quorum signal AgrD [44] [45]. ArgA is activated by autoinducing peptide which leads to AgrA 
being phosphorylated. Once phosphorylated, AgrA regulates transcription of genes encoding 
different metabolic factors as well as phenol-soluble modulin (PSM) peptides including 
virulence δ-toxin [16] [42]. PSM peptide expression is controlled by AgrA in an sRNA 
independent manner. It is speculated that AgrA binds directly to δ-toxin promoter region, 
however this has yet to be demonstrated [46]. AgrA also controls the transcription of RNAIII. 
RNAIII is a sRNA that is responsible for controlling the expression of additional virulence 
factors in S. aureus via interactions with rot repressor protein [42]. Molecular simulations 
revealed that in oxidative stress conditions the presence of intramolecular Cys199/Cys228 
disulfide bond present in AgrA prevents the response regulator from interacting with gene for 
coding for RNAIII leading to downregulate of S. aureus virulence factors [16]. Mutation of 
Cys199 to Ser was found to make AgrA more susceptible to oxidative stress (see figure 15) [16]. 
AgrA has been previously shown to downregulate the expression of oxidative stress defense 
enzyme glutathione peroxidase either directly or through RNAIII transcription [47]. In the 
presence of H2O2, AgrA being unable to interact with gene for RNAIII leads to the upregulation 
of glutathione peroxidase making S. aureus more resistant to oxidative stress [16]. Analogous 
Cys199 and Cys228 residues are found to be conserved among AgrA homologs indicating that 
this method for sensing oxidative stress is conserved in some response regulators [16]. 
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In V. cholerae response regulator AphB responsible for the expression of key virulence 
factors also contains key Cys residues that allow the bacteria to respond appropriately to 
oxidative stress conditions [17]. Under oxygen-limiting conditions V. cholerae virulence genes 
are found to be highly expressed [17]. In AphB, Cys235 was found to be the key residue in 
responsible for allowing the protein to respond to oxidative stress. Mutation of Cys235 to Ser 
made AphB active even in highly aerobic conditions [17]. Dimerization is known to be important 
for the activity of AphB and that Cys235Ser mutant was able to form a dimer under both aerobic 
and anaerobic conditions. While oxygen reacting at Cys235 was shown to inhibit dimer 
formation. Liquid chromatography coupled with tandem mass spectrometry revealed that Cys235 
forms a disulfide bond with either Cys76 or Cys94 during aerobic conditions. In the compact 
crystal structure of AphB the distance between the Cαs of Cys235 and Cys94 and Cys235 and 
Cys94 were found to be too large to indicate disulfide bond formation [48]. Currently it is 
unknown how disulfide bond formation may occur in AphB. Addition of DTT to WT AphB was 
found to promote dimer formation and DNA binding activity of AphB [17]. Similar to AgrA 
with gene for glutathione peroxidase, active AphB was found to repress the gene for ohrA which 
encodes for a specific organic peroxide-specific peroxiredoxin by binding directly to promoter 
region [49].     
Similar to S. aureus and V. cholerae, V. alginolyticus most likely encounters oxidative 
stress during the later portions of infection and due to this VarS/VarA two component system 
may have evolved the same catalytic machinery to regulate gene transcription in the presence of 
oxidative stress [49]. While oxidative stress regulation mechanisms are present in response 
regulators AgrA and AphB; response regulator VarA contains only a single Cys residue at 
position 43 and based on AgrA and AphB having multiple Cys residues is likely not involved in 
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oxidative stress-based transcription regulation. It is known that some sensor histidine kinases are 
specifically activated by ROS [50] [51]. However, non ROS activated histidine kinases with 
redox regulatory control motifs are less common. Below we describe a potential mechanism for 
oxidative stress-based transcription regulation in the histidine kinase portion of a two-component 
system. Depending on the stress encountered, bacteria may have evolved different regulation 
mechanisms based on the most encountered stressors for the bacteria.  
DALI results indicate that potential mechanism for gene regulation in the presence of 
oxidative stress may be conserved in some histidine kinase HPT sub-domains. Structure of HPT 
from Shewanella (PDB:3MYF) and HPT from E. coli BarA histidine kinase (PDB:3IQT) show 
that two Cys residues are in the same location as the HPT homology model Cα distance for both 
structures is approximately 11 Å not within the appropriate distance for disulfide bond 
formation. However, piston-like movements common in four helix bundle motifs may position 
the two Cys residues within 2 Å for formation of disulfide bridge [25]. HPT domains from Maize 
(PDB:1WN0), M. truncatula (PDB:3US6) (PDB:4G78) have Cys892 conserved near the HPT 
active site and multiple others clustered nearby all within potential disulfide bond length. 
Location of the specific Cys residues involved in disulfide bond formation may be different for 
each species. For protein with multiple Cys residues SS bonds are not listed. It may be that 
disulfide bond formation is intermolecular and not intramolecular as only Cys892 is highly 
conserved throughout the DALI structures. In R. capsulatus sensor histidine kinase RegB plays a 
role in control of many cellular processes. It is a simple histidine kinase that has evolved an Arg-
Cys-Arg motif downstream from dHp domain that forms an intermolecular disulfide bond in 
oxidizing conditions. Intermolecular disulfide bond converts RegB from active dimer to an 
inactive tetramer [18]. Switch to from dimer to tetramer may disrupt binding interface between 
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CA and dHp domain. Something similar may be occurring for VarS HPT domain where 
intermolecular disulfide bond disrupts binding interface between REC and HPT. More 
experimentation will be needed to determine if disulfide bond is intra or intermolecular.   
For VarS, we speculate that Cys883/Cys892 disulfide bond inhibits phosphate transfer 
similar to how disulfide bond present in AgrA or AphB inhibits DNA binding [16] [17]. In the 
presence of oxidative stress, phosphate transfer may be stopped or slowed by disulfide bond 
formation. Based on comparison with crystal structure of YPD1:SNL1 complex with beryllium 
fluoride and Mg2+ the active site interface between HPT domain and REC consists of 
hydrophobic and hydrophilic interactions from α-helices b, c, d and e from the HPT homology 
model and α-helices a’ and e’ from loop between α-helix e’ and β-sheet E’ and loop between β-
sheet B’ and α-helix b’ from the REC homology model [1]. Intra/intermolecular disulfide bond 
formation between Cys883 and Cys892 may partially disrupt the interface between HPT and 
REC domain which may partially inhibit phosphate transfer between REC and HPT (see figure 
16).  
Partial disruption of the REC:HPT interface would explain the qRT-PCR results where 
transcription of sRNA2 is only partially downregulated when V. alginolyticus culture is 
incubated with 25 μM menadione prior to RNA isolation (see figure 14). The difference in 
sRNA2 transcription after addition of 25 μM menadione or 2 mM H2O2 to V. alginolyticus 
culture may be due to the different lifetimes of their initial redox biproducts. Menadione is a 
quinone that undergoes catalytic electron redox cycling to reduce molecular O2 to superoxide 
anion which has a half-life of 1 to 15 mins. While H2O2 reacts with metals to produce metal or 
hydroxyl radicals which have half-lives of about 10-9 s [52]. In addition to its shorter half-live, 
H2O2 is known to react slowly with free thiols and is driven by the pKa of sulfhydryl group from 
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the thiol [53]. pH of VarS during qRT-PCR experiment is 7.5 which mean that only a small 
portion of sulfhydryl groups are deprotonated. While H2O2 is a stronger oxidizing agent than 
superoxide anion its short half-life may explain its inability to affect sRNA2 transcription in V. 
alginolyticus. 
VarS/VarA two component system directly regulates the transcription of sRNA2. Newly 
transcribed sRNA2 interacts with RNA binding protein CsrA which is bound to mRNA for Col 
A vibrio collagenase. Removal of CsrA allows for the gene encoding Col A collagenase to be 
expressed [3]. Slowing down sRNA2 transcription in the presence of oxidative stress would slow 
down expression of vibrio collagenase and potentially allow for gene for oxidative stress repair 
pathways to be turned on. Currently it is unknown if sRNA2 represses the expression of 
oxidative stress repair enzymes similar to S. aureus with RNAIII and glutathione peroxidase 
[16]. Future experiments would be needed to confirm if this is the case.  
6.4 Conclusion 
For HPT domain, Itasser derived homology model gives a structure that is primarily α-
helical containing the common four helical bundle consistent with all HPT domains. Structural 
comparison of Itasser derived homology model with results from DALI search revealed that 
active site Cys residues close to phosphate accepting His are relatively conserved throughout 
HPT domains. Pz-peptidase assay for VarS Cys883Ser reveals that potential cytoplasmic 
disulfide bond is not necessary for promoting phosphate transfer. Based on the presence of Cys 
in a region of the protein that is cytoplasmic as well as oxidative stress based mechanism for 
shutting off response regulators it is speculated that these residues play a role in allowing VarS to 
sense oxidative stress and stop phosphate transfer/gene transcription in its presence. qRT-PCR 
showed that sRNA2 transcription was only slightly downregulated in the presence of menadione 
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and not affected at all in the presence of H2O2. Further experiments will need to be performed to 
see if this potential oxidative stress gene regulation system is present for VarS. 
For HPT, homology model presents a structure with a flexible N-terminus. Truncation of 
the 20 residue N-terminus may lower entropy of the protein enough so that crystallization 
becomes a spontaneous reaction [29]. To investigate the potential role of active site Cys residues 
for HPT the potential role of sRNA2 in repressing oxidative stress repair pathways will need to 
be determined. For fully active AgrA and AphB response regulators repression of glutathione 
peroxidase and peroxiredoxins was seen. The same correlation may be seen for VarS/VarA two-
component system. To further understand the roles Cys play in sRNA2 transcription qRT-PCR 
expression may need to be repeated with Cys mutated to Ser. Mutating both Cys to Ser would 
prevent disulfide bond formation from occurring in the protein regardless of oxidative stress. For 
wild type VarS, in the presence of 25 μM menadione sRNA2 transcription was downregulated 
however, it is unknown if Cys residues played a role in stopping transcription. If sRNA2 
transcription for the VarS Cys883Ser Cys892Ser in the presence of 25μM menadione is identical 
to the wild type it would reveal that Cys residues are necessary for shutting down sRNA2 
transcription in the presence of oxidative stress. 
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Chapter 6: Figures 
 
  
Figure 1: Crystal structure of Ypd1. Structure for Ypd1 is well known so it is considered a 
model structure for HPT domains. Primary structural motif is the four helix bundle (αB-αC-
αD-αG). Phosphorylated His residue is shown as a stick figure. α-helices A, B, C and D are 
responsible for interacting with the response regulator Sln1. Figure is from Fassler et al. 2013 
[2]. 
.  
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Figure 2: Sequence alignment of RegB with VarS. Phosphate accepting His is in green while RegB 
Cys is in red. Cys present in HPT domain of VarS may play the same role as Cys in RegB. 
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Figure 3: A. SEC results for VarS sensor histidine kinase in buffer without reducing agent. B. 
SEC results for VarS after treatment with TCEP. Shift in elution peaks indicates structural 
change that occurs upon addition of a reducing agent 
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Figure 4: A. SDS PAGE results for TCEP treated VarS SEC fragments. VarS with and 
without TCEP were included as controls. Reducing the protein with TCEP causes it to break 
into 3 bands B. Cartoon representation of explanations for TCEP treated VarS.  
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Figure 5: Mass spectra used to confirm +6 charged disulfide bridged trypsin digest fragments 
691-710/759-795 from VarS.  
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Figure 6: Mass spectra used to confirm +7 charged disulfide bridged trypsin digest fragments 
691-710/759-795 from VarS.  
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Figure 7: Mass spectra used to confirm +3 charged disulfide bridged trypsin digest fragments 
876-887/890-900 from VarS.  
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Figure 8: Mass spectra used to confirm +4 charged disulfide bridged trypsin digest fragments 
876-887/890-900 from VarS.  
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Figure 9: Homology model of REC sub-domain II containing linker region to HPT. Distance 
between Cys697 and Cys789 in the model is approximately 25 Å which is way longer than 
disulfide bond in nature. Position of linker containing Cys789 may not be accurate and it may 
be closer to Cys697. Repositioning linker so that it is closer would bring it closer to the active 
site. Repositioning linker closer to active site would not make sense as it may inhibit 
phosphate transfer. Cys697/Cys789 disulfide bridge may only be present in vitro.   
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Figure 10:  Sequence for cytoplasmic portion of VarS sensor histidine kinase. Cys residues 
and disulfide bridges are denoted. Due to its close proximity to phosphate accepting His 
residue (underlined) the disulfide bond between Cys883 and Cys892 was chosen for further 
study. 
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Figure 11: A. Homology model of VarS HPT domain derived from Itasser. Phosphate 
accepting His is shown in purple while Cys residues are orange. Four helix bundle is 
consistent with HPT domains in other species. B. CD spectrum of wild type HPT domain. 
Minima at 225 nm and 205 nm are consistent with a protein that is primarily α-helical. C. 
Tryptophan emission spectra for wild type HPT. Max at 340 nm indicates that Trp residue at 
N-terminus must be solvent exposed. 
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Figure 12: A. Table summarizing DALI results B. Homology model for HPT superimposed 
with DALI matches C. Sequence alignment of results from B using Clustal omega. Cys 
residues are colored red, key His is blue, key Gly are green, key basic residues are orange, 
key hydrophobic residues are purple and key acidic residues are pink. Cys892 appears to be 
far more conserved Cys883.  
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Figure 13: Pz-peptidase activity for V. alginoltyicus with wild type VarS, C883S VarS and no 
VarS (negative control). Potential cytoplasmic disulfide bridge between Cys883 and Cys892 
does not appear to be necessary for maintaining structure or function of VarS. 
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Figure 14: qRT-PCR experiment was performed to monitor the transcription of sRNA2 
necessary for collagenase expression during normal and oxidative stress conditions. For 
oxidative stress conditions either 2 mM H2O2 or 25 μM Menadione were added to V. 
alginolyticus cultures during incubation. After RNA isolation it was shown that transcription 
was only affected by 25 μM Menadione (transcription downregulated by approximately 
30%). More experiments need to be performed to determine the true effect of oxidative stress 
on collagenase expression. 
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Figure 15: Cartoon representation of results for Sun et al. 2012. Disulfide bond formation 
between Cys199 and Cys228 in AgrA prevents the response regulator from binding to DNA 
which prevents downregulations glutathione peroxidase. Mutation of Cys199 to Ser prevents 
disulfide bond formation and makes S. aureus more susceptible to oxidative stress. 
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Figure 16: Model interface between HPT and REC in VarS. Model was constructed by 
superimposing HPT domain (R.M.S.D. = 4.041 Å) and REC domain (R.M.S.D. = 0.671 Å) 
with YPD1:SLN1 crystal structure (PDB: 2R25) [1]. Disulfide bond formation in HPT may 
be caused by piston-movements. Piston like movement may disrupt the binding interface 
between HPT and REC lowering the rate of phosphate transfer.   
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Chapter 7: Conclusion 
Based on their ability to target and degrade collagen both Col G and Col H are potential 
medical tools of interest. Biomolecules fused to non-catalytic segments of Col G (PKD, CBD1 
and CBD2) and Col H (PKD1, PKD2 and CBD) are non-immunogenic and their ability to heal 
bone fractures and promote hair regrowth in mice is well known [1] [2]. Col G CBD1CBD2s 
ability to wedge between parallel oriented tropocollagens makes it ideal for the localized 
delivery of bFGF while Col H’s lower binding affinity makes it better for promoting systemic 
effects of PTH [1] [3] [4]. Understanding the role of PKD domains in Col H binding may help in 
linker design for fusion proteins [5]. Full-length Col G and Col H have been used to isolate 
pancreatic islets and stem cells for purposes of auto cell transplant [6] [7]. In order to further 
improve Col G for cell isolation, future experiments should focus on strengthening the linker 
region between CBD1 and CBD2. Site directed mutagenesis of Lys residues to Asn or Asp in 
linker region may make the region resistant to trypsin and clostripain. Full-length SAXS derived 
structures for Col G and Col H may help to identify regions in the enzymes that can be 
chemically modified to reduce immune response in patients. Further understanding on how Col 
G and Col H enzymes work together to degrade collagen would help to further their development 
as medical tools.  
 In order to better understand collagenase expression the VarS/VarA two-component 
system from V. alginolyticus was studied. This systems or closely related systems are responsible 
for the expression of virulence factors for all Vibrio species [8] [9] [10] [11]. In two-component 
systems a signal is received which causes the protein to dimerize, following this a phosphate is 
donated from ATP to a conserved His residue in the dHp domain, next the phosphate is passed 
(either in a cis or trans method and through a normal or phosphorelay pathway) to a conserved 
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Asp residue on a response regulator, responsible for transcription and translation of specific 
genes and proteins. In a phosphorelay pathway phosphate passed to His residue in the dHp 
domain is passed through internal REC and HPT domains within the sensor histidine kinase. 
Once phosphate is passed to HPT it is then passed to response regulator like in the normal 
histidine kinase. Response regulator then modulates gene transcription. Solving the crystal 
structure of REC domain from VarS would give a new target for the design of anti-biotics. While 
investigating the potential redox sensing Cys residues in HPT may help to understand how some 
bacteria are able to survive contact with host immune systems. 
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Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Crysol fit file for PKDCBD1CBD2 pCa 3. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 1.16 indicates 
the fit between the two is good. 
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Figure 2: Crysol fit file for PKDCBD1CBD2 pCa 6. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 3.173 indicates 
the fit between the two is good. 
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Figure 3: Crysol fit file for CBD1CBD2:[(POG)10]3. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 21.44 indicates 
the fit between the two could be better (ideally χ2 = 1). Repositioning domains in 
envelope may give a better fit. 
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Figure 4: Crysol fit file for PKDCBD1CBD2:[(POG)10]3. Experimentally derived 
scattering profile is in blue and scattering profile for crystal structure is in purple. The red 
graph is the experimentally derived scattering profile in absolute scale. χ2 value of 6.45 
indicates the fit between the two is good. 
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Figure 5: Crysol fit file for Col G pCa 3. Experimentally derived scattering profile is in 
blue and scattering profile for crystal structure is in purple. The red graph is the 
experimentally derived scattering profile in absolute scale. χ2 value of 111.15 indicates 
the fit between the two could be better. Averaging crystal structures for open and closed 
catalytic domain confirmations may give a better fit. 
 
230 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Crysol fit file for Col G pCa 6. Experimentally derived scattering profile is in 
blue and scattering profile for crystal structure is in purple. The red graph is the 
experimentally derived scattering profile in absolute scale. χ2 value of 11.597 indicates 
the fit between the two is good.  
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Figure 7: Crysol fit file for Col G -∆CBD2 pCa 3. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 163.21 
indicates the fit between the two could be better. Averaging crystal structures for open 
and closed catalytic domain confirmations may give a better fit. 
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Figure 8: Crysol fit file for Col G -∆CBD2 pCa 6. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 210.62 
indicates the fit between the two could be better. Averaging crystal structures for open 
and closed catalytic domain may give a better fit. 
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Figure 9: Crysol fit file for PKD2CBD. Experimentally derived scattering profile is in 
blue and scattering profile for crystal structure is in purple. The red graph is the 
experimentally derived scattering profile in absolute scale. χ2 value of 3.134 indicates the 
fit between the two is good.  
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Figure 10: Crysol fit file for PKD2CBD:[(POG)10]3. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. Fit between experimental 
and theoretical scattering profile appears good however, χ2 value of 972.67 indicates that 
fit could be better.  
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Figure 11: Crysol fit file for PKD2CBD:[(POG)13]3. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 33.432.67 
indicates that fit could be better. Removing bumps in the high s region and recalculating 
may give a better fit.  
 
236 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Crysol fit file for 4 Ser PKD2CBD. Experimentally derived scattering profile 
is in blue and scattering profile for crystal structure is in purple. The red graph is the 
experimentally derived scattering profile in absolute scale. χ2 value of 4.034 indicates that 
fit is good.  
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Figure 12: Crysol fit file for 4 Ser PKD2CBD:[GPRG(POG)13]3. Experimentally derived 
scattering profile is in blue and scattering profile for crystal structure is in purple. The red 
graph is the experimentally derived scattering profile in absolute scale. χ2 value of 12.524 
indicates that fit is good.  
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Figure 13: Crysol fit file for PKD1PKD2CBD. Experimentally derived scattering profile 
is in blue and scattering profile for crystal structure is in purple. The red graph is the 
experimentally derived scattering profile in absolute scale. χ2 value of 4.962 indicates that 
fit is good.  
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Figure 14: Crysol fit file for PKD1PKD2CBD:[GPRG(POG)13]3. Experimentally derived 
scattering profile is in blue and scattering profile for crystal structure is in purple. The red 
graph is the experimentally derived scattering profile in absolute scale. χ2 value of 4.905 
indicates that fit is good.  
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Figure 15: Crysol fit file for 2 Ser PKD1PKD2CBD. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. χ2 value of 13.199 
indicates that fit is good.  
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Figure 16: Crysol fit file for 2 Ser PKD1PKD2CBD:[GPRG(POG)13]3. Experimentally 
derived scattering profile is in blue and scattering profile for crystal structure is in purple. 
The red graph is the experimentally derived scattering profile in absolute scale. χ2 value of 
323.06 indicates that fit between the two could be better. Removing low s region may 
improve fit. 
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Figure 17: Crysol fit file for 6 Ser PKD1PKD2CBD. Experimentally derived scattering 
profile is in blue and scattering profile for crystal structure is in purple. The red graph is 
the experimentally derived scattering profile in absolute scale. While the fit between the 
two appears good χ2 value of 3085.88 indicates that 6 Ser PKD1PKD2CBD data may 
need to be reprocessed 
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Figure 18: Crysol fit file for 6 Ser PKD1PKD2CBD:[GPRG(POG)13]3. Experimentally 
derived scattering profile is in blue and scattering profile for crystal structure is in purple. 
The red graph is the experimentally derived scattering profile in absolute scale. χ2 value of 
11.942 indicates that fit between the two is good. 
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Figure 19: Crysol fit file for full-length Col H. Experimentally derived scattering profile 
is in blue and scattering profile for crystal structure is in purple. The red graph is the 
experimentally derived scattering profile in absolute scale. χ2 value of 321.77 indicates 
that fit between the two could be better. 
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Video 1: High speed AFM video for full-length Col G at physiological Ca2+ 
concentration. Full-length protein is highly dynamic 
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Video 2: High speed AFM video for full-length Col H at physiological Ca2+ 
concentration. Full-length protein is highly dynamic 
